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Units
k 103 m 10-3 1  - 10-6
n 10'9 p 10-12 f - io-15
bp - base pairs kb - kilo base pairs
A Amperes V - Volts
W Watts Ci - Curies
°C - degrees Centigrade g grammes
1 litres m metres
M molar mol - moles
h hours min - minutes
sec seconds rpm  - revolutions per minute
cps counts per second cpm - counts per minute
dpm  - disintegrations per minute
Chemicals /Reagents.
APS ammonium persulphate
ATP adenosine triphosphate
BSA bovine serum albumin
DMF dimethyl formamide
DMS dimethyl sulphate
DNase I - deoxyribonudease I
dNTP
DTT
EDTA
EtBr
EtOH
IPTG
MNNG
MOPS
OPA
PIPES
RHB
SDS
TMED
Tris
deoxynudeoside triphosphate 
dithiothreitol
ethylenediaminetetraacetic add  (disodium salt)
ethidium bromide
ethanol
isopropyl p-D-thiogalactopyranoside 
N-methyl-N'-nitro-N-nitrosoguanidine 
3-[N-morpholino]propanesulphonic add  
o-phthaldialdehyde
piperazine-N,N'-bis[2-ethanesulphonic add] 
resolvase dilution buffer 
sodium dodecyl sulphate 
N^N^N'-tetramethylethylenediam ine 
tris-(hydroxymethyl)aminoethane
Other Terms
Xr - resistance to X. Xs - sensitivity to X.
ori - origin of replication. . FIS - factor for inversion stimulation.
PAGE - polyacrylamide gel electrophoresis.
s.c. (plasmid) - supercoiled. o.c. (plasmid) - open circular.
Mutants of Gin or Cin are identified by the original amino add, the substitution 
made and its position in the protein sequence, e.g. GinMV114 has a methionine 
to valine substitution at position number 114.
Mutants of yb resolvase are denoted by the original amino add , position and 
substitution made, e.g. yb M106C resolvase has a methionine to cysteine 
substitution at amino add  position 106.
Unless stated otherwise, base positions within a (specified) subsite of res are 
indicated by the general term fXnB', where X can be L or R, indicating the left or 
right half of the subsite, respectively; n is the base position, num bered from each 
end of the subsite (as shown in Fig. 3.20); and B is the base being described (i.e. 
A, C, G or C).
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SUMMARY
Tn3 resolvase binds to three subsites within its DNA target, res. Complexes of 
resolvase bound to res can be isolated using non-denaturing polyacrylamide 
electrophoresis (PAGE). Six complexes are generated with Tn3 res and resolvase, 
bu t only three complexes have been reported for the related yb resolution system. 
By varying the conditions used for non-denaturing PAGE it was demonstrated 
that the different methods used were not solely responsible for the observed 
differences in the patterns of complexes produced.
In vivo overexpression of Tn3 resolvase in the presence of several tritiated amino 
acids was used to produce tritiated resolvase. Substantial purification of the 
radiolabelled resolvase was achieved using a method adapted for use with small 
amounts of material, but based on a previously published resolvase purification 
method. The 3H-resolvase sample produced was used, with 32P end-labelled 
DNA fragments, to determine the relative and absolute stoichiometry of the 
protein/D N A  complexes observed for Tn3. Although with res one complex 
(complex 5) was not isolated, the observed results indicate that the stoichiometry 
of the least retarded complex (complex 1) is one resolvase monomer per res site, 
and that this value increases by one monomer per res for each successively more 
retarded complex, to a value of six resolvase monomers per res site for the most 
retarded complex (complex 6). This is consistent with the prediction that each 
subsite of res can be bound by a dimer of resolvase.
A synthetic DNA was used to generate subsite II in isolation from subsites I and 
III. Binding of Tn3 resolvase to subsite II produced two (or sometimes three) 
complexes. The stoichiometry of complexes of subsite II with resolvase was 
consistent with results produced for res, i.e. the first complex had a ratio of one 
monomer of resolvase per DNA site and this value increased by one monomer 
per site for successively more retarded complexes. Synthetic derivatives of a 
subsite II sequence were also produced, with an additional 5 or 10 base pairs (bp) 
of DNA sequence inserted at the subsite centre (named subsite (II + 5) and 
subsite (II + 10), respectively). Tn3 resolvase was shown to bind to these altered 
subsites, but the distribution of complexes produced was different from those for 
subsite II. Complexes of subsite (II + 10) had the same stoichiometry as 
equivalent complexes of subsite II, as did the first two complexes of subsite 
(n + 5). DNase I footprinting and methylation interference analysis of Tn3 
resolvase binding to subsites II, (II + 5) and (n + 10) suggested that the 
protein/D N A  contacts made were equivalent to those made by resolvase binding
to a normal subsite within res. Hence it was concluded that the differences in 
complex formation observed with subsites (II + 5) and (II + 10) are likely to result 
from an alteration of contacts made between resolvase molecules bound at these 
sites.
Binding analysis of several different DNA fragments carrying subsite II or 
subsite (II + 10) was used to show that binding of a monomer or a dimer of Tn3 
resolvase induces a bend at the centre of each subsite. From previous studies it 
seems likely that resolvase monomer-induced bending of DNA is a common 
feature for binding to each subsite of res.
Purified samples of y5 resolvase and of a y8 resolvase mutant, y8 M106C, (both 
supplied by Nigel Grindley) were also used in binding experiments. The amino 
a d d  substitution present in y8 M106C allows the formation of covalently linked 
dimers of resolvase. Comparison of binding of Tn3, y8 and y8 M106C resol vases 
to subsites II, (II + 5) and (II + 10) showed that y8 resolvase binds as a 
predominantly dimeric spedes, and that Tn3 resolvase binds as a predominantly 
monomeric spedes. This comparison also suggested that binding of Tn3 
resolvase to subsite II is co-operative.
A model of Tn3 resolvase binding to res, based on these results, is proposed, in 
which the majority of resolvase is monomeric and occupies the res site in six 
successive steps, each representing binding of a resolvase monomer to one half of 
a subsite, until each subsite is bound by a dimer of resolvase. The subsites are not 
occupied in only one spedfic order, but in a variable order, probably reflecting 
the affinity of resolvase for each target site. It seems likely that resolvase bound 
to one half of a subsite can 'shuffle' between binding positions of res during non­
denaturing PAGE, without complete dissodation of the retarded complex.
A mutagenesis strategy was developed for the production and isolation of 
m utants of Tn3 resolvase capable of directing resolution between isolated subsite 
I elements. Initial attempts to produce such mutants were unsuccessful. A new 
vector for mutagenesis and expression of resolvase was produced and the 
resolution substrates, used to screen for mutants, were improved.
v
Chapter One 
Introduction
1.1 Transposon Tn3.
The transposition mechanism of transposon Tn3 has two distinct steps (Fig. 1.1), 
each directed by a different transposon-encoded protein (reviewed in Ref. 77). 
The tnpA gene product, transposase, mediates intermolecular replicative 
transposition of Tn3, resulting in fusion of the donor and target molecules and 
duplication of the transposon. Although this increases the number of copies of 
the transposon, the number of Tn3-carrying DNA molecules has not been 
increased. Resolvase, the tnpR gene product, can direct recombination between 
specific DNA sites, called res, on each Tn3 element, producing discrete recipient 
and donor DNA molecules, each now carrying a copy of Tn3. The product of 
resolution is a DNA catenane and DNA gyrase is believed to separate the 
interlinked circles in vivo10. The structure of Tn3, its mechanism of transposition 
and the structure of Tn3 res are summarised in Fig. 1.1.
1.2 Prokaryotic Site-specific Recombinases.
Prokaryotic site-specific recombination systems are classified into two 
families4'71'82, based on similarities in the protein sequences (Fig. 1.2), 
recombination site organisation (Fig. 1.3) and reaction mechanisms of the various 
systems (Fig. 1.4). The resolvase and DNA invertase family (to which Tn3 
resolvase belongs) has several members for which in vitro recombination has 
been studied. The most extensively investigated member of the other family is 
the integrase system of bacteriophage X87. This family also includes the 
Saccharomyces cerevisiae 2pm plasmid FLP/FRT inversion system, the 
bacteriophage PI lox/Cre system, the Escherichia coli type I fimbrial phase 
variation system and the XeiC/XerD recombination system (also of E. coli) which 
is required for efficient segregation of the E. coli chromosome and the naturally 
occurring ColEl plasmid (and other related plasmids)4'18'78.
A further subdivision can be made within the resolvase family, based on the type 
of reaction mediated by each system29. Resolvases act on directly repeated sites 
giving resolution (deletion or excision) of the intervening DNA, while the DNA 
invertases act on inverted repeat sites to give, as the name suggests, inversion of 
the DNA sequence in between (Fig. 1.4).
1.3 Tn3 Resolvase and Tn3 res.
Resolution by Tn3 resolvase of a negatively supercoiled plasmid carrying two 
directly repeated res fragments has been demonstrated both in vivo and in 
vitrcflQAb. In vitro resolution of an appropriate supercoiled substrate only requires 
resolvase and one of a number of simple buffering systems, indicating that there
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Figure 1.1. Transposon Tn3.
(a) Structure of Tn3. Terminal inverted repeats (38 bp each) are denoted by 
small arrows. Directions of transcription are as shown.
(b) Replicative Transposition of Tn3. The relative orientation of the Tn3 
elements is indicated by an arrowhead. The transposition step also requires 
DNA polymerase for replication of Tn3, and the resolution step requires 
DNA gyrase to decatenate the products of co-integrate resolution.
(c) Structure of Tn3 res. Subsites I, II and III are indicated by boxes and the 
position of DNA cleavage by resolvase is also shown. An asterisk is used to 
denote positions at which resolvase becomes covalently linked to the DNA. 
All sizes/distances are in base pairs.
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Figure 1.3. Organisation of recombination sites of members of the 
resolvase/invertase family.
Subsites of res are arranged as shown, where subsite I is the crossover site. 
For the inversion sites both the crossover sites {gix or hix: unfilled boxes) 
and accessory (HS-binding) sites {sis: filled boxes) are shown. 
Phosphodiester co-ordinates are defined from the centre of the crossover 
sites. The num ber below each site indicates the co-ordinate of the site 
centre, and the (sub)site name is shown above. Arrowheads denote partial 
inverted repeat sequences within a site. The ends of the recombinase genes 
(i.e. tnpR, gin, hin) are also shown where possible.
B
Resolution
(Fusion)
B
B
Inversion
Figure 1.4. Simple representation of the outcomes of resolution and 
inversion.
(a) resolvase: resolution of a circular substrate carrying directly repeated 
sites, (the reverse reaction is fusion, which resolvase does not normally 
catalyse).
(b) invertase: inversion of a circular substrate carrying inverted repeat sites. 
(See Fig 1.7 and 1.8 for topological details of the specific reactions 
catalysed). Recombination sites are indicated by blank or shaded boxes, 
with arrow heads to show their orientation, defined by sequence 
asymmetry. A and B are sequence markers, e.g. restriction endonuclease 
recognition sites.
is no absolute requirement for other specific factors81. Footprinting and 
methylation protection have been used to demonstrate sequence-specific 
interactions of resolvase with three regions within the res site (these are named 
subsites I, n  and III)41. Fig. 1.3 shows the arrangement of the Tn3 res site, in 
comparison with the recombination sites of some members of the same family. 
The subsites are of unequal length and are unevenly spaced but each has 
imperfect dyad symmetry. UV photofootprinting experiments have shown that 
resolvase binds to res on a supercoiled substrate much as it does to a linear res 
fragm ent15. Band shift analysis of Tn3 resolvase with res produced six discrete 
complexes and such studies suggest that each subsite might be bound by a dimer 
of resolvase7. Tn3 resolvase shows significant homology with other resolvases 
and invertases in the family (Fig. 1.2) and appears to contain two distinct 
structural domains (by partial proteolysis; see section 1.4). A putative 'helix-tum- 
helix' DNA binding motif lies close to the C-terminus59 (Fig. 1.2). Similar motifs 
in X Cro and X repressor have been shown to be responsible for binding of the 
protein to its target DNA sequence, primarily by insertion of one a  helix into the 
major groove of the DNA, to allow sequence-specific protein/D N A  
interactions13'35. Experiments in which the C-terminal region of Tn21 resolvase 
was replaced by that of Tn3 resolvase further support the importance of these 
sequences for DNA binding5.
1.4 y5 Resolvase and y5 res.
Tn3 resolvase and res are very similar to those of the y8 transposable element 
(TnlOOO). Indeed Tn3 and y5 resolvase and res (and those of Tnl and R46) are 
functionally interchangeable19'41'63. Hence many features of the Tn3 resolution 
system are thought to also apply to y8, and vice versa. Footprinting analysis of y8 
resolvase bound to res gives equivalent results to those produced for TnS25. An 
alignment of the DNA sequence of the Tn3 and y5 res sites is shown in Fig. 1.5.
Limited proteolysis of y5 resolvase produces a 43 amino ad d  C-terminal 
fragment and a large N-terminal fragment (of about 140 amino adds)1. Purified 
C-terminal domain has been shown to bind to res, and footprints to the ends of 
each subsite67. Hence it is expected to be primarily responsible for the DNA 
binding activity of resolvase. The N-terminal domain is believed to contain the 
catalytic site1. The crystal structure of the N-terminal domain of y8 resolvase has 
been determined at 2.7 A74. Only one of the four dyad-related dimers observed 
had the two catalytic serine residues at a distance appropriate for cleavage at res 
74. Mutational analysis of y8 resolvase suggests that this is not the dimer 
responsible for binding subsites of res. The active sites in the dimer believed to
2
subsite I
- 3 0  ................. - 2 0 ...................- 1 0  .........................(
T n3 TTTAAGAGAAGTGCAACCQTTCQAAATATTA
) .....................1 0 ...................... 2 0
TAAATTATCAGACATAGTAA
y8 A ...............ATTTT..................... C ........................... ...............A . . G C .  . . C . T A . .
R 46 A .............. ATTTG..................... C ...........................
T n l AG............TTTT........................ C ................G . . .
subsite II
.................... 3 0 ..................... 4 0 ......................5 0 ......................6 0 ....................... 7 0
Tn3 AACGGCTTCGTTTGAGTGTCCATTAAATCGTCATTTTGGCATAATAGACA
y8 . . . A . TGCT. . . AAT...............T ........................A TT.............T T -------- C ...........
R 46 . .T .  . TG . T . . C .A G ...............T ........................ATT............ T T -------- C ...........
Tnl .................................... .................................................................................
subsite m
.................... 8 0 ...................... 9 0 ...................1 0 0  1 1 0 .  .
Tn3 GATGGTGTGTGATATTCGATTTAAGGTACATTTTTATGCGAA
y5 . TG. T _____C .................T ...........G . A.  .  ..................................... C
R46 . CCAC_____C .................T ...........G . A.  .  ..................................... C
Tnl ..........   - ................
Figure 1.5. Sequence of the Tn3 res site.
The Tn3 sequence shown represents nucleotide positions 3074 to 3216 of 
Tn3. Base positions given above the res sites are numbered relative to the 
phosphodiester bond at the centre of the crossover site (subsite I) which is 
marked as position 0 and indicated by a colon (:). Note: this is not the 
position at which resolvase cleaves this DNA strand, but the central point 
around which the 2 bp staggered break is made (see Fig. 1.1).
Subsites of res are denoted by underlining of the relevant sequences. Shown
beneath the Tn3 sequence are the base variations which are found in the y5, 
R46 and Tnl res sites. Sequence identical to Tn3 res is denoted by dots (.). 
Spaces inserted for the purposes of sequence alignment are denoted by a 
dash (-).
bind to each subsite were more than 3 nm apart34. Although the crystals studied 
were produced from intact yb resolvase the C-terminal domain was disordered, 
and so its position could not be determined.
Non-denaturing polyacrylamide gel electrophoresis of binding reactions of res 
w ith resolvase has indicated a potential difference between the Tn3 and yb 
resolution systems, as six protein/DNA complexes are generated for Tn37 but yb 
produces only three28. In vitro recombination of substrates containing wild type 
and m utant res sites suggests that the yb synapse may be more stable than that of 
Tn381.
1.5 The Resolution Reaction.
Resolvase-directed cleavage and strand exchange of res sites occurs at subsite I 
only. A double stranded DNA break is made at the central AT dinudeotide of 
subsite I, creating 2 bp 3’ protruding ends (Fig. 1.1 and 1.6). A 5'-phosphoserine 
bond covalently joins the res site to resolvase (at the active site serine 10 
residue)28'65; the resolvase/DNA bond is broken on re-ligation of the DNA ends 
(Fig. 1.6).
The major product of in vitro intramolecular recombination of two directly 
repeated res sites (on a supercoiled substrate) is a -2 catenane89. It is believed that 
this is also the product of in vivo resolution, and that the DNA rings are 
decatenated by DNA gyrase10. In vitro recombination conditions can also be 
adjusted to allow intramolecular or intermolecular reactions of linear or relaxed 
substrates, but these reactions are ineffitient.
The specificity of the product created by resolution is believed to reflect 
topological selectivity in the resolvase recombination mechanism80. Analysis of 
minor in vitro resolution products, resulting from multiple rounds of strand 
exchange without synapse dissociation, led to the deduction that, during 
resolution, three negative interdomainal DNA nodes (or crossings) are trapped 
between the recombination sites, and that strand exchange proceeds in a right- 
handed sense89'90 (Fig. 1.7). It has been demonstrated that a linkage change, ALk, 
of +4 accompanies conversion of a supercoiled resolution substrate to a -2 
catenane product11. The reverse reaction, resolvase-directed fusion of a -2 
catenane, can occur only at low superhelical densities. A ALk value of -4 has been 
determined for this reaction80. These results are consistent with models of 
synapsis based on plectonemic interwrapping of the res sites (Fig. 1.7), but not 
those involving a solenoidal synapse.(For reviews of Tn3 resolution see Ref. 79 
and 82).
3
Figure 1.6. Events at the crossover sites during catalysis of recombination 
by resolvase.
Resolvase subunits are represented by shaded ovals; the ends of the 
crossover region by inverted black and white arrowheads; the two base 
pairs in the overlap region by vertical lines; and the phosphates that are 
attacked by the resolvase by black diamonds. The DNA strands are shown 
as thick and thin lines, with shading to differentiate the two substrate 
crossover sites. (Adapted from Ref. 82).
Figure 1.7. Two-step synapsis model for resolvase-catalysed recombination.
Resolvase monomers are represented by filled circles; DNA by thin lines; 
and subsites of res by thick lines. Subsites are numbered (I, II, III) as for 
Fig. 1.1.
(a) Binding of resolvase to each res site (a dimer of resolvase at each site).
(b)-(c) Step 1 of synapsis; antiparallel alignment of subsites II and III of res 
by wrapping of subsites around resolvase tetramer 'cores', formed by 
resolvase dimer-dimer interactions.
(c)-(d) Step 2 of synapsis; synapsis of crossover subsites (I) by a third 
resolvase dimer-dimer interaction, to give a recombination proficient 
synapse with three (-) interdomainal nodes between the crossover subsites.
(d)-(e) Cleavage, strand exchange and re-ligation at subsite I (see Fig. 1.6).
(e)-(f) Dissociation of the synaptic structure.
(See Ref. 79 for further details).
1.6 The DNA Invertase Sub-family.
The best characterised members of the invertase family (reviewed in Ref. 23) are 
phage Mu Gin, phage PI Cin and Salmonella typhimurium Hin. Gin is responsible 
for inversion of the G-segment of Mu, altering the expression of tail fibre genes, 
and hence the phage host range. Tail fibre gene expression in phage PI is altered 
by inversion by Cin. In Salmonella typhimurium the expression of flagellin genes is 
switched by Hin-directed inversion of promoter sequences. These invertases are 
functionally complementary61. The recombination sites at which they act (gix, cix 
and hix, respectively) are structurally similar to a single res subsite, i.e. they are 
similar in size and have imperfect dyad symmetry (Fig. 1.3).
1.7 The Inversion Reaction.
In addition to the invertase protein, efficient inversion of a supercoiled DNA 
substrate carrying two inverted repeat sites requires host-encoded FIS, supplied 
in trans, and FIS binding sites (sis) on the DNA molecule36'45. In the absence of 
FIS (or sis) the in vivo rate of inversion is reduced at least 100-fold. Each inversion 
site is believed to bind a dimer of invertase (R. Kahmann; unpublished data). Gin 
is believed to bind to gix in monomer steps (R. Kahmann; unpublished data). The 
C-terminal domain of an invertase is also expected to be largely responsible for 
binding of the invertase to DNA. The inversion sites do not have a central AT 
dinucleotide but the invertase does produce a double stranded 2 bp staggered 
break at the centre of the site and the protein is also linked to the DNA via a 5'- 
phosphoserine bond42 (to the equivalent of serine 10 in resolvase; see Fig. 1.2).
The inversion enhancer complex formed by binding of FIS to sis is believed to 
stabilise the -2 synapse required for recombination between the inversion sites43. 
Strand exchange proceeds by a right handed 180° rotation, giving an unknotted 
product and a linkage change of +437.
Data produced for inversion reactions are consistent with a simple rotation 
model of recombination based on a plectonemically w rapped synapse, 
equivalent to that proposed for resolution by resolvase11/38 (Fig. 1.8). In these 
models subsites II and III of res act as accessory sites, stabilising the required 
synapse, much as the inversion enhancer complex acts during inversion. 
Invertase m utants have been produced which can direct efficient inversion in the 
absence of FIS or sis26'43. Hence the possibility of making mutants of resolvase 
which can direct resolution at subsite I in the absence of subsites II and III is an 
inferred consequence of these comparative models of resolution and inversion.
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1.8 Project Aims.
A long term aim of this work is the production of mutants of resolvase which can 
recombine subsite I sequences without accessory sites. The creation of such 
m utants requires the production of an appropriate resolvase expression vector, to 
act as a mutagenesis target, and of one or more in vivo resolution substrates 
which can be used to screen for the desired recombinase. It is desirable that the 
mutagenesis strategy adopted should be compatible with the generation of 
further mutants of resolvase in the future.
All other objectives arise from the general aim of increasing our understanding of 
the interactions required for binding of resolvase to res, prior to synapsis.
At the outset of this work, interpretation of band shift assay results was based 
upon predictions of the protein and DNA content of each complex. No direct 
evidence had been produced regarding this matter. It was considered 
appropriate to determine the stoichiometry of complexes produced with 
resolvase and res (and other DNA sites, if possible), particularly as several 
m utants of res and resolvase had been categorised according to the number and 
mobility of complexes they generated. We hoped that a combination of protein 
and DNA detection methods could be found which would prove suitable for this, 
and future stoichiometric determinations (e.g. with altered resolvases or DNA 
sites, or for synaptic complexes). Whether or not this was the case the data 
produced would serve as a reference point for other binding analysis.
In order to extend such comparisons to band shifts of 76 resolvase and res, 
another aim was to determine the basis of the differences in complex formation 
observed for the Tn3 and 78 resolution systems.
One further, more general objective was to investigate interactions of resolvase 
w ith a DNA site by the production of altered res sequences. This matter was 
somewhat simplified by considering one subsite of res (subsite II) in isolation.
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Chapter Two
Materials and Methods
2.1 Bacterial Strains.
Most bacterial strains used were derivatives of Escherichia coli K-12. The only 
exception is BL21, an Escherichia coli B derivative. All strains used are listed in 
Table 2.1.
Strain. Genotype. Source.
AB1157 thrl, leu6, hisG4, thil, aralA, proAl, argE3, galK2, 
sup37, xyll5, rat/1, tsx33, str31
AB2463 AB1157, but rec A13 D.J.Sherratt
BL21 hsd, gal W.Studier
BL21(DE3) hsd, gal, (kcl ts 857, indl, Sam7, ini5, lac\jy^-T7 
gene-1)
W.Studier
DS941 AB1157, but recFU3, supEU, tocZAM15, lacfl D.J.Sherratt
EMI DS941, but mulS E.Morrell
JM101 supE, thi, AQac-proAB), [F', traD36, proAB, 
focZAM15, lacfl]
M.R.Boocock
JM109
end A l, recAl, gyrA96, thi, hsdR17 (iv , mk+), 
relAl, supEM, X~, AQac-proAB), [¥', traD36, proAB, 
/acZAM15, lacfl]
Promega
Table 2.1 Bacterial Strains.
2.2 Plasmids.
Plasmids which were used (or constructed) in this work are listed in Table 2.2.
2.3 Synthetic Oligonucleotides.
The oligonucleotides listed below were all synthesised on an Applied Biosystems 
391 PCR-Mate oligonucleotide synthesiser using standard reagents supplied by 
Applied Biosystems or Cruachem Ltd. After synthesis all oligonucleotides were 
deprotected by incubating the glass support in 1 ml of fresh 30% aqueous 
ammonia for 1-2 h at room temperature. The sample was vortexed and the 
supernatant was removed following centrifugation. 1 ml of fresh 30% aqueous 
ammonia was added to the supernatant which was then incubated overnight at 
50 °C in a tightly sealed tube (not Eppendorf tubes). After cooling, the 
deprotected DNA solution was transferred to several Eppendorf tubes, 
ammonium acetate was added to 0.5 M, and the DNA was precipitated with 2 
volumes of ethanol.
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(1) Tn3 subsite II derivatives.
The design and use of these oligonucleotides is further described in Chapters 3 
and 5. Key to sequences:
Tn3 sequences are bounded by (parentheses).
UNDERLINED text denotes subsite II sequence.
ITALICISED text denotes substitutions or insertions.
(a) Subsite II
Two complementary oligonucleotides, producing subsite II on a 50 bp Xba 1/ Pst 
I fragment.
Top strand (IIAXP54):
S’CTAGAfTTGAGTGTCCATTAAATCGTCATTTTGGCATAATAGACACATCG)
CTGCA3'
Bottom strand (IITPX46):
5'G(CGATGTGTCTATTATGCCAAAATGACGATTTAATGGACACTCAA)T3’
(b) Subsite (II + 5)
Two complementary oligonucleotides, producing subsite II with an additional 5 
bp inserted at its centre. Gives a 55 bp Xba 1/ Sal I fragment.
Top strand (+5GXS55):
S’CTAGACTTGAGTGTCCATTAAATCGTCATTTCATTTTGGCATAATAGACAC
ATCG)G3’
Bottom strand (+5TSX55):
S'TCGAaCGATGTGTCTATTATGCCAAAArGAAATGACGATTTAATGGACA
CTCAA)T3'
(c) Subsite (II +10)
Two complementary oligonucleotides, producing subsite II with an additional 10 
bp inserted at its centre. Gives a 58 bp Xba I fragment.
Top strand (5'+10T58):
S'CTAGACTGAGTGTCCATTAAATCGTCATTTATCGTCATTTTGGCATAATAG
ACACATOT3’
Bottom strand (3'+10X58):
5’CT AG A(G ATGTGTCTATTAIGCCAAAAT GACGATAAATGACGATTTAATG 
GACACTCA)T3’
(d) Subsite II (B)
Two complementary oligonucleotides, producing subsite II on a 48 bp Xba I 
fragment.
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Top strand (5WTEX48):
5,CTAGA(TGAGTGTCCATTAAATCGTCATTTTGGCATAATAGACACATC)T3,
Bottom strand (3'WTIIX48):
5'CTAGA(GATGTGTCTATTATGCCAAAATGACGATTTAATGGACACTCA)T3,
(e) Subsite IIBN
Two complementary oligonucleotides, producing subsite II containing a Bgl II 
and an Nsi I restriction site. Gives a 48 bp Xba I fragment.
Top strand (51IBNX48):
5'CTAGA(TGAGTGTCCATTAGATCTTCATTTA7GCATAATAGACACATOT3, 
Bottom strand (3TIBNX48):
5,CTAGA(GATGTGTCTATTATGCATAAATGAAGATCTAATGGACACTCA)T3'
(2) pSelect-1 Mutagenesis Oligonucleotides.
Details of the use of these oligonucleotides is given in Chapter 6.
Key to sequences:
UNDERLINED text denotes changes from target sequence.
Text in ITALICS denotes sequence synthesised using mixed DNA 
precursors, in an attempt to introduce degeneracies.
(a) Ampicillin Repair Oligo (GApr27).
This oligonucleotide contains a four base insertion in the pSelect-1 target 
sequence. When this change is made in pSelect-1 the resultant plasmid gains 
ampicillin resistance. A Pst I site is also introduced by this insertion. 
5’GTTGCCATTGCTGCAGGCATCGTGGTG3’
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(b) Tn3 tnpR Degenerate Oligonucleotide (GXho66).
This 66 bp oligonucleotide was designed to anneal to the Tn3 tnpR sequence 
coding for amino acids M103 to E124 of resolvase. The 6 bases at each end of the 
oligonucleotide were synthesised as normal. A translationally silent base change 
(from tnpR sequence) was produced at the 3' end of the oligonucleotide which 
would create a unique Xho I site in mutagenised tnpR derivatives, allowing easier 
identification of plasmids produced from the mutagenesis protocol. The 
remaining 54 bases were synthesised using nucleotide precursor reagents which 
were contaminated with a small amount of the other three precursors (about 
1.5% of normal concentrations of each). This should produce an average of one 
degeneracy in each full length DNA molecule synthesised31'73. The sequence of 
this oligonucleotide is shown beneath the protein sequence coded.
M G Q M V V T I  L S A V A Q
5'ATG g g g  c a a  a t g  g t g  g t c  a c c  a t c  c t g  t c g  g c t  g t g  g c a  g a g
A E R R R I L E 
GCT GAA CGC CGG AGG ATC CTC GAG3’
2.4 Chemicals.
Chemicals 
General chemicals, biochemicals and 
organic solvents.
Media.
Agarose.
Radiochemicals.
lOx restriction enzyme buffers.
5x ligation buffer.
Deoxynudeotide triphosphates.
2.5 Proteins.
Tn3 resolvase 
y5 resolvase
y5 resolvase mutant, M106C 
Tn21 resolvase
Eco RI restriction endonudease
Source
Aldrich/Sigma, BDH, Fluka, May and 
Baker.
Difco, Oxoid.
BRL, Flowgen.
NEN-DuPont.
BRL, Boehringer Mannheim, Promega. 
BRL.
Promega.
gift from Martin Boocock 
gift from Nigel Grindley (Yale), 
gift from Nigel Grindley (Yale), 
gift from Steve Halford (Bristol), 
gift from Steve Halford (Bristol).
Other DNA restriction and modification enzymes were purchased from Bethesda 
Research Laboratories, Boehringer Mannheim, New England Biolabs, Promega 
and United States Biochemical.
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2.6 General Stock Solutions.
(a) DNA Electrophoresis.
50x TAE: 1210 g Tris, 410 g sodium acetate, 93 g Na2EDTA.2H20,71 ml
glacial acetic acid, made to 5 litres in deionised water, lx  TAE should be pH 8.2.
lOx TBE: 109 g Tris, 55 g boric acid, 9.3 g N a2EDTA.2H20 , m ade to 1 litre in
deionised water. Gives pH 8.3.
5x "single colony" final sample buffer: 10% ficoll, 5% SDS, 0.05% bromophenol
blue, 0.25% orange G in lx  TAE. Diluted 5-fold in lx  TAE and RNase A added to 
10 (ig/m l (pretreated by boiling for 10 min to inactivate DNase) for lx  stock.
Final Sample (loading) Buffer: 10% ficoll, 0.5% SDS, 0.05% bromophenol blue,
0.25% orange G in lx  TAE.
4x K mix: 25% sucrose, 0.2 m g/m l protease K, 0.01% bromophenol blue in
deionised water. Only for use in agarose gel electrophoresis.
(b) Protein Electrophoresis.
lOx Laemmli gel buffer: 30 g Tris, 144 g glycine, 10 g SDS, made to 1 litre in
deionised water.
(c) In vitro DNA manipulation.
restriction digest buffers: lOx stocks as recommended (and supplied) for each 
restriction enzyme; stored at -20 °C. Appropriate restriction digest buffers were 
used for Klenow polymerase and CIP treatment.
5x KGB: 0.5 M potassium glutamate, 125 mM Tris-acetate (pH 7.6), 50 mM
magnesium acetate, 250 jig/m l BSA, 2.5 mM 2-mercaptoethanol. Stock was filter 
sterilised and stored at -20 °C.
5x ligase buffer: BRL, stored at -20 °C.
lOx TE: 0.1 M Tris.HCl (pH 8.0), 10 mM EDTA, in deionised water.
(d) Other Stocks.
Phenol: Buffered against 0.5 M Tris.HCl (pH 8.0). Contained 0.1% 8-
hydroxyquinoline.
2.7 Conditions for Escherichia coli Growth and Selection.
(a) Media.
L-Broth: 10 g bacto-tryptone, 5 g bacto-yeast extract, 5 g NaCl, made to 1
10
litre in deionised water, adjusted to pH 7.5 with NaOH. Where required, 
supplemented with 0.2% glucose.
L-Agar: L-Broth with 15 g/1 agar.
2x YT Broth: 16 g bacto-tryptone, 10 g bacto-yeast extract, 5 g NaCl, made to 1 
litre in deionised water, adjusted to pH 7.0 with NaOH.
MacConkey Agar: 40 g/1 MacConkey agar base (Difco), 1% appropriate sugar 
(in this case galactose) in deionised water.
4x Davis and Mingioli salts (D&M salts): 500 ml deionised water, 28 g
K2HPO4.3H2 0 ,8 g KH2PO4, 4 g (NH4)2S04 , 1 g tri-sodium citrate.2H20 , 0.4 g 
MgS0 4 .7H 20 , made to 1 litre with deionised water.
lOx M9 salts: 128 g Na2HP0 4 .7H20 , 30 g KH2PO4, 10 g N H 4CI, 5 g NaCl,
2.5 g MgS0 4 .7H20 , made to 1 litre with deionised water.
lOx M63 salts: 136 g K2HPO4.3H20 , 20 g (NH4)2S0 4/ 5 g FeS04.7H20 , 2 g
MgS0 4 .7H20 , made to 1 litre with deionised water.
Minimal Broth: D&M, M9 or M63 salts diluted in sterilised deionised water,
to give lx  concentration. Supplemented with 5 pg /m l thiamine (vitamin Bi), an 
appropriate carbon source (generally 0.2% glucose), and amino acids if required 
(at 40 pg/m l).
Minimal Agar: As for minimal broth but with the addition of 1.5% agar.
Phage Buffer: 7 g K2HPO4.3H20 , 3 g KH2P 0 4/ 5 g NaCl, 0.25 g
MgS0 4 .7H20 / 15 mg CaCl2.2H20 , 1 ml 1% gelatin, made to 1 litre in deionised 
water.
Tetrazolium Agar: 25.5 g Antibiotic Medium 2 (Difco), 50 mg 2,3,5-triphenyl- 
2H-tetrazolium chloride, 950 ml deionised water. Supplement with 50 ml of a 
20% sugar solution. Rehydrated Difco Antibiotic Medium 2 contains 1.5 g/1 
bacto-beef extract, 3.0 g/1 bacto-yeast extract, 6.0 g/1 bacto-peptone and 15.0 g/1 
bacto-agar.
Prior to the addition of supplements growth media were sterilised at 120 °C for 
15 min and minimal salts at 120 °C for 20 min. CaCl2 was sterilised at 114 °C for 
10 m in and other supplements at 108 °C for 10 min.
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(b) Indicators.
X-gal (5-bromo-4-chloro-3-indolyl-p-galactoside): used (at 20 to 40 |ig /m l in solid 
growth medium) to test for expression of the a  subunit of lacZ from derivatives 
of pUC18 (or pSelect-1) in DS941. Blue colonies are formed by lacZ expressing 
cells which can cleave X-gal, to give a blue product. The colourless X-gal is not 
cleaved by lacZ" cells which give white colonies. Stock X-gal (40 m g/m l in DMF) 
was stored at -20 °C.
The indicators used in MacConkey medium and Tetrazolium medium both 
respond to the pH of colonies grown on the plates. These are discussed further in 
Chapter 6. Tetrazolium Chloride 1% solution (in deionised water) was stored at 
4 °C.
(c) Antibiotics.
The following concentrations of antibiotics were used for both liquid and solid 
selective media.
Antibiotic Stock Solution Selective Conditions
Streptomycin (Str) 10 m g/m l in H2O 100 (ig/m l
Ampicillin (Ap) * 5 mg /m l in H2O 50 |xg/ml
Tetracycline (Tc) 1 m g/m l in 10 mM HC1 10 pg /m l
Chloramphenicol (Cm) 2.5 m g/m l in Ethanol 25 |ig /m l
Kanamycin (Kn) 5 m g/m l in H2O 50 ^g /m l
Table 2.3 Antibiotics.
*: For production of Tn3 resolvase from JM101 pMA6111 ampicillin was used at 
a final concentration of 100 (ig/ml.
Stock solutions were stored at 4°C. For agar plates, molten agar was stabilised at 
between 50 °C and 60 °C prior to the addition of antibiotic.
(d) Growth Conditions.
Liquid cultures were grown at 37 °C with vigorous shaking. Growth on agar 
plates was at 37 °C for at least 12 h, with plates inverted. Antibiotics, indicators 
and inducers were used as required. Bacterial strains to be stored were grown 
overnight in L-Broth and diluted 2-fold with 40% glycerol, 2% peptone prior to 
storage at -70 °C.
(e) Induction.
Induction of expression from IPTG-indudble promoters was generally produced 
by the addition of IPTG at 0.1 - 0.5 mM final concentration, to the appropriate 
media. IPTG stocks (100 mM in deionised water) were stored at -20 °C
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2.8 Plasmid DNA Preparation.
(1) Large Scale DNA Purification.
The method used is derived from that of Bimboim and Doly9.
Solution B.D.#1 50 mM glucose, 25 mM Tris.HCl pH  8.0,10 mM EDTA.
Solution B.D.^2 0.2 M NaOH, 1.0% SDS (made freshly).
Solution B.D.#3 0.6 vol 5M CH3COOK, 0.115 vol CH3COOH, 0.285 vol H20 .
L-broth (200 ml), with appropriate antibiotics, was inoculated with plasmid- 
containing cells and incubated at 37 °C, with vigorous shaking, for approximately 
12 h (or until stationary phase is reached). The cells were harvested by 
centrifugation (12,400g, 5 min, 4 °C). The cell pellet can be stored at -20 °C for 
several weeks. The pellet was resuspended in  4 ml of B.D.#1 by mixing for 5 min 
at 0°C. 8 ml B.D.#2 was added, the sample was mixed by gentle inversion and 
then cooled for 4 min on ice. 6 ml cold B.D.^3 was added and the solution was 
mixed with cooling. The plasmid DNA solution was separated from the cell 
debris by centrifugation (39,200g for 30 min a t 4 °C, stopped without braking). 
Each supernatant was poured into 12 ml isopropanol and the DNA was 
precipitated for about 15 min at room temperature. The precipitated material was 
pelleted by centrifugation (27,200g, 10 to 30 m in at 20 °C). The pellet was washed 
with 70% ethanol, vacuum dried and resuspended in 2.09 ml of lx  TE buffer to 
allow further purification by CsCl/EtBr gradient ultracentrifugation. 5 g of CsCl 
was dissolved in 3 ml H20  and then mixed with the DNA solution. 270 pi of 
15 m g/m l ethidium bromide was added and the solution was placed in an 
ultracentrifugation tube. The tubes were placed in a Beckman Ti70 fixed angle 
rotor and spun at 200,000g for 16 h at 25 °C. DNA bands were visualised using a 
long wave UV source (365 nm). Generally two bands were visible, the upper 
containing chromosomal and nicked plasmid DNA, the lower containing the 
desired supercoiled plasmid DNA. The lower band was removed using a 1 ml 
syringe and the ethidium bromide removed by repeated extraction with 0.5 vol. 
butanol. In some cases the DNA was then dialysed twice in lx  TE. Alternatively 
the solution was diluted four fold with H20 ,  then ethanol precipitated, dried and 
resuspended in lx  TE buffer.
(2) Small Scale DNA Preparation.
An Eppendorf microcentrifuge was used for all centrifugation steps described in 
the following protocols.
(i) Alkaline Lysis Mini-prep.
This method is adapted from the above large scale prep, and uses the same 
B.D.^1, B.D.#2 and B.D.^3 solutions.
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Colonies picked from plates were used to inoculate 5 ml of 2x YT broth (with 
antibiotics). The cultures were grown (37 °C with shaking) to stationary phase 
(normally overnight). 1.5 ml of culture was harvested by centrifugation (14,000 
rpm  for 30 sec ) and the supernatant removed. The cell pellet was resuspended in 
100 pi of cold B.D.^1 and incubated for 5 min at room temperature. Next 200 pi 
of B.D.#2 was added and mixed, then placed on ice for 5 min. 150 pi of cold 
B.D.#3 was added and the solution was mixed gently on ice for 5 min. Cell 
debris was pelleted by centrifugation (14,000 rpm for 5 min) and the supernatant 
was transferred to an equal volume of 1:1 phenol/chloroform. This was mixed by 
vortexing and the phases separated by centrifugation (14,000 rpm  for > 2 min). 
The aqueous (upper) phase was transferred to 2.5 vols. ethanol and incubated at 
room temperature for > 2 min to allow the nucleic acid to precipitate. The 
precipitate was pelleted by centrifugation (14,000 rpm for 5 min) and the pellet 
was washed with 1 ml of 70% ethanol. The pellet was dried (5 min at room temp) 
and then resuspended in 30 to 50 pi of lx  TE.
(ii) STET preparation (adapted from Holmes and Quigley32).
STET b uffer: 8% sucrose, 5% Triton X-100,50 mM EDTA, 50 mM Tris.HCl pH 8.0 
Cells were grown to stationary phase in 10 ml L-broth (37 °C with shaking) with 
selection. Cultures were harvested by centrifugation (14,000 rpm  for 10 min) and 
the pellets resuspended in 700 pi of STET buffer and 50 pi of a 10 m g/m l 
lysozyme solution was added. The samples were boiled for 45 sec and then 
centrifuged (14,000 rpm  for 15 min at 4 °C). The pelleted cell debris was removed 
using a toothpick and the remaining supernatant was extracted once with an 
equal volume of phenol and twice with equal volumes of chloroform (taking the 
aqueous phase in each case). The solution was then mixed with 1 vol isopropanol 
and incubated for 15 min at room temperature. The nucleic acid precipitate was 
pelleted by centrifugation (14,000 rpm  for 15 min) and the pellet was dried at 
room temperature before being resuspended in 50 pi of lx  TE.
2.9 Bacterial Transformation w ith Plasmid DNA.
(1) High Efficiency Transformation Using Rubidium Chloride.
(a) Preparation of Competent Cells.
'F b ro th : 2% w /v  tryptone, 0.5% w /v  yeast extract, 20 mM MgSC>4, 10 mM
NaCl, 5 mM KC1, adjusted to pH 7.5 with KOH.
T F B I: 30 mM KOAc, 100 mM RbCl, 10 mM CaCl2, 50 mM MnCl2 /15%
v /v  glycerol, adjusted to pH 5.8 with 0.2 M AcOH
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TFB II: 10 mM MOPS (or 10 mM PIPES), 75 mM CaCl2, 10 mM RbCl, 15%
v /v  glycerol, adjusted to pH 6.8 w ith 0.1 M HC1 or KOH as 
required.
TFB I and TFB II were filter sterilised.
4 ml of stationary culture, grown in 20 ml of broth was added to 200 ml 
prewarmed broth in a large flask. The culture was grown to give OD600 = 0.46 
to 0.6. The cells were rapidly cooled and then harvested by centrifugation (3,840g 
for 10 min at 4 °C). The pellet was gently resuspended in 40 ml of cold TFB I and 
then placed on ice for 30 min. The cells were repelleted by centrifugation (3,840g 
for 10 min at 4 °C) and resuspended in 8 ml of cold TFB II, then placed on ice for 
15 min. 200 pi aliquots of cells were then dispensed to prechilled 1.5 ml 
Eppendorf tubes which were then capped and placed in liquid nitrogen to freeze 
the cell suspension. The aliquots of frozen cells were stored at -70 °C.
(b) Transformation Procedure.
Aliquots of competent cells were allowed to thaw on ice. Once thawed 50 pi of 
cells was added to <i 10 pi of plasmid DNA in lx  TE. The samples were heat 
shocked, i.e. 5 min at 37°C (or 2 min at 42 °C) then cooled to 0 °C. 5 vols. of 2x YT 
were added and the samples were incubated at 37 °C for 1 h, before plating the 
cells on selective media and incubating at 37 °C overnight.
(2) Transformation Using Calcium Chloride.
(a) Preparation of Competent Cells.
1 ml of stationary culture, grown in 2.5 ml L-broth, was diluted 20 fold in fresh L- 
broth. This culture was grown at 37 °C with shaking to give A600nm of 0.4 to 0.5. 
The cells were harvested by centrifugation (12,100g, 1 min, 4 °C) and 
resuspended in 10 ml of cold 50 mM CaCl2. The cells were repelleted (12,1 OOg,
1 min, 4 °C) and resuspended in 1 ml of cold 50 mM CaCl2. At this point 15% v /v  
glycerol was mixed with the cells which were then dispensed to 200 pi aliquots 
and stored at -70 °C. However, if the cells were required within 48 h then the cells 
were kept on ice (for at least 30 min) until needed.
(b) Transformation.
200 pi of competent cells (kept or thawed on ice) was mixed with < 50 pi of DNA 
in lx  TE. The sample was incubated on ice for 15 min prior to heat shock (5 min 
at 37 °C, or 2 min at 42 °C) and then returned to ice for another 15 min. 200 pi L- 
broth was added and the sample was incubated at 37 °C for 60 min. 50 to 100 pi of 
culture was spread on selective plates and grown overnight.
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Note : The incubation step prior to plating of the transformation mixture is to 
allow expression of plasmid-encoded resistance genes, required for growth 
under the selective conditions. As ampicillin does not directly prevent this gene 
expression, transformants being selected just by ampicillin resistance can be 
plated directly after the second cooling of the heat shock step.
2.10 Restriction Endonuclease Digestion of DNA.
Restriction digests generally used a 2-fold to 10-fold excess of enzyme to ensure 
complete cleavage of the DNA. Digests were incubated at the suppliers' 
recommended temperature for >1 h and were terminated by the addition of a 
loading buffer, or by heating (>70 °C), or phenol extraction. The buffer used for 
digests was either that suggested by the supplier or an appropriate concentration 
of KGB buffer54. KGB was mainly used where more than one restriction 
endonuclease was included in a digest.
Partial restriction digests were produced using dilutions of stock enzyme. An 
appropriate level of DNA cleavage was determined prior to digesting large 
amounts of purified plasmid DNA.
2.11 Calf Intestinal Phosphatase (CIP) Treatment of DNA.
Approximately 0.5 units of CIP was added to some restriction digests (to remove 
5' phosphate groups from linearised DNA fragments) to prevent ligation of 
certain fragments to each other, or themselves. The digests were then incubated 
for 15 min further at 37 °C. CIP was then separated from the sample by organic 
extraction, or by electrophoresis and recovery of the DNA fragment.
2.12 Filling of 3' Recessed DNA Fragment Ends.
Digested DNA was incubated at room temperature in KGB buffer (l.Ox, 1.5x or 
2.0x) with 100 pM each of dATP, dCTP, dGTP and dTTP, and 2 units of Klenow 
fragment of DNA polymerase I, in a total volume of 25 pi. The reaction was 
stopped after 15 to 30 min by heating the sample to 70 °C for 5 min.
2.13 5' Phosphorylation of Oligonucleotides.
T4 polynucleotide kinase was used to phosphorylate oligonucleotides as 
described in the 'Altered Sites' technical manual62.
2.14 Ligation of DNA Fragments.
DNA fragments (1-2 pg) were ligated (normally in a volume of 10 pi) in lx  BRL 
ligation buffer with 1 unit of T4 DNA ligase. Samples were incubated at 16 °C 
overnight, or for 2-4 h at room temperature. Aliquots (~3pl) of the ligation mix
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were used to transform competent cells. If more DNA was used then reactions 
were scaled up accordingly. The ratio of insert to vector was (very roughly) 3:1 
for 'sticky end' ligations and 10:1 for blunt end ligations.
2.15 DNA Precipitation.
Where necessary the salt concentration of the DNA solution was made to 0.3 M 
with sodium acetate. 2 vols EtOH were added and the sample was mixed and 
incubated at 0°C or -20 °C for >15 min (sometimes overnight). The precipitated 
material was pelleted by centrifugation. The pellet was rinsed with 70% EtOH 
and dried prior to further manipulation.
2.16 Gel Electrophoresis
(1) Agarose Gels.
0.7-1.5% agarose gels were produced by dissolving agarose powder in lx  TAE by 
boiling (steam bath or microwave oven). The solution was allowed to cool to 
about 60 °C before pouring it into a gel former, and leaving to set at room 
temperature.
(a) Purified DNA samples.
Isolated plasmid DNA, restriction digest products and recombination products 
were analysed using submerged horizontal lx  TAE gels. The most commonly 
used gels were >15 cm long and were run overnight at about 1.5 V/cm.
(b) 'Single colony' samples.
A single colony was patched to a fresh plate (patches >1 cm2). After overnight 
growth a sterilised toothpick was used to scrape the cells from the plate to 100- 
150 pi of 'single colony7 final sample buffer. After mixing, the sample was 
incubated at room temperature for 15 min and then spun in a microcentrifuge 
(full speed) for 30 min. Avoiding the sticky pellet, 30-50 pi of supernatant was 
loaded on to a 1.2% agarose gel which was placed in, but not under, lx  TAE 
buffer. Once all the samples were loaded electrophoresis was started (50-80 V). 
Once the samples had been given time to enter the gel (separation of the two dye 
bands was used to indicate this) lx  TAE was added to submerge the gel. 
Electrophoresis was then completed as for other agarose gels.
(2) Polyacrylamide Gels
(a) Non-denaturing Polyacrylamide Gels for DNA Analysis.
These gels were mostly used for restriction analysis of plasmid constructs but
were also used for purifying small double stranded DNA fragments. The
concentration of acrylamide used varied with the size of fragments being run.
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Acrylamide 
[% (w/v)]
Effective Range of 
Separation (bp)
3.5 1,000 - 2,000
5.0 80 - 500
8.0 60-400
12.0 40 - 200
15.0 25 -150
20.0 6-100
Table 2.4 Effective Range of Separation of Double Stranded DNA on 
Polyacrylamide Gels.
A number of different sized vertical gel kits were used, commonly with 0.75 mm 
spacers. These gels were sealed around the edges with plastic tubing, which was 
clamped between the gel plates. The acrylamide gel mix was poured between the 
plates and left to set at room temperature after the insertion of a well former. 
Once the gel was set, the clamps and tubing were removed and the formed gel 
was clamped into the gel kit. Buffer was generally added before removing the 
well former. The gels were run at room temperature in lx  TBE at a constant 
voltage, normally between 100 and 200 V. Depending on the material rim, the 
gels were ethidium bromide-stained, silver-stained, or bands were visualised by 
autoradiography of the wet gel.
The different sized kits used required 10,30 or 45 ml of acrylamide mix. The 
following recipe for a 30 ml gel was directly adjusted for other gel volumes.
Reagent Volume Added
30% acrylam ide: 0.8% 
bisacrylamide (w /v)
Xm l
lOxTBE 3 ml
h 2o (27 - X) ml
10% APS (w /v) 360 pi
TMED 18 pi
Table 2.5 Components of an X% (w/v) Polyacrylamide Gel (for DNA).
(b) Non-denaturing Polyacrylamide Gels for Analysis of DN A/Protein 
Complexes.
These gels were used to separate protein/D NA complexes. The most frequently 
used type of gel was a 6% polyacrylamide, 50 mM Tris.Glycine pH  9.4,0.1 mM 
EDTA gel (called TG 9.4), e.g.1 Table 2.6 shows the components for 30 ml of TG
9.4 gel mix.
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Reagent Volume Added
30% acrylamide: 0.8% 
bisacrylamide (w /v)
6 ml
0.5 M Tris.Glycine pH 9.4 3 ml
0.2 M EDTA 15 pi
h 2o 20.5 ml
10% APS (w /v) 360 pi
TMED 18 Ml
Table 2.6 Components of a 6% (w/v) Polyacrylamide Gel (TG 9.4).
Other gel buffers used were 10 mM Tris.HCl pH  8.2,0.1 mM EDTA (called TH 
8.2) and 0.5x TBE. After setting the gels were placed in the appropriate buffer 
and prerun at 200 V constant voltage at 4 °C for 60 to 90 min. Samples were 
loaded with the gel running at 100 V constant voltage and after loading, the gels 
were run at 200 V constant voltage for 3 to 4 h. The method of detecting bands 
was, again, dependent on the nature of the material run. For binding experiments 
using small amounts of 32P end-labelled DNA, the gels were transferred to three 
layers of 3 MM filter paper and dried under vacuum (80 °C for 45 - 60 m in ). The 
DNA bands were then visualised by autoradiography of a sheet of Kodak XS1 or 
Fuji RX100 film. Large scale band shift assays were either EtBr- or silver-stained.
(c) Denaturing Polyacrylamide Gels for DNA.
This type of gel was used for plasmid sequencing, purification of synthetic single 
stranded oligonucleotides, DNase I footprinting and methylation interference 
analysis. The products of plasmid sequencing, DNase I footprinting and 
methylation interference experiments were all analysed using an IBI Base Runner 
sequencing gel kit. All the gels used contained 0.5 g /m l urea and lx  TBE. The 
acrylamide used was a 40% (w /v) stock solution containing a 19:1 ratio of 
acrylamide to bisacrylamide. Gels were prerun in lx  TBE running buffer for 15 to 
60 m in to allow the desired temperature (55 °C) to be achieved (this prevents 
renaturation, and anomalous migration of the single stranded DNA). Other 
variant features of the gels used are summarised in Table 2.7.
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Plasmid
Sequencing.
DNase I 
Footprinting.
Methylation
Interference.
Gel Thickness. 0.2 mm 0.2-0.4 mm wedge 0.2 mm
Gel Length 45 cm 60 cm 45 cm
% Acrylamide 8% 8% 20%
Power 45 W 55 W 45 W
Run Time 1-2 h 2-3 h ~4 h
Table 2.7 Features of 'Sequencing Type' Polyacrylamide Gels Used.
After running, these gels were fixed in 10% acetic acid and dried under vacuum. 
Bands were visualised by autoradiography.
Polyacrylamide gels used for purification of synthetic oligonucleotides also 
contained urea as a denaturant. These gels were used as described in Sambrook 
et al73.
(d) Denaturing Polyacrylamide Gels for Proteins (Laemmli gels).
The protein SDS-PAGE system used was that of Laemmli48.
(3) Staining of Gels.
(a) Ethidium Bromide Staining of DNA.
All agarose and some polyacrylamide DNA gels (and some large scale band shift 
gels) were stained by soaking for 20-30 min in a solution of 0.6 |ig /m l EtBr in 
running buffer (or water). The gels were then destained by soaking in water for 2 
x 10 min. Bands were visualised by exposure to a 254 nm  UV source. Where 
DNA was to be isolated for further manipulation (e.g. for cloning) a longer wave 
length UV source (365 nm) was used to reduce photochemical damage of the 
DNA sample.
(b) Coomassie Staining of Proteins.
Some Laemmli gels were stained by soaking in a solution of 1% Coomassie Blue, 
50% MeOH, 10% AcOH for 1-1.5 h with shaking, followed by destaining in 10% 
MeOH, 10% AcOH as required.
(c) Silver Staining of Protein and /o r DNA.
Some Laemmli gels and non-denaturing DNA polyacrylamide gels were stained 
using this method. Most of the large scale band shift assays described (Chapters 3 
and 5) were also stained this way.
Solution A: 0.2 g/1 silver nitrate in deionised water.
Solution B: 4.2 ml 1.8% NaOH, 1.4 ml 30% aqueous ammonia.
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Solution C: Drop-wise addition of 4 ml Soln. A to Soln. B, with stirring (use
within 5 min of preparing).
Solution D: 2.5 ml 1% citric add, 0.25 ml 38% formaldehyde, made to 0.51 with 
deionised water.
The gel was soaked, with shaking, in 50% MeOH for 1 h  and then placed in Soln. 
C for 15 min. Next the gel was washed in deionised water for 5 min and then 
placed in Soln. D until bands had developed sufficiently (about 10 min). The 
reaction was stopped by transferring the gel to a 10% acetic ad d  solution for 10- 
20 min. After washing in deionised water, the gel was photographed and then 
dried under vacuum.
(d) 'Stains-All' Staining of Synthetic Oligonudeotides.
'Stains -all' (l-ethyl-2-[3-(l-ethylnaphtho[l,2-d]thiazolin-2-ylidene)-2- 
methylpropenyl]naphtho [1,2-rf] thiazolium bromide; from Aldrich) is a cationic 
carbocyanine dye which can be used for staining of DNA, RNA or protein 
analysed by PAGE. Protein, RNA, double stranded DNA, and single stranded 
DNA all stain differently with 'Stains-all1.
70 ml water and 20 ml isopropanol were mixed with 10 ml of a 0.1% (w /v) 
solution of 'Stains-all' (in formamide). The gel was soaked in this solution until 
suffident staining was observed (5-20 min). The gel was then destained in water 
as necessary. Single stranded DNA oligonudeotides gave cyan or purple bands, 
depending on their size (smaller molecules stained cyan, larger molecules stained 
purple). This is a suitable method of staining for DNA which is to be extracted 
after electrophoresis, as the gel is not exposed to a UV source.
(4) Photography.
All gels were photographed using Polaroid type 667 Land film or a Pentax 35 
mm SLR camera loaded with Ilford HP5 or Pan F film. EtBr-stained gels were 
photographed under illumination from a 254 nm UV source, w ith a Kodak 
W ratten filter No.23A on the camera. Coomassie-stained and silver-stained gels 
were photographed on a fluorescent light box.
2.17 Extraction of DNA After Electrophoresis.
(a) Agarose Gels.
EtBr-stained DNA bands were visualised using a long wave UV source (365 nm) 
and cut from the gel w ith a scalpel. The DNA was extracted using the 
centrifugation method of Heery et al.30. The DNA produced was purified by 
phenol extraction and EtOH precipitation, before further manipulation.
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(b) Polyacrylamide Gels.
(1) Synthetic Oligonucleotide Purification.
Oligonucleotide purification from denaturing polyacrylamide gels was as 
described in Sambrook et al7$, except that bands were visualised using 'Stains- 
all' (see section) 2.16 part 3d).
(2) Double Stranded DNA Purification.
After staining, bands were cut from the gel using a scalpel. DNA was then eluted 
by the 'crush and soak' method of Maxam and Gilbert53.
2.18 End-labelling of DNA fragments.
The DNA fragment to be labelled was produced as a restriction digest product 
with at least 1 3' recessed end. Most labelling reactions were in a volume of 20 |il, 
containing 1-2 pg of linear DNA, three unlabelled dNTP’s (each at 10 pM final), 
one a (32P)dNTP (at 5 pCi per pmol of DNA ends to label) 1 unit of Klenow 
fragment of DNA polymerase I and appropriate buffer. As DNA was often 
added directly from a restriction digest buffers used were 1.5x KGB, lx  BRL 
REact2, lx  BRL REact4 or 0.5x BRL REact3. The sample was incubated at room 
temperature for 15-20 min before adding 1 pi of 1 mM dNTP stock (unlabelled 
dATP, dCTP, dGTP and dTTP at 1 mM each), followed by 10 pi of 0.2 M EDTA to 
stop the reaction. Labelled DNA was separated from enzymes and 
unincorporated dNTP by phenol extraction and EtOH precipitation or by gel 
electrophoresis and elution of the desired DNA band.
2.19 Band Shift Analysis (Gel Binding Assays).
Dilutions of Tn3, Tn21, y8 and y8 M106C resolvases were made at 0 °C with lx  
resolvase dilution buffer [1 M NaCl, 10 mM Tris.HCl pH 7.5,0.2 mM EDTA, 50% 
glycerol (v/v)]. Dilutions were stored at -20 °C. Some dilutions of Tn3 resolvase 
were made in 1 M NaCl, 50 mM Tris.HCl pH 8.2,0.1 mM EDTA, and were stored 
on ice for up to 1 week.
Binding Buffers:
2x TG 9.4: 20 mM Tris.glydne pH 9.4,0.2 mM EDTA, 20% (v /v) glycerol.
2x TH 8.2: 20 mM Tris.HCl pH 8.2,0.2 mM EDTA, 20% (v /v) glycerol.
(1) Small scale reactions.
Purified pUC18 DNA (freshly diluted to about 50 pg/m l) was mixed with an 
equal volume of 2x binding buffer. An appropriate amount of end labelled DNA 
fragment was added (approximately 0.1 ng /p l res fragment) and the binding mix 
was dispensed to 10 pi samples (stored at room temperature). 0.4 pi of a
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resolvase dilution (or resolvase dilution buffer) was added to each sample, which 
was mixed and incubated at 37 °C for 10 min (or as stated). After incubation 
samples were transferred to ice and loaded onto the gel as soon as possible 
(about 10 m in maximum).
(2) Large scale reactions.
(a) With unlabelled DNA.
As for small scale reactions except; no pUC18 carrier DNA was included and 
target DNA concentration was much greater, i.e. 10 pi aliquots were prepared 
containing lx  binding buffer, about 100 ng unlabelled res fragment (and about 
900 ng vector fragment).
(b) For stoichiometry determinations.
As for (a) above except; some target DNA was labelled; amounts of material used 
were all as described or all increased 5-fold (i.e. 50 pi reactions, no change in 
concentrations of components.
2.20 In Vitro Recombination.
Tn3 resolvase dilutions were prepared as for binding reactions (section 2.18). 
lx  C9.4 recombination buffer: 50 mM Tris.HCl pH 9.4,10 mM M gCk/ 0.1 mM
EDTA, 20% (v /v ) glycerol.
40-80 pi samples containing approximately 1 pg plasmid DNA in lx  C9.4 were 
mixed with 1-2 pi of diluted resolvase (or resolvase dilution buffer). The 
reactions were incubated at 37 °C for 0.5-18 h and then stopped by incubation at 
70 °C for 5 min. Half of each sample was digested with an appropriate restriction 
endonuclease (after adjusting the reaction buffer). Where appropriate 1 pi of each 
sample was used to transform competent DS941, and the remaining material was 
extracted against butanol (to reduce sample volume). Samples were then mixed 
w ith 5 pi of K mix. Digested and undigested material was analysed by agarose 
gel electrophoresis.
Note: an 18 h incubation time was used when recombination of some substrates 
examined was expected to be poor. For an efficiently resolved substrate 30 min 
incubations were more typical.
2.21 Direct Sequencing of Double Stranded Plasmids.
The method used was mainly as described in the Sequenase T7 DNA polymerase 
technical m anual88 based on the method of Sanger et al? 5. The exception to this 
was the way in which plasmid template was prepared. 2-3 pg of double stranded 
plasmid DNA was incubated in 30 pi of 0.2 M NaOH for 15 min at room 
temperature. 5 pmol of sequencing primer was added and the sample was
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vortexed briefly. Next 120 pi of ice cold EtOH and then 12.75 pi of 5 M 
ammonium acetate (pH 7.5) were added and the sample was incubated at -70 °C 
for 5 min. The DNA was pelleted by centrifugation (for 30 min at 4 °C), washed 
in 70% EtOH and then pelleted again. After drying briefly the template DNA was 
resuspended as described in the Sequenase protocol.
2.22 DNase 1 Footprinting.
Tn3 resolvase dilutions were as for band shift assays (section 2.18). Dilutions of 
1 m g /m l DNase I were made in DNase I dilution buffer and stored at -20 °C. 
DNase I dilution buffer: 50 mM Tris.HCl pH 8.0,50% (v/v) glycerol.
C8.2 buffer: 50 mM Tris.HCl pH 8.2,10 mM MgCl2, 0.1 mM EDTA.
The method used was as derived from that of Galas and Schmitz21.
End-labelled target DNA (labelled on one strand only) was purified after PAGE. 
The DNA was resuspended in C8.2 binding mix to give an activity of >25 cps, 
and then dispensed in 4 pi aliquots. 0.2 pi of diluted resolvase (or dilution buffer) 
was added to the DNA which was incubated at room temperature for 5 min.
Next 1 pi of diluted DNase I (or dilution buffer) was added and the sample was 
mixed thoroughly. After 5 min at room temperature the reaction was stopped by 
the addition of 4 pi of stop mix (3 vol Sequenase loading dye: 1 vol 100 mM 
EDTA). The samples were heated to 80 °C before loading <4 pi onto a sequencing 
gel.
Optimal concentrations of DNase I (6.25 pg/m l) and resolvase (see chapter 3) 
were determined by preliminary experiments. No carrier DNA was included in 
these binding reactions.
2.23 M ethylation Interference Experiments.
Plasmid containing the site of interest was digested and end-labelled to give a 
small target DNA fragment and larger vector fragment, each labelled on one 
strand only. About 20,000 counts per second of this material was resuspended in 
20 pi of C8.2. After adding 2 pi of 10% (v/v) DMS (freshly diluted in water) the 
samples were incubated for 5 min at room temperature. Methylation was 
terminated by the addition of 1 pi of 2-mercaptoethanol. The sample was m ade to 
70 pi w ith lx  TE and then extracted with an equal volume of phenol, then 1:1 
phenol/chloroform  and finally chloroform. The DNA was precipitated with 2.5 
vol of EtOH and resuspended in 10 pi of lx  TE.
Methylated and unmethylated DNA samples were used in TG 9.4 band shift 
assays (each sample being used for two resolvase reactions and one 'blank' 
control). An autoradiograph was made of the wet gel and bands of interest were 
cut from the gel. DNA from the gel chips was eluted using an adapted 'crush and
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soak' method (elution buffer consisted of 0.5 M ammonium acetate, 1 mM EDTA, 
20 pg /m l yeast tRNA). After elution DNA samples were EtOH precipitated and 
resuspended in 5 pi deionised water.
The DNA was cleaved at modified positions by addition of 50 pi 10% (v/v) 
piperidine followed by incubation at 90 °C for 30 min. The samples were 
lyophilised and resuspended three times, finally resuspending in 5 |il of 
deionised water. The resuspended DNA was mixed with 4 pi of Sequenase 
loading dye, heated to 80 °C and loaded to a sequencing gel. An attem pt was 
made to balance the activity loaded to adjacent tracks to simplify interpretation 
of the bands produced.
2.24 Expression and Purification of Tritiated Tn3 Resol vase.
The materials and methods used are described fully in Chapter 4.
2.25 N-Methyl-N'-N itro-N-N itros oguanidine M utagenesis.
The method used was as described by Miller56. The recommended MNNG 
treatment of cells is with 50 pg /m l MNNG (final) for 30 min. In addition to this 
other samples were treated using final MNNG concentrations of 100 p g /m l and 
200 pg/m l. Different exposure times of 10,30 and 60 min were used with each 
MNNG concentration.
2.26 pSelect-Based Directed Mutagenesis.
The method used was as described in the 'Altered Sites' technical m anual62 
except that the mutagenesis template was produced by denaturing double 
stranded plasmid DNA which had been nicked by DNase I in the presence of 
EtBr to give an average of one single stranded nick per plasmid molecule81.
2.27 Preparation of Protein Samples for Amino Acid Analysis.
A known volume of protein sample was mixed with a known volume (and 
concentration) of taurine solution in a large glass tube. The samples were made 
to 500 pi with deionised water. 500 pi of concentrated HC1 was added to each, 
and the tubes were sealed. After degassing the samples, the sealed tubes were 
incubated at 105 °C overnight. After hydrolysis the samples were lyophilised 
(overnight), resuspended in about 500 pi deionised water, lyophilised again and 
finally resuspended in a small volume (50 or 100 pi).
Between 10 and 20% of the sample was taken for OP A derivatisation for each 
analysis. Derivatised amino acids were analysed by D. Mousedale and E. O'Neil 
using HPLC separation.
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2.28 Concentration of Resolvase Samples.
Resolvase. Resolvase
Fraction
Monomer
Concentration
Method of 
Estimation.
Tn3 R14 f45 -250 [iM comparison (& Bradford's)
i t R14 f46 -250 fiM comparison (& Bradford's)
i f R14f47 -150 |iM comparison (& Bradford's)
i t R17f47 20 pM amino ad d  analysis
11 R17f48 -160 pM comparison with R17 f47
i t R17f49 -500 |iM comparison with R17 f47
11 R D 8f7 62 |iM amino a d d  analysis
11 R D 9f6 19 |JM amino a d d  analysis
78 -40 pM comparison with R17 f47
78 M106C -100 |iM comparison with R17 f47
Tn21 101 pM amino ad d  analysis
Table 2.8 Estimated (monomer) Concentration of Resolvase Samples.
All values are estimations, but those derived from amino a d d  analysis are likely 
to be most accurate. All other values were estimated comparatively by silver- or 
Coomassie-stained Laemmli gels and, where appropriate, by comparison of 
resolution or binding activities. R14 samples were also measured by Bradford's 
assay12, but resolvase is believed to give low results by this method, when 
compared with BSA standards.
The only experiments for which an absolute resolvase concentration was 
required were those to determine the absolute stoichiometry of complexes of 
resolvase with res (i.e. that of RD 9 f6).
2.29 Preparation of Polyacrylamide Gel Chips for Scintillation Counting.
Material was cut from the gel using a scalpel. Each gel chip was placed in a 
sealed sdntillation vial with 1 ml of H2O2, and incubated at 55 °C for 24-72 h 
(until the gel chip was dissolved). After cooling, 10 ml of /Ecosdnt/ sdntillation 
cocktail was added. The re-sealed vials were mixed by vortexing and then 
sdntillation counted as required.
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Chapter Three 
Binding of Resolvase to res and Its Subsites
3.1 Introduction.
Non-denaturing polyacrylamide gel electrophoresis (PAGE) has been used to 
allow the detection of complexes of a wide variety of nucleic a d d  binding 
proteins bound to their target sites, including Tn3 resolvase bound to the res site. 
Six discrete, reprodudble complexes were observed on binding of Tn3 resolvase 
to Tn3 res7, but only three complexes were produced by equivalent analysis of 
the yb res/resolvase system28 and of the Tn21 res/resolvase system5. It was not 
clear whether these differences reflected variation in the mechanism of binding 
of the resolvases or resulted from something trivial, such as the difference in 
binding and gel conditions used for each system.
Analysis of the yb resolvase used in these experiments indicated that the major 
spedes present was approximately the size expected for a resolvase dim er34. 
Considering the binding pattern observed, this suggests that each complex could 
result from binding of successive resolvase dimers (or possibly tetramers) to the 
res site (Fig. 3.1b). However, it was not proved that the major species observed 
during size analysis was also the major spedes present under the different 
conditions used for the formation, or electrophoresis, of complexes.
The band shift assay allows investigation of early steps within the resolution 
reaction and, as such, is very useful for analysing the effects of altered resolvases 
or sites which prove incapable of completing recombination, but may still exhibit 
some binding activity. An isolated subsite I sequence was produced by 
exonudease HI digestion of the Tn3 res site. A plasmid containing subsites II and 
III, but not subsite I, was produced using the same method. Binding analysis of 
these substrates showed that two complexes were produced for each intact 
subsite present7. A DNA fragment containing just over half of subsite I, 
produced by further dissection of res, generated one complex w ith resolvase. 
However, this result alone is insuffident to show a general relationship of one 
complex produced for each half subsite present in the DNA fragment examined.
The general pattern of binding of Tn3 resolvase to res, or its subsites, has been 
described as co-operative, due to the small range of resolvase dilutions over 
which large increases in binding are produced. However experiments have not 
been conducted to spedfically investigate the co-operative nature of this process.
To account for the complexes observed with the Tn3 resolution system, different 
resolvase binding models were considered7. If the resolvase bound as a dimer (as 
predicted for yb) and the order of occupation of half sites was random, then
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Figure 3.1. Schematic Representation of Models for Dimers of Resolvase 
Binding to a res Site.
!U' indicates an unbound DNA fragment. Complexes are numbered in 
order of decreasing mobility. Resolvase is represented by circles, and the 
DNA by lines, with thicker lines indicating die subsites.
(a) Random order occupation of subsites by a dimer binding unit, 
without shuffling. This model predicts that 7 complexes w ould be 
generated with a full res site; 3 complexes with 2 subsites and 1 
complex for an isolated subsite.
(b) Random order occupation of subsites by a dimer binding unit, with 
shuffling. 3 retarded bands would be expected from binding to res 
(as shown). 2 retarded species would be seen with two subsites and 
1 with a single subsite (not shown).
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seven complexes would be expected from binding to a res site, three complexes 
from two subsites, and one complex from a single subsite (Fig. 3.1a). Complexes 
resulting from resolvase dimers binding to different subsites of res w ould be 
expected to have different mobilities, due to the differences in the size and 
position of the bend produced (section 3.6). However, if the bound resolvase can 
switch between free subsites on the same fragment, or 'shuffle'49, then the 
mobility of each complex would result from the average position of the resolvase 
molecules bound, reflecting the affinity of resolvase for each subsite. In this case 
(still considering resolvase binding as a dimer) one complex would be expected 
for each subsite on the DNA fragment investigated, e.g. res would produce three 
complexes (Fig. 3.1b), as seen for y5 resolvase. Methylation interference analysis 
of the least retarded y8 complex gave partial interference patterns at subsites I 
and II28. This is believed to be the result of the resolvase 'shuffling7 between all 
three subsites, but having a comparatively low affinity for subsite III. Observed 
features of y8 binding do fit this model (Fig. 3.1b), but Tn3 binding does not.
Rather than a dimer, Tn3 resolvase could bind as a monomer, to one half of a 
subsite in each step. If the order of occupation was random, and if no shuffling 
occurred, binding to res in monomer steps would produce sixty-three different 
complexes. In a model including shuffling, six complexes would be predicted for 
binding to a res site, and more generally two complexes would be expected for 
each subsite in a DNA fragment (Fig. 3.2a). Alternatively the order of subsite 
occupation could follow a non-random path in such a w ay that six complexes 
would be generated from a res site (Fig. 3.2b). This model is believed to be 
incorrect due to the similar behaviour of different isolated subsites, and because 
of the previously mentioned evidence for shuffling.
Gel filtration analysis of Tn3 resolvase indicates that it is dimer-sized under the 
conditions used (M. Boocock; pers. comm.). It could bind each subsite as a dimer, 
to give a weak complex, before undergoing a conformational change (e.g. Fig. 
3.3a), producing a second, more retarded complex. Alternatively a resolvase 
dimer bound to a subsite could, by dissociation of a monomer, break down to 
give another complex containing a bound monomer (Fig. 3.3c). These 
mechanisms (incorporating shuffling) could account for the binding patterns 
observed with Tn3 res and resolvase. Two other models which would also 
account for the observed two complexes per subsite are also shown in Fig. 3.3. 
Models of dimer binding in which only one half of the dimer contacts the DNA 
(or one half of the dimer, and then the other) could be proposed. From such 
models the predicted patterns of complexes would be as described for monomer
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Figure 3.2. Schematic Representation of Models for Monomers of 
Resolvase Binding to res.
TJ' indicates an unbound DNA fragment:. Complexes are num bered in 
order of decreasing mobility. Resolvase iis represented by circles, and the 
DNA by lines, with thicker lines indicatimg the subsites.
(a) Random order occupation of subsitces by a monomer binding unit, 
with shuffling. Different species created by shuffling within a 
subsite are not shown. 6 different complexes would be produced 
with a full res site. 4 complexes wouild be expected for two subsites, 
and 1 complex with one subsite (noit shown).
(b) Ordered occupation of subsites by a  monomer binding unit, without 
shuffling between subsites, but allowing shuffling of monomers 
between the two halves of a subsite;, as shown. As for the model 
presented in (a), 6 complexes w ould  be observed with res. 4 
complexes would be expected for tw o subsites; and 1 with a single 
subsite (not shown). The same patterns of complexes would be 
expected for ordered occupation wiithout shuffling between halves 
of a subsite.
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Figure 3.3. Schematic Representation of Models for Binding of 
Resolvase in Two Steps per Subsite of res.
'U' indicates an unbound DNA fragment. Complexes are numbered (and
positioned) in order of decreasing mobility. Resolvase is represented by
circles, and the DNA by lines, with boxes indicating the subsites.
(a) Binding of a resolvase dimer to the entire subsite, followed by a 
conformational change to produce a second, more retarded complex.
(b) Binding of a resolvase dimer to one half of the subsite (with 
shuffling), followed by a conformational change to allow binding of 
the same dimer to the other half of the subsite, to generate a more 
retarded complex.
(c) Binding of a resolvase dimer to the entire subsite, followed by 
dissociation of one half of the dimer, leaving a resolvase monomer 
bound (with shuffling between halves of the subsite).
(d) Binding of a resolvase monomer to the subsite (with shuffling), 
followed by binding of a second monomer, to form a bound dimer.
binding models. Tetramer binding models, in which only two resolvase 
monomers end up in contact with the DNA, would give patterns of complexes as 
predicted by dimer binding models.
At the time of starting this work, our favoured model for Tn3 resolvase binding 
to res had resolvase binding in monomer steps, with an apparently random  order 
of occupation, and incorporating shuffling (Fig. 3.2a).
Intrinsically bent DNA sequences have been shown to migrate 
anomalously during gel electrophoresis52. Similarly, protein-induced bending of 
a DNA fragment would be expected to cause retardation of the resulting complex 
during electrophoresis49. However the presence of bound protein would also 
cause migration of the complexed material to be slower than that of the naked 
DNA fragment. The degree of retardation observed for a bent DNA fragment 
(with an intrinsic or an induced bend) is dependent on both the size of the bend, 
and its position within the fragment. The centre of a DNA bend can be estimated 
by comparison of the gel mobilities of a number of fragments, each containing 
the proposed DNA bend at a different point within the same sequence context. 
Plotting the relative mobility of the fragments indicates the point of maximum 
retardation, at which the bend is predicted to be at the centre of the DNA 
fragment93. Such experiments have been used to detect protein-induced bending 
of DNA sites7'47'69/93, but not all systems examined exhibited a variation in the 
mobility of the complexes produced24'93. This suggests that, where observed, 
these differences in mobilities are not just a result of changing the position of the 
bound protein within the DNA fragment. Obviously the unbound DNA species 
m ust also be examined in these experiments, to eliminate the effect of any 
intrinsic bend. As bending of subsites, induced by resolvase binding, is predicted 
to play an important role in the structure and formation of the res synaptic 
complex79, examining the position and extent of resolvase-induced bending may 
yield valuable information.
W ork described in this chapter will also include footprint analysis and 
methylation interference analysis of Tn3 resolvase bound to Tn3 subsite n, and 
some subsite II derivatives.
3.2 Binding of Tn3 Resolvase to Tn3 res.
Band shift analysis of Tn3 resolvase bound to a Tn3 res site (using a 262 bp Eco RI 
fragment of pMA1441 and TG 9.4 conditions) gives rise to six complexes (Fig.
3.4), named complex 1 to 6, as indicated. The alternating weak and strong nature 
of the complexes (with decreasing mobility) is consistently observed. Prolonged
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Figure 3.4. Binding of Tn3 Resolvase to Tn3 res.
End-labelled res fragment (pMA1441 Eco RI) was incubated for 10 min at 
37 °C with dilutions of Tn3 resolvase, as indicated, using TG 9.4 conditions. 
Lane Resolvase
1 R.H.B.
2 2-8 R14 f45
3 2'7
4 2'6
5 2'5
incubation on ice gives increased levels of weak complexes (i.e. complexes 1,3 
and 5) w ithout significantly affecting strong complex levels (i.e. complexes 2 ,4  
and 6). This effect is shown in Fig. 3.5a.
3.3 Comparison of Binding of the Tn3, y8 and Tn21 Resolvases Using 
D ifferent Band Shift Conditions.
As mentioned, the pattern of binding described for Tn3 resolvase /res was 
different to that reported for the y5 and Tn21 systems. In an attem pt to rule out 
any differences arising from variations in the experimental approaches used, 
band shift assays of Tn3 resolvase with Tn3 res were conducted under different 
conditions. Fig. 3.5a shows the retarded complexes observed w ith TG 9.4 
conditions, and Fig. 3.5b shows equivalent samples prepared using the TH 8.2 
system. The complexes on the TG 9.4 gel are much sharper than those on the TH
8.2 gel, possibly indicating an increased stability of the res/resolvase interaction. 
Six complexes are visible on each gel. Aliquots of the samples rim  on the TH 8.2 
gel were also rim on a 0.5x TBE gel, with 0.5x TBE electrophoresis buffer, (Fig. 
3.5c). In this case four diffuse complexes are produced, indicating that the gel 
conditions used can affect the number and nature of the complexes observed. 
This is not surprising as measurements of the half-life of res/resolvase complexes 
in solution suggest that it is much less than the length of time for which these 
gels are run7. It is believed that discrete complexes would not be observed 
w ithout the 'cage' effect of such gels49.
Although y8 complexes have been detected with 0.5x TBE gels, the experiments 
described so far have not exactly replicated the band shift conditions used to 
examine one resolution system in the analysis of another. Gifts of y5 resolvase 
and pRW80 DNA (containing a y5 res site) from Nigel Grindley, and of Tn21 
resolvase and pAA3 DNA (containing a Tn21 res site) from Steve Halford 
allowed this omission to be redressed. TG 9.4 conditions were used to examine 
the binding of the y8 and Tn21 resolvases to their respective res sites (Fig. 3.6). It 
is clear that each set of reactions produces more than (the previously observed) 
three complexes, but it is not clear that the pattern observed is comparable to that 
of Tn3 (Fig. 3.5a).
3.4 Binding of Tn3 Resolvase to an Isolated Subsite II.
The absence of restriction endonuclease sites between subsites II and III of Tn3 
res prevented examination of the binding of these subsites in isolation. Such 
analysis was required to further test the general observation that two complexes 
were produced for each intact subsite present on the DNA fragment used.
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Figure 3.5. Effects of Different Gel Conditions on Complexes Observed 
using Tn3 Resolvase and Tn3 res.
End-labelled res fragment (pMA1441 Eco RI) was incubated for 10 min with 
dilutions of resolvase, as indicated. All incubations were at 37 °C unless 
stated otherwise. Binding and gel conditions were as described.
Lane Resolvase
1 R.H.B.
2 2'8 R14 f45
3 2'7
4 2'6
5 2'5
6 2'7 " (0 °C incubation)
(a) TG 9.4 binding reactions and gel.
(b) TH 8.2 binding reactions and gel.
(c) TH 8.2 binding reactions but 0.5x TBE gel.
Figure 3.6. Binding of y5 Resolvase to y5 res, and of Tn21 Resohase to 
Tn21 res.
TG 9.4 band shift assays of y5 resolvase/res and of Tn21 resolvast/res. All 
incubations were for 10 min at 37 °C unless stated otherwise.
Lane Resolvase
1 R.H.B.
2 2-8
3 2-7
4 2-6
5 2-5
6 2-7 I(0 °C incubation)
A y5 resolvase dilution with y5 res (pRW80 Sal l /H in  dill)
B Tn21 resolvase dilution with Tn21 res (pAA3 Eco R I/BamHl)
Subsite II was of particular interest as bending predictions for the res site 
suggested that subsite II would be bent most on binding of resolvase, and this 
feature was incorporated in the Glasgow model of Tn3 res synapsis11.
As it could not be cloned from Tn3 res, an isolated subsite II element was 
produced synthetically.
3.4.1 Construction of Subsite II.
The sequences of the two complementary oligonucleotides used to m ake subsite 
II are given in Fig. 3.7 (and in Chapter 2). Their sequences were designed to give 
subsite II flanked at each end by 5 bp of adjacent Tn3 DNA, which w as directly 
next to the restriction sites used for cloning. The oligonucleotides were 
deprotected, purified and annealed (as described; Chapter 2) to give a 50 bp 
DNA fragment, w ith overhanging Xba I and Pst I ends. This fragment was cloned 
between the Xba I and Pst I sites of pUC18, giving the plasmid pDB2004 (Fig. 3.7). 
The cloned subsite II DNA was checked by Sanger di-deoxy sequencing.
3.4.2 Band Shift Analysis of Tn3 Resolvase with Subsite II.
The plasmid pDB2004 was used as a source of isolated subsite II for band shift 
analysis. The pattern of complex formation (Fig. 3.8) appeared equivalent to that 
previously observed for Tn3 res, for subsites II and III, and for subsite I7, i.e. two 
major complexes were produced and these were alternately weak and strong, 
w ith decreasing mobility. These complexes were observed using a 'normal' range 
of resolvase dilutions. However, a third, more retarded complex was produced at 
higher resolvase concentrations.
To gain more information about the complexes formed, a binding time course 
experiment was conducted using subsite II (Fig. 3.9). A single binding reaction 
was prepared, containing ten times the normal amount of material. This was 
incubated at 23 °C, and a control sample was removed (and loaded to the gel) 
prior to the addition of resolvase. A second sample was transferred to the gel 
directly after the addition of resolvase. Incubation was continued at 23 °C, with 
further time points taken at 20 sec and then at 1 ,2 ,4 ,8  and 16 min.
Some binding of resolvase is visible at the first time point. Even in experiments 
where samples were incubated on ice, some complex formation was observed in 
the first samples taken. At the earliest time point approximately equal amounts 
of complexes 1 and 2 are present. However, the amount of complex 2 present 
increases with each time step (and the amount of unbound DNA decreases), 
whereas complex 1 levels remain fairly constant throughout. This gel supports
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(b)
EcoRI SstI Kpnl Smal BamHI Xbal Subsite II
GjAATTCGAGCTpGGTACpCpGGpATCCT|CTAGATTGAG|rGTCCATTAAATCGTCA
CTTAApC|TCGAGC|CATGGGpCCCTAGpAGATC|TAACTC ACAGGTAATTTAGCAGT
 Subsite n________  PstI SphI Hindm
TTTTGGCATAATAGACAJCATCGCTGCApGCATGpAjAGCTT
AAAACCGTATTATCTGTbTAGCGlACGTCdGTACGTTCGAK
Figure 3.7. Map of pDB2004.
(a) Map of pDB2004.
(b) Sequence of polylinker region of pDB2004, showing inserted subsite 
II element (in bold type).
res subsite II
1 2 3 4 5 6 1  2 3 4 5 6
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Figure 3.8. Binding of Tn3 Resolvase to an Isolated Subsite II.
TG 9.4 band shift assays of Tn3 resolvase (dilutions of R14 f46) with res 
(pMA1441 Eco RI) or an isolated subsite II (pDB2004 Eco R l /H in  dill). All 
incubations were for 10 min at 37 °C.
Lane Resolvase
1 R.H.B.
2 2-8
3 2-7
4 2-6
5 2-5
6 2-4
subsite (II + 10)
1 2 3 4 5 6 7 8
subsite II
Figure 3.9. Time Course of Binding to Subsite II and to Subsite (II + 10).
TG 9.4 band shift assays of Tn3 resolvase (2-5 dilution of R14 f46) with 
subsite II (pDB2004 Eco R l/H in  dill) or subsite (II + 10) (pDB2107 
Eco R l/H in  dill). All incubations were at 23 °C for the time indicated.
Two 'zero' time points were produced for each subsite. One before the 
addition of resolvase, the other was taken immediately after adding 
resolvase to the binding reaction. Subsite (II + 10) is described in section 
3.5.
Lane Incubation time.
1 0 sec (no resolvase)
2 '0 sec'
3 20 sec
4 1 min
5 2 min
6 4 min
7 8 min
8 16 min
the general assumption that other binding reactions, incubated at 37 °C for 10 
min, have reached equilibrium (complex formation was observed to be slower at 
23 °C than at 37 °C; data not shown).
3.5 Binding of Resolvase to Derivatives of Subsite II w ith Altered Spacing.
Our interpretation, at the time, of the complexes formed with subsite II was that 
complex 1 comprised subsite with resolvase bound at one half site only, bu t 
complex 2 had the subsite fully occupied (and exhibited greater stability). In 
addition, it was possible that complex 1 was an intermediate in the formation of 
complex 2, and that, in the time course experiment reported in section 3.4.2, 
larger amounts of complex 1 do not accumulate over time due only because of 
the equilibrium between complexes 1 and 2. Binding to form complex 2 m ight be 
co-operative (see section 3.11)
Two derivatives of subsite II were produced in an attempt to disrupt the 
apparent co-operative nature of binding to subsite II. One derivative, subsite 
(II + 10), contained an additional 10 bp of DNA inserted at the centre of the 
subsite II sequence. The other, subsite (II + 5), contained only 5 bp of additional 
DNA, at the same position. If subsite II forms a helical structure with 10 -11 bp 
per turn, then the ends of the subsite (i.e. the proposed resolvase binding sites) 
will be separated by three full helical turns of DNA, and so will lie 'in phase' 
w ith each other. Insertion of another full helical turn (-10 bp) should not disrupt 
the phase of the subsite ends. Reduced binding caused by such an insertion 
w ould be expected to result from the change in the distance between the subsite 
ends. Insertion of a half helical turn of DNA (-5 bp) would be expected to 
dramatically alter the phase of the two binding sites, such that the relative 
position of the bound resolvase would be very different from when bound to 
subsite II. Aligning resolvase units bound to subsite (II + 5) as for binding to 
subsite II (perhaps by resolvase/resolvase interactions) would be predicted to 
result in major distortion of subsite (II + 5) and /o r resolvase.
3.5.1 Construction of Subsite (II + 5) and Subsite (II +10).
The sequence of subsite (II +10), shown in Fig. 3.10 (and in Chapter 2), was 
designed to produce an altered subsite II flanked by 4 bp of adjacent Tn3 DNA 
on each side. This additional Tn3 sequence was placed directly next to the 
restriction enzyme sites (Xba I sites) used to clone the subsite. The change from 
the natural sequence within the subsite was the insertion of an additional 10 bp 
of new sequence, positioned centrally within the subsite. The inserted sequence 
was chosen in an attempt not to disrupt the periodicity of the predicted
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Subsite (11+10) Xbal SaH PstI SphI Hindin
CGTGATTTTGGCATAATAGACA CATCT |CTAGAGfTCGACCTGCA|3GCATG|2A|AGCTT 
GCAGTAAAACCGTATTATCTGT 3TAGAGATC | TCAGC T)3G|aC G TC Cp TAC GTTC G A .^
Figure 3.10. Map of pDB2107.
(a) Map of pDB2107.
(b) Sequence of polylinker region of pDB2107, showing inserted subsite 
(n +10) fragment (in bold type). The shaded region within the 
subsite indicates the 10 bp not present in subsite II.
Minor Groove
’Out'
'In'
Subsite II ■
“ V ' l ' V .................
’Out’
'In’
TGTCCATTAAATCGTCAITTTTGGC ATAATAGACA
Subsite (11+10)
' V V V V
TGTCCATTAAATCGTCATTTAUCGTCATTTTGGCATAATAGACA
'Out' Subsite (II+5)
I I 1 m
v
+++H
TGTCCATTAAATCGTCATT'J’CATTTTGGCATAATAGACA
Figure 3.11. Predicted 'Bending Preference' of Subsite II and Its 
Derivatives.
Bend preference values have been plotted for each dinucleotide in the 
sequence of subsites II, (11+10) and (II+5). These values were calculated 
using the formula
f.cos(0)
where f, the fractional variation in occurrence, and 0, the phase angleO,
are as defined and determined by Satchwell et al.76.
The sequence of each subsite is aligned below the relevant plot, and the 
centre of each subsite is marked with a small line. The predicted position 
of the minor groove within a DNA bend is indicated, e.g. minor groove 
'in' means the minor groove would lie to the inner side of the DNA bend.
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GlAATTCGAGCltGGTACbcbGGbATCCTlCTAGATTQAGfrQTCCATTAAATCGTCATCT 
CTTAAlGctrCGAGClCATGGGCCCCTAGbAGATCh'AACTC ACAGGTAATTTAGCAGTAAA
Subsite (n+5)________  Sail PstI SphI Hindin
CXt TTTGGCATAATAGACA|CATCGG fTCGACCTGCApGCATGpA|AGCTT 
GTAAAACCGTATTATCTGTGTAGCCAGCTbGlACGTCdGTACGTTCGAK
Figure 3.12. Map of pDB2507.
(a) Map of pDB2507.
(b) Sequence of polylinker region of pDB2507, showing inserted subsite 
(II + 5) fragment (in bold type). The shaded region within the 
subsite indicates sequence not present in subsite II.
'bendability* of subsite II (Fig. 3.11). The 'bendability' predictions presented are 
based on data from studies of chicken nudeosome core DNA76. The sequence of 
subsite (II + 5), shown in Fig. 3.12 (and Chapter 2), was designed to conform to 
that of subsite (II + 10), i.e. the sequence of the 5 bp inserted at the centre of 
subsite (II + 5) was derived by deleting the central 5 bp of the 10 bp at the centre 
of subsite (n + 10). These oligonucleotides have 5 bp of additional Tn3 sequence 
flanking the subsite, and this sequence is directly adjacent to the Xba I and Sal I 
restriction endonudease sites used to clone the subsite.
Each pair of complementary oligonudeotides was deprotected, purified and 
annealed (as described; Chapter 2). Subsite (II +10) was cloned to the Xba I site of 
pUC18, giving the plasmid pDB2107 (Fig. 3.10), and subsite (II + 5) was doned 
between the Xba I and Sal I sites of pUC18, to give pDB2507 (Fig. 3.12) The cloned 
subsite sequences were checked by Sanger di-deoxy sequendng.
3.5.2 Band Shift Analysis of Tn3 Resolvase with Subsite (II +10) and
with Subsite (II + 5).
Plasmids pDB2107 and pDB2507 were used as a source of subsite (II + 10) and 
subsite (II + 5), respectively. Binding of Tn3 resolvase to each subsite gave a quite 
different pattern of complexes from that expected. The lowest levels of resolvase 
used with subsite (n + 10) produced two complexes (Fig. 3.13), but in this case, 
the less retarded complex (complex 1) was the major spedes. In the presence of 
higher resolvase concentrations the amount of both complexes increased. At the 
highest resolvase concentration almost equal amounts of each complex were 
formed, enough for each to be considered 'strong' complexes. At the higher 
resolvase concentrations, a third, fainter complex was formed, which had the 
lowest mobility of the complexes observed. Band shift assays of Tn3 resolvase 
with subsite n, using unlabelled DNA (and no additional carrier DNA) are also 
shown in Fig. 3.13.
At the lowest concentration of resolvase used, only one complex (complex 1) was 
produced by binding of resolvase to subsite (II + 5), (Fig. 3.13a). In the presence 
of greater amounts of resolvase three other, more retarded, complexes were 
detected. Complex 1 remained the major spedes present, although large amounts 
of complex 2 were also produced. The two remaining complexes (3 and 4) ran as 
a doublet, a little more slowly than complex 2. The pattern of complexes 
produced with subsite (II + 5), and their order of appearance over the resolvase 
titration, resembles that of subsite (II +10), i.e. complex 1 and complex 2 of 
subsite (II + 5) seem similar to those of subsite (II +10), and complexes 3 and 4 of
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Figure 3.13. Binding of Tn3 Resolvase 
to Subsites (II + 5) and 
(II +10).
TG 9.4 band shift assays of Tn3 resolvase 
with subsite II (pDB2004 Eco R l/H in  dill), 
subsite (II + 5) (pDB2507 Eco R l/H in  dill) or 
subsite (II + 10) (pDB2107 Eco R l/H in  dill). 
All incubations were for 10 min at 37 °C.
(a) End-labelled DNA fragments with 
dilutions of R14 f46.
(b) Unlabelled DNA with dilutions of R17 
f47 (no carrier DNA, EtBr-stained gel).
Lane Resolvase
1 R.H.B.
2 2'8
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subsite (II + 5) behave like complex 3 of subsite (n +10). This w as somewhat 
surprising as the inserted sequence of subsite (n +10) was designed to disrupt 
binding as little as possible, whereas the inserted sequence of subsite (II + 5) was 
expected to interfere with binding by the resultant rotational displacement of the 
half-sites, relative to each other.
3.6 Resolvase-Induced Bending of Subsite II and Subsite (II +10).
The plasmid pBend2 (Fig. 3.14) is designed to allow the production of circularly 
perm uted DNA fragments39, without creating directly repeated copies of the 
sequences which are being examined. Plasmids containing large directly 
repeated sequences are often prone to rearrangement. W ith pBend2 the sequence 
of interest is cloned to the centre of the polylinker and then re-isolated on a 
num ber of different restriction fragments in which the relative position of the 
insert (to the fragment ends) varies, but its sequence context remains the same.
Subsite II and subsite (II +10) were each cloned to pBend2. The plasmid pDB2118 
(Fig. 3.14) was produced by cloning subsite (II +10), as a synthetic Xba I 
fragment, to the Xba I site of pBend2. The fragment used was as described in 
section 3.5.1. The sequence and orientation of subsite (II + 10) within pDB2118 
was checked by Sanger di-deoxy sequencing. Several attempts were m ade to 
subclone subsite II from pDB2004 to pBend2. Clones with the expected restriction 
fragment pattern were obtained each time, but in all cases these plasmids proved 
unstable, and underwent rearrangement before large scale plasmid preparations 
could be produced. Because of this, a second pair of complementary 
oligonucleotides was synthesised, to give a 48 bp Xba I fragment ('subsite II(p)', 
Chapter 2) containing subsite II. The arrangement of this subsite II fragment is 
similar to that of the subsite (II + 10) fragment described. A stable subsite II 
construct, pDB2060 (Fig. 3.14), was produced by cloning subsite II(p) to the Xba I 
site of pBend2. The sequence and orientation of the inserted DNA was checked 
by Sanger di-deoxy sequencing.
The plasmids pDB2060 and pDB2118 were each digested using several restriction 
endonucleases, to produce a series of DNA fragments, for band shift analysis, in 
which the relative position of the resolvase binding target was varied, but its 
sequence context remained constant. The DNA was prepared and used for non­
radioactive band shift assays (described in Chapter 2) using TG 9.4 conditions. 
The complexes generated using pDB2060 (subsite II) were visualised by silver 
staining the gel produced (Fig. 3.15) and the mobilities of the complexes, and 
unbound DNA bands, were measured directly from the stained gel. The subsite
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Figure 3.14. Map of pBend2, pDB2060 and pDB2118
(a) Map of pBend2. Not all pairs of restriction enzyme sites are shown 
in die polylinker, but all sites used are shown in the correct order.
(b) Map of pDB2060 and pDB2118. These two plasmids are identical to 
pBend2 with the exception of the subsite sequences inserted at the 
Xba I site. These are not shown to scale.
(c) Representation of DNA fragments produced, from pDB2060 and 
pDB2118, for bend analysis by the band shift assay.
(n +10) gel was stained using EtBr, and the DNA was visualised by UV 
exposure. The mobilities of the different species generated from subsite (II + 10) 
(Fig. 3.16) were measured from a photograph of the gel. The mobilities, listed in 
Tables 3.1 and 3.2, were each measured from the bottom of the appropriate well 
to the band centre. It should be noted that the pattern of complexes produced for 
each subsite was as described previously in this chapter, and in Chapter 5.
Restriction
Fragment
Inter-centre 
Distance (bp).
Mobility (mm) Relative Mobility
U c l c2 c 1 c2
Mlu I -48.5 105 77 60 0.73 0.57
B%1 ii -42.5 104 74 57 0.71 0.55
Xho I -12.5 103 67 48 0.65 0.47
Eco RV -0.5 103 66 48 0.64 0.47
Sma I 11.5 103 68 49 0.66 0.48
Ssp I 29.5 104 72 53 0.69 0.51
Kpn I 35.5 104 74 56 0.71 0.54
Bam HI 54.5 104 81 65 0.78 0.63
Table 3.1 Relative Mobilities of Complexes Generated with Subsite II from 
pDB2060.
The different subsite II DNA species are denoted by;
U = Unbound DNA fragment. c 1 = Complex 1.
c 2 = Complex 2.
Restriction
Fragment.
Inter-centre 
Distance (bp).
Mobility (mm] Relative Mobility
U c 1 c2 c 3 c 1 c 2 c 3
Mlu I -48.5 123 93 80 74 0.76 0.65 0.60
Btf II -42.5 122 91 78 72 0.75 0.64 0.59
Xho I -12.5 120 85 73 68 0.71 0.61 0.57
Eco RV -0.5 119 84 72 67 0.71 0.61 0.56
Pvu n 5.5 119 85 73 68 0.71 0.61 0.57
Sma I 11.5 119 86 74 69 0.72 0.62 0.58
Nru I 23.5 120 88 75 70 0.73 0.63 0.58
Rsa I 35.5 121 92 78 73 0.76 0.64 0.60
Bam HI 54.5 123 100 85 79 0.81 0.69 0.64
Table 3.2 Relative Mobilities of Complexes Generated with Subsite 
(II + 10) from pDB2118.
The different subsite (II + 10) DNA species are denoted by;
U = Unbound DNA fragment. c 1 = Complex 1. 
c 2 = Complex 2. c 3 = Complex 3.
It is clear from the mobility values listed for the two sets of unbound DNA that 
the subsite II and subsite (II + 10) fragments exhibit some degree of bending. The 
effects of this have been taken into account by calculating relative mobility values
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Key: Data Points Restriction Fragments.
■ complex 1 a = Mlu I b = Bgl II c = Xho I
□ complex 2 d = Eco RV e = Sma I f = Ssp I
g = Kpn I h = Bam HI
Figure 3.15. Analysis of Resolvase Induced Bending of Subsite II.
(a) TG 9.4 band shift assay of subsite II DNA fragments (generated from
digestion of pDB2060) with Tn3 resolvase (2-4 dilution of R17 f49). 
Restriction endonucleases used for lanes ’a* to ’h’ were as shown in 
the key.
(b) Plot of ’Relative Mobility’, of each complex generated, against the 
’Inter-Centre Distance’ of the fragment used. Relative mobility values 
were calculated by dividing the measured mobility of a retarded 
complex by that of the unbound DNA species in the same track. The 
inter-centre distance is the number of bases by which the centre of 
subsite II is offset from the centre of the DNA fragment used. Points 
are marked ’a’ to ’h’ to indicate the different DNA fragments used.
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■ complex 1 a = Mlu I b = Bgl II c = Xho I
□ complex 2 d = Eco RV e = Pvu II f = Sma I
♦ complex 3 g = Nru I h = Rsa I i = Bam HI
Figure 3.16. Analysis of Resolvase Induced Bending of Subsite (II + 10).
(a) TG 9.4 band shift assay of subsite (II + 10) DNA fragments (generated
from digestion of pDB2118) with Tn3 resolvase (2-3 dilution, R17 f47). 
Restriction endonucleases used for lanes 'a' to T were as shown in the 
key.
(b) Plot of 'Relative Mobility', of each complex generated, against the 
'Inter-Centre Distance' of the fragment used. Relative mobility values 
were calculated by dividing the measured mobility of a retarded 
complex by that of the unbound DNA species in the same track. The 
inter-centre distance is the number of bases by which the centre of 
subsite II is offset from the centre of the DNA fragment used. Points 
are marked 'a' to 'i' to indicate the different DNA fragments used.
for each of the complexes. The relative mobility values listed in Tables 3.1 and 3.2 
were calculated by dividing the measured mobility of a  complex by that of the 
unbound DNA in the same track. Relative mobility values were plotted against 
the 'inter-centre distance', which is the distance by w hich the centre of the subsite 
is displaced from the centre of the restriction fragment; used. From the graphs 
produced (Fig. 3.15 and 3.16) it can be seen that all the complexes analysed 
exhibit protein-induced bending, and it can be estimated that the bend centres for 
subsite II and subsite (II + 10) are at the centres of each subsite.
It is possible to examine whether the induced bending of complex 2 is greater 
than that of complex 1, by expressing complex 2 values relative to the mobility of 
complex 1; i.e. by dividing the mobility of complex 2 by  that of complex 1 from 
the same track. Complex 2 of subsite II did appear to show a small degree of 
additional bending when analysed in this way. Complexes 2 and 3 of subsite 
(II + 10) did not show additional bending in the equivalent analysis. However, 
the small differences involved in this secondary examination require that it is 
interpreted with caution.
3.7 DNase I Footprinting of Subsite II and Derivatives of Subsite II.
DNase I footprinting (as described in Chapter 2) was used to test if the position 
of resolvase bound to an isolated subsite II was the same as for subsite II within 
the res site. Both strands of subsite II (from pDB2004) were footprinted (Fig. 3.17). 
The observed patterns of protection from, and enhancement of cleavage were as 
reported for subsite II within res15'25. This technique was also used to determine 
whether resolvase was binding to subsites (n + 10) and (n + 5) as it was to subsite 
II. Only one strand of each altered subsite was footprinted (as shown Fig. 3.19 
and 3.20). This was considered an acceptable initial investigation because of the 
similarity of the footprints produced w ith each strand of subsite II. Footprinting 
gels of subsites (II +10) and (II + 5) are shown in Fig. 3.18. Comparison of the 
footprints for all three subsites (Fig. 3.19) suggests that the resolvase is contacting 
the ends of each subsite in a similar fashion. Each half of the subsites analysed 
can be aligned as shown in Fig. 3.20. If the nucleotides are then numbered from 
the left hand side, as indicated, positions 1 to 10 are predicted to be most 
important in the interaction between the DNA and the C-terminal domain of the 
resolvase68. Enhanced DNase I cleavage was observed on the top strand (as 
written) at the bonds between nucleotides 4 and 6, and on the bottom strand at 
the bond between nucleotides 1 and 2 (an A-C dinucleotide in each case). This 
suggests that some sort of resolvase-dependent bending or distortion occurs at 
these positions. No other bonds within the first 10 bases of the half-sites showed
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Figure 3.17. DNase I Footprint of Tn3 Resolvase Bound to Subsite II.
(a) Subsite II (-) strand. pDB2004 digested Eco RI/Bam HI, 3'end-labelled at 
Bam HI site. Sequence determined relative to Pst I digest of the same end- 
labelled material.
(b) Subsite II (+) strand. pDB2004 digested Sma l/H in  dill, 3'end-labelled at 
Hin d ill site. Sequence determined relative to Xba I digest of the same end- 
labelled material.
For (a) and (b), binding reactions (containing an R17 f49 dilution, or 
resolvase dilution buffer) were incubated in C8.2 buffer for 5 m in at room 
temperature, prior to the addition of DNase I (or DNase I dilution buffer). 
Samples were then incubated for a further 5 min at room temperature. The 
reactions were terminated by the addition of loading buffer, heated to 
80 °C and then loaded to an 8% polyacrylamide sequencing gel.
Lane R17 f49 dilution DNase I
1 R.H.B. D.D.B.
2 2-5 tf
3 R.H.B. 1 |xl @ 6.25 pg /m l
4 2-9 tf
5 2-8 »t
6 2-7 tt
7 T 5 tf
8 2-3 ft
9 marker sample
D.D.B. = DNase I dilution buffer.
The subsite sequence is placed approximately alongside the gel inside a 
box. Positions of enhanced cleavage are indicated by arrows. Regions of 
protection are indicated in Fig. 3.19 and 3.20.
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Figure 3.18. DNase I Footprint of Tn3 Resolvase Bound to Subsites 
(II + 5) and (II +10).
(a) Subsite (II + 5) (+) strand. pDB2507 digested Sma l/H in  d ill, 3’end- 
labelled at Hin d ill site. Sequence determined relative to Xba I digest of the 
same end-labelled material.
(b) Subsite (II +10) (+) strand. pDB2107 digested Sma l/H in  d ill, 3'end- 
labelled at Hin d ill site. Sequence determined relative to Xba I digest of the 
same end-labelled material.
For (a) and (b), binding reactions (containing an R17 f49 dilution, or 
resolvase dilution buffer) were incubated in C8.2 buffer for 5 min at room 
temperature, prior to the addition of DNase I (or DNase I dilution buffer). 
Samples were then incubated for a further 5 min at room temperature. The 
reactions were terminated by the addition of loading buffer, heated to 
80 °C and then loaded to an 8% polyacrylamide sequencing gel.
Lane R17 f49 dilution DNase I
1 R.H.B. D.D.B.
2 2-5 II
3 R.H.B. 1 pl @ 6.25 lig/m l
4 2-9 II
5 2-8 i i
6 2-7 H
7 2-5 i i
8 2-3 i i
9 marker sample
D.D.B. = DNase I dilution buffer.
The subsite sequence is placed inside a box (approximately) alongside the 
g e l . Positions of enhanced cleavage are indicated by arrows. Regions of 
protection are indicated in Fig. 3.19 and 3.20.
0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 2 2
1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2
I I I I I I I I I I I I I I I I I I I I I I
-T -G -T -C + C + A -T -T -A -A  A - T - C - G - T - C  A - ......................
-A + C -A -G -G -T -A -A -T -T  T A - G - C - A - G - T ......................
-T-G-T-C+T+A T -T  A - T - G - C - C - A  A A A  
-A+C-A G - A - T - A -A - T - A - C  G+G+T T -T  T-
T -G -T -C + C + A -T -T -A -A + A -T -C -G -T -C  A - T - T - T  A -T -  
A C A G G T A A T T T A G C A G T A A A T A
T G T C T A T T A T G C C A A A A T G A C G  
-A + C -A -G -A -T -A -A -T -A  C-G G -T -T  T T -A  C -T -G -C -
- T -G -T -C + C + A -T -T -A -A  A - T - C - G - T - C - A - t - T - T -  
A C A G G T A A T T T A G C A G T A A A
T G T C T A T T A T G C C A A A A T G  . . .
-A + C -A -G -A -T -A -A  T - A - C - G - G - T - T - T  T A C - . . .
I I I I I I I I I I I I I I I I I I I I I I 
0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 2 2  
1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2
Figure 3.20. Alignment of Halves of Subsite II and Its Derivatives, 
Showing Footprint Data.
Subsite halves are aligned from the first T of the TGT motif 
corresponding to position 1 of the top strand. Each half site is named 
according to the subsite from which it has come, and L or R, to indicate 
the left or right end. Descriptions of cleavage patterns (in the main text) 
use the numbering system shown. An approximation of the cleavage 
patterns observed is indicated by the symbols placed at bond positions 
within each sequence;
+ indicates enhanced DNase I cleavage in the presence of 
resolvase.
- indicates reduced DNase I cleavage (i.e. protection) in the 
presence of resolvase.
Where no symbol is present either no change was seen in DNase I cutting 
at that position, or no data were obtained for that bond. Dots are to assist 
comparison of the aligned sequences.
A more detailed representation of the same data is shown in Fig. 3.19.
HL
HR
(n+ io iL  
m + m  r  
(n+5) l  
(n+5) r
increased cleavage, and almost all exhibited some degree of protection.
3.8 M ethylation Interference Experiments Using Subsite II and Derivatives 
of Subsite II.
Methylation interference experiments were used to give further comparison of 
binding of resolvase to subsites II, (II + 10) and (II + 5), and to investigate the 
parts of each subsite required for the formation of each complex produced. The 
method used is described in Chapter 2, but the important features are outlined in 
Fig. 3.21. The principle of a modification interference experiment is that 
modification of a nucleotide which is involved in binding will result in the 
disruption of that particular interaction. To produce a clear interference pattern it 
is necessary to achieve approximately one modification per DNA fragment used.
The modification experiments were conducted using dimethyl sulphate to 
methylate the G residues of each subsite. Only one strand of each subsite was 
analysed (shown in Fig. 3.22 and 3.23). The results of the methylation 
interference experiments for subsites II, (11 + 10) and (II + 5) are shown in Fig.
3.22. These results are summarised in Fig. 3.23. Again the results were similar for 
each of the subsites investigated. Methylation of the G residue at position R2G of 
each subsite prevented formation of complex 2 (and other more retarded 
complexes), but appeared not to interfere with complex 1. The production of 
complexes was affected by the methylation of only one other G residue. 
Modification of the G residue at position L5G of each subsite prevented 
formation of all complexes. Both of these positions have been shown to be 
important in the binding of resolvase to subsite II of an intact res site, as have the 
equivalent nucleotides on both strands of subsites I, II and III15'25. However, 
differences in the importance of each residue were not previously observed as 
the experiments did not involve analysis of material from complex 1.
Methylation of some residues in subsite (II + 5) gave enhanced binding of 
resolvase. The position of methylation of these bases is unknown.
3.9 Binding of y5 Resolvase, and y8 M utant M106C, to Subsites II, (II + 5) 
and (II +10).
To allow further comparison of binding of the Tn3 and y8 resolvases, dilutions of 
y8 resolvase were used in TG 9.4 band shift assays with subsites II, (II + 10) and 
(II + 5), (described in sections 3.4.1 and 3.5.1). A m utant of y8 resolvase, M106C 
(supplied by Nigel Grindley), was also used.
M106C has a methionine to cysteine substitution at amino acid position 106 of the 
y8 sequence. This residue is at the subunit interface in the crystal 1-2 dimer74. It is
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Modified DNA
End-labelled DNA.
Modify DNA at 
specific bases (to an 
average of one 
modification per 
fragment)
B i n d i n g  R e a c t i o n s .
m n i n k u i
*■
+-
Isolate gel chips 
containing bands of 
interest. Extract DNA 
from each. Treat purified 
DNA with piperidine, to 
cleave at modified 
positions. Denature 
samples and run on 
sequencing gel.
Marker Fragment 
(digested labelled 
fragment)
Gaps indicate 
positions at which 
modification 
interferes with 
complex formation.
Figure 3.21. Outline of Modification Interference Experiments.
DNA molecules are represented by double lines, with thicker lines
indicating the binding site. * indicates 32P labelled DNA strands, and 
is used to denote points of modification, with some of the possible 
modifications being shown for one strand only. DNA species on gels 
were visualised by autoradiography.
In the experiments described in this chapter the form of modification 
used was methylation (mainly of G residues) by dimethyl sulphate.
(a)> subsite II
R11G
L16G
L13G
(b) sulibsite (II + 5)
1 22 3 4 5 6
RUG
R19G
L16G— [
L13G-
L5G-  
L4G— [
(c) subsite (11 + 10) 
1 2 3 4 5err■Hi
R2G-----
R11G-----
R19G-----
R22G-----
L16G-----
L13G-----
L5G-----
L4G-----
J
Figure 3.22. M ethylation Interference of Tn3 Resolvase Binding to 
Subsites II, (II + 5) and (II +10).
Bam HI/P st I fragments carrying subsite II (pDB2004), subsite (II + 5) 
(pDB2507) or subsite (II +10) (pDB2107) were 3'end-labelled at the Bam HI 
end (giving labelled (-) strand). Methylation, complex formation and 
sample preparation were as described in Chapter 2, and summarised in 
Fig. 3.21. These samples were run on an 8% polyacrylamide sequencing 
gel. Xba I digested DNA samples were also run (not shown) as markers of 
sequence position.
Lane Sample
1 methylated DNA stock
2 unbound DNA band
3 complex 1 band
4 complex 2 band
5 complex 3 band
6 complex 4 band
G residues are marked and numbered as described in Fig. 3.20. Those 
which are shown to be required for complex formation are underlined. The 
start and end of each subsite sequence is marked by an unlabelled line.
(a) Subsite n.
(b) Subsite (II + 5).
(c) Subsite (II +10).
0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 2 2
1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2
I I I I I I I I I I I I I I I I I I I I I I
-T -G -T -C + C + A -T -T -A -A  A - T - C - G - T - C  A - ......................
H !  I I I 6 4 I M M M 6 M 6 I
-A +C -A -G -G -I-A -A -I-T  X A - £ - £ - A - £ - X ...................
-I-G -I-C + I+ A  T - I  A-X-G-C-C-A A A A  
DR I 9 I I I I I I I I 9 I I I I I I
-A+C-A G - A - T - A -A - T - A - C  G+G+T T -T  T-
T -G -T -C + C + A -T -T -A -A + A -T -C -G -T -C  A - T - T - T  A -T -
(n+iO)L I i i 6 4 l l l l i l l 6 l l 6 l l l l l l
A C A G G X A A X T T A G C A G T A A A X A
T G T £ T A T T A X G £ £ A A A A T G A £ G  
(n+10)R I 9 I I I I I I I I 9 I I I I I I I 9 I I 9
- A + C -A -G -A -T -A -A -T -A  C-G G -T -T  T T -A  C -T -G -C -
-T -G -T -C + C + A -T -T -A -A  A - T - C - G - T - C - A - T - T - T - . .
(n +5) L I i i d ) 4 l l i i 4 i i 6 l l 6 l l l l
A £ A £ £ X A A X X X A £ £ A Q X A A A .  .
X £ X £ X A X I A X £ £ £ A A A A X Q .  . .
(n+5)R I 9 I ?  I I I I I 1 9 9 9 1  I I I 1 9
-A + C -A -G -A -T -A -A  T - A - C - G - G - T - T - T  T A C - . . .
I I I I I I I I I I I I I I I I I I I I I I
0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 2 2  
1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2
Figure 3.23. Summary of Data From M ethylation Interference 
Experiments.
Subsite halves are aligned from the first T of the TGT motif 
corresponding to position 1 of the top strand (as in Fig. 3.20). Each half 
site is named according to the subsite from which it has come, and L or R, 
to indicate the left or right end. DNase I protection patterns (as described 
in Fig. 3.20) are retained for reference.
Methylation interference data are indicated as follows:
#  methylation inhibits formation of all complexes.
O methylation inhibits formation of all complexes except complex 1. 
o  no effect of methylation observed.
•  methylation gives enhanced formation of some, or all, complexes.
Methylation symbols are placed directly above or below the modified 
base. Sequences for which methylation interference was investigated are 
indicated by underlining. For G residues the interfering modification is 
expected to occur at position N-7, facing into the major groove. For other 
modified bases the position of the modification is unknown.
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proposed that a 1-2 dimer binds to res34. The sample of M106C used had been 
oxidised to create a disulphide bond between the subunits of the dimer. Fig. 3.24 
shows Tn3 resolvase, 78 resolvase and M106C, run on denaturing polyacrylamide 
gels, under reducing and non-reducing conditions. Under reducing conditions all 
three proteins run as monomer sized species. The same is also true for Tn3 and y5 
resolvase under non-reducing conditions, but the M106C sample predominantly 
contains a resolvase dimer sized species (although some monomer sized material 
is present). This would suggest that the cysteine residues at position 106 of 
M106C have been linked to create dimers.
Binding of 78 and M106C resolvases to Tn3 subsite II, and subsites (II + 10) and 
(II + 5) is shown in Fig. 3.25,3.26,3.27 and 3.28. Binding of Tn3 resolvase is also 
shown in Fig. 3.25, for comparison. It is very striking that for all three subsites 
examined the same pattern of complexes is generated w ith the 78 and M106C 
resolvases. This supports the proposal that the crosslinked dimer observed for 
M106C is the dimer involved in binding of 78 resolvase. Although such results do 
not prove that the 78 resolvase binding unit is a dimer, they certainly support this 
argument. To interpret the pattern of complexes produced in this way requires 
that the monomeric resolvase observed in M106C is also capable of binding (see 
Chapter 7). As with Tn3, the complexes produced are num bered in order of 
increasing retardation. This is not meant to suggest that all complexes with the 
same name are necessarily thought to be equivalent species.
For subsite II the complexes generated with 78 and M106C resolvases appear 
similar to those observed with Tn3 resolvase. Complex 1 appears faint at quite 
low resolvase concentrations, and remains faint in the presence of more 
resolvase. Complex 2 appears as the major complex for all tracks in which 
binding was observed. A third complex is produced with the highest resolvase 
levels, as was sometimes observed using Tn3 resolvase. However, complex 3 is 
also visible at lower concentrations of 78 and M106C resolvase, and appears as a 
stronger band than with Tn3 resolvase. The concentration range over which 
M106C binding is observed is much larger than with Tn3 resolvase, while the 78 
range appears to be somewhere in between.
The range of concentrations over which M106C resolvase bound to subsites 
(II + 10) and (n + 5) also appeared greater than for Tn3 resolvase (with 78 in 
between again). However, the complexes produced seemed dissimilar to those 
generated with Tn3 resolvase. Binding of the 78 and M106C resolvases to subsite 
(II + 10) produced at least three complexes. Complex 1, unlike that for Tn3, was a
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y8 M106C 
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Figure 3.24. Denaturing PAGE of Tn3, y8 and yd M106C Resolvase 
Samples.
(a) Dilutions of resolvases with 2-mercaptoethanol as a denaturant.
(b) Dilutions of resolvases with urea as a denaturant.
Lane Resolvase
1 neat R17f48
2
2-l • •
3 2 - 2 It
4 neat yd
5 2-l ft
6 2 - 2 ii
7 neat Y5M106C
8 2-l II
9 2 - 2 II
Gel (a) does not give a comparison of the relative resolvase concentration 
of each sample as some material leaked from the wells after loading.
(a) subsite II subsite (II+5) subsite (11+10)
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6
(b) 1 subsite II subsite (II+5) subsite (11+10)
! 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6
Figure 3.25. Comparison of Tn3 and y5 Resolvase Binding to Subsites II, 
(II + 5) and (II +10).
(a) Binding of Tn3 Resolvase (R17 f49).
(b) Binding of yb Resolvase.
End-labelled subsite II (pDB2004 Eco RI/H in  dill), subsite (II + 5) (pDB2507 
Eco RI/Hm  dill) or subsite (II + 10) (pDB2107 Eco RI/Hm  dill) was 
incubated for 10 min at 37 8C with a resolvase dilution (as indicated) using 
TG 9.4 conditions.
Lane Resolvase Dilution
1 R.H.B.
2 2" *
3 2"7
4 T 6
5 2'5
6 2"4
y§ M106C resolvase y8 resolvase
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Figure 3.26. Binding of y5 and y8 M106C Resolvases to Subsite II.
End-labelled subsite II (pDB2004 Eco RI/Hm dill) was incubated for 10 min 
at 37 °C with resolvase, as indicated, using TG 9.4 conditions.
Lane Resolvase sample Lane Resolvase sample
1 R.H.B. 11 2-5 ySM106C
2 2'14 y8 M106C 12 2'4 t!
3 2~13 " 13 2-3 ft
4 2-12 14 2-8 y5
5 2~11 •• 15 2-7 tt
6 2_10 * 16 2-6 it
7 2-9 " 17 2-5 tt
8 2~8 •• 18 2‘4 tt
9 2-7 •• 19 2-3 tt
10 2-6 »
y8 M106C resolvase 78 resolvase
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Figure 3.27. Binding of yb and yb M106C Resolvases to Subsite (II + 10).
End-labelled subsite (II + 10) (pDB2107 Eco RI/Hm dill) was incubated for 
10 min at 37 °C with resolvase, as indicated, using TG 9.4 conditions.
Lane Resolvase sample Lane Resolvase sample
1 R.H.B. 11 2-5 y8 M106C
2 2"14 yS M106C 12 2-4 II
3 2 ” 1 3  « 13 2-3 II
4 2 " 1 2  » 14 2-9 yb
5 2 ~ l  1  " 15 2 - 8 ♦t
6 2 _ 1 0  m 16 2 - 7 »f
7 2 _9  ti 17 2 - 6 i»
8 2 * 8  » 18 2 - 5 it
9 2 - 7  ti 19 2 - 4 ii
10 2_6 " 20 2 - 3 1
yd M106C resolvase yd resolvase
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Figure 3.28. Binding of yb and yb M106C Resolvases to Subsite (II + 5).
End-labelled subsite (II + 5) (pDB2507 Eco RI/Hm dill) was incubated for 
10 min at 37 °C with resolvase, as indicated, using TG 9.4 conditions.
Lane Resolvase sample Lane Resolvase sample
1 R.H.B. 11 2-5 y8M106C
2 2'14 y8 M106C 12 2'4 ff
3 2"13 » 13 2-3 tf
4 2-12 '• 14 2-9 yb
5 2"ll " 15 2-8 ft
6 2~10 » 16 2-7 if
7 2-9 » 17 2-6 ff
8 2-8 » 18 2-5 if
9 2-7 " 19 2-4 ft
10 2"6 » 20 2-3 ff
m inor complex, when present. Although the second complex was the strongest at 
low resolvase concentrations, complex 3 clearly became the major species as 
resolvase levels were increased. Some faint, highly retarded complexes were 
visible in many of the tracks.
Four complexes were observed on binding of 76, M106C or Tn3 resolvase to 
subsite (II + 5). However, as with subsite (II + 10), complex 1 for the y8 and 
M106C resolvases was a minor species, where present. Again complex 2 was the 
major band only at low resolvase concentrations, with complex 4 the major 
species in most tracks. The increase in amounts of complex 3 trailed that of 
complex 4, but complex 3 remained faint at all times.
The results described in this section are very suggestive regarding models of 
binding for y5 resolvase, and also Tn3 resolvase. However, the results presented 
in Chapter 5 are also very significant, and so binding models will be discussed, in 
light of all the results presented, in Chapter 7.
3.10 Binding of Resolvase to Each Half of an Altered Subsite II.
Binding of intact resolvase to one isolated half of a res subsite has not been 
demonstrated. Tn3 resolvase has been shown to generate one complex on 
binding to a fragment containing subsite I sequence lacking the first eight bases 
(of a total of twenty-eight), from the left hand end7. The C-terminal dom ain of y8 
resolvase has also been shown to produce one complex on binding to a DNA 
fragment containing all of subsite I, bar the first five bases of the left end68.
A derivative of subsite II (subsite IIBN, Fig. 3.29) was designed with two 
particular aims in mind. By introducing two restriction endonuclease sites (by 
base substitutions) at specific points within the subsite II sequence, DNA 
fragments could be produced containing pieces of the subsite which contain 
slightly more, or slightly less, than half of the subsite. However, w ith two 
restriction sites, each end of the subsite could be produced as the smaller, or 
larger, fraction of the subsite. Secondly the restriction endonuclease sites could 
be used to reduce the spacing between the ends of subsite II (by site cleavage 
with filling or polishing of sticky ends, followed by re-ligation), or to increase the 
spacing [as w ith subsites (II + 10) and (II + 5)] by the insertion of additional 
DNA. The subsite was cloned to pUC18 such that restriction endonuclease 
digestion (i.e. Bam HI and Bgl II or Nsi I and Pst I), followed by ligation, could be 
used to produce derivatives in which one half of subsite IIBN is deleted. From 
these derivatives fragments containing a half-site, surrounded by non-Tn3 
sequence, could be produced.
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(a)
P v u n
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subsite IIBN
Avan pDB2201
2734 bp
Hindin
HincU
Xbal
BamHI
Smal
Kpnl
— Pvun SadEcoRI
Avail
(b)
Subsite IIBN Bgl nEcoRI SstI Kpnl Smal BamHI Xbal 
G|AATTCGAGCTlC:GGTACpC|3GGt3ATCCT|CTAGATGAGfrGTCCATTA|3ATC7TCA 
CTTAA|GCtrCGAGdCATGGGbcCCTAGt3AGATCh,ACTdACAGGTAATCTAGt!A G T
Nsi I Subsite IIBN Xbal Sail PstI SphI Hindffl
TTTiiGCAfTAATAGACA|CATCT|CTAGAGfrCGACCTGCA|3GCATGt:A|AGCTT
JTAGAGATC |TCAGCT13G|aCGTCC|3TACGTTCGAK
Figure 3.29. Map of pDB2201.
(a) Map of pDB2201.
(b) Sequence of polylinker region of pDB2201, showing inserted subsite 
IIBN fragment (in bold type). The shaded region within the subsite 
indicates substitutions for subsite II sequence.
3.10.1 Construction of Subsite IIBN.
The design and synthesis of subsite IIBN was as described for subsite II(P) 
(section 3.6), except the sequence of subsite IIBN contained the following 
substitutions (numbered from left or right end of subsite II, as indicated in Fig. 
3.20);
A to G at position L10A. G to T at position L14G.
G to T at position R13G. T to A at position R14T.
The complete sequences of the two oligonucleotides synthesised are given in Fig. 
3.29 (and Chapter 2). The substitutions in the left hand side of the subsite 
produce a Bgl II site, while those on the right create a Nsi I site (Fig. 3.29). The 
Xba I fragment produced was cloned to the Xba I site of the pUC18 polylinker, 
giving pDB2201 (Fig. 3.29). The sequence and orientation of subsite IIBN in 
pDB2201 was checked by Sanger di-deoxy sequencing.
3.10.2 Band Shift Analysis of Tn3 Resolvase with Subsite IIBN.
Tn3 resolvase bound less well to subsite IIBN than to subsite II, under TG 9.4 
band shift assay conditions. This was not a result of differences in the 
preparation of the DNA fragments used, as the same effect was observed when 
the two fragments were mixed in a binding reaction (Fig. 3.30). Tn3 resolvase 
failed to bind to each of the partial subsites produced, by restriction 
endonuclease digestion, from subsite IIBN (Fig. 3.30).
Substitution of the A at position 10 left (to G, used to introduce the Bgl II site) has 
probably had the greatest effect on the binding of resolvase. Substitution of 
position 10 Right of y5 subsite I was shown to greatly reduce the affinity of the 
C-terminal domain of y8 resolvase for the subsite68. None of the other 
substitutions introduced have been shown to greatly affect the binding of 
resolvase, and so the lack of binding of resolvase to the right end fragments of 
subsite II is still considered to be significant.
3.11 Co-operativity of Resolvase Binding.
A similar degree of binding to subsite II was observed at the highest 
concentrations of Tn3 resolvase (Fig. 3.13a) and y8 M106C (Fig. 3.26) used (i.e. at 
a 2^  dilution of each stock solution). However a 2-8 dilution of Tn3 resolvase 
produced very little complex with subsite II, yet with an equivalent dilution of 
M106C almost 50 % of the subsite II fragment present was in retarded complexes. 
Even with a 2 '13 dilution of M106C resolvase some subsite n  complex was 
generated. The absolute concentration of the M106C resolvase stock is unknown, 
but comparison with Tn3 resolvase (Fig. 3.24) suggests that the Tn3 resolvase
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subsite II(p)subsite IIBN
Figure 3.30. Binding of Tn3 Resolvase to Subsite IIBN.
(a) Binding to subsite IIBN.
End-labelled subsite II(P) (pDB2054 Eco 'Rl/Hin dill) or subsite IIBN 
(pDB2201 Eco R l/H in  dill) was incubated for 10 min at 37 °C with Tn3 
resolvase (dilutions of R17 f49, as indicated) using TG 9.4 conditions. 
Lane Resolvase Lane Resolvase
1 R.H.B. 7 2-5
2 2-10 8 2-4
3 2-9 9 2-3
4 2*8 10 2"2
5 2-7 11 2 '1
6 2-6
(b) Binding to Partial Subsites.
End-labelled DNA was incubated as in (a). Lane numbers correspond to 
resolvase dilutions as for (a). End-labelled DNA fragments were as follows: 
A subsite II (pDB2004 Eco B l/H in  dill) +
subsite IIBN (pDB2201 Eco Rl/H in  dill)
B subsite IIBN (pDB2201 Bam H l/H in  dill) digested by Bgl n
C subsite IIBN (pDB2201 Bam H l/H in  dill) digested by Nsi I
D subsite IIBN (pDB2201 Bam H l/H in  dill)
All resolvase-dependent complexes in tracks containing partial subsites are 
the result of binding to undigested subsite IIBN fragment.
stock is about 2-fold more concentrated than the M106C stock. Hence the most 
likely explanation for the observed binding differences is that Tn3 resolvase is 
binding to subsite II in a co-operative manner. Binding of the M106C dimer (to 
give complex 2) would be expected to be non-co-operative, unless more than 1 
dimer is bound to each subsite.
The amounts of DNA in complex 2 and in the unbound band were m easured for 
each lane containing Tn3 resolvase with subsite II (Fig. 3.13a) and M106C with 
subsite II (Fig. 3.26). Measurements were made by analysing an autoradiograph 
of each gel, using a scanning densitometer. The values produced were used to 
calculate the ratio c2/c0, where c2 is the amount of DNA in complex 2, and cO is 
the amount of DNA in the unbound band. A graph of log2(R) against Iog2(c2/c0) 
was plotted for each set of binding reactions (Fig. 3.31), where R is the relative 
concentration of resolvase used (i.e. the resolvase dilution factor). The 
densitometer did not detect any complexed material in the 2-8 Tn3 resolvase 
track, but some complex 2 was visible on the autoradiograph. An estimate was 
made of the upper limit of c2/c0 for this sample, and this point was also plotted. 
If this point is included, the Tn3 data set gives a line with a gradient of >1, 
whereas the M106C data give a gradient of about 1. Inclusion of estimated values 
for M106C samples which were below the sensitivity of the densitometer did not 
alter the gradient of the line produced.
For a simple binding system in which the protein, P, binds to DNA site, D , to 
give complex, PD, following the equation
P+Dx=*PD 
the dissociation constant, Kd, is defined as;
When the protein is in large excess it can be assumed that [P] * [P]0, where [P]o is 
the initial concentration of unbound protein, and so;
If the amount of bound DNA, b, and unbound DNA, u, can be determined (the 
absolute concentrations are not required) then
M = M , E 3 a
[D] k d  k d
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Figure 3.31. Comparison of Tn3 and yd M106C Resolvases B inding to 
Subsite II.
The ratio of DNA in complex 2 (c2) to unbound DNA (cO) in each track 
was calculated from values produced by measuring the intensity of bands 
on the relevant autoradiographs, using a scanning densitometer. The 
tracks for which measurements were made are shown in Fig. 3.13 (Tn3 
resolvase) and Fig. 3.26 (yd M106C resolvase). R is the dilution factor of 
(stock) resolvase added to the binding reaction.
Using a 2"8 dilution of Tn3 resolvase (with subsite II) a small am ount of 
complex 2 was observed. However no complex 2 was detected w hen this 
track was scanned using the densitometer. An estimated value (upper 
limit) has been plotted for this track, demonstrating a difference between 
the two sets of binding reactions.
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=» log f - ]  = los[p] -  logKD = log[P]0 -  logKD
Hence a plot of log^—J against log[P]o should give a straight line w ith an x-axis
intercept of -logKD- For a simple binding mechanism a line with a gradient of 1 is 
expected (i.e. a two-fold increase in resolvase concentration corresponds to a 
two-fold increase in the ratio of bound to unbound DNA). A gradient of >1 is 
expected for co-operative binding.
For a number of reasons these equations can not be applied directly to 
information produced by scanning autoradiographs of the band shift assays 
described in this chapter.
(i) Sensitivity of Scanning Densitometer.
The scanning densitometer used does not give accurately values for the 
faintest or most intense bands observed. This can give misleading results.
(ii) Sensitivity of Autoradiograph Film.
The response of the autoradiograph film is not linear for all activities 
detected. The faintest and most intense bands produced lie outw ith the 
linear response range of the film. This will compound the problems 
associated with the sensitivity of the scanning densitometer.
(iii) Detection of Complexes by the Band Shift Analysis Method.
The complexes observed by the band shift assay may not accurately reflect 
those present in solution. Unstable complexes could be lost during 
electrophoresis. If such complexes remain intact for the time it takes to 
enter the gel matrix they may dissociate to give DNA smearing. In this 
case the amount of unbound material is likely to be accurately detected, 
but not the total DNA present.
(iv) Presence of Competitor DNA.
Including competitor DNA in binding reactions can alter the actual free 
resolvase level in each sample, which may not be in vast excess over the 
target DNA fragment. The actual free resolvase concentration m ay not 
change linearly with the concentration of resolvase added when 
competitor DNA is present.
(v) Differences from Simple Binding Model.
Binding of resolvase, even to subsite n , does not fit the simple equation
P+Dv=*PD
For M106C resolvase, ignoring complexes of the monomeric resolvase (i.e. 
complex 1; see Chapter 7), more than one complex is produced. Complex 2
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is proposed to contain dimer-bound subsite, but the nature of complex 3 is
unknown. Hence an equation such as
n P j+ D ^  (n-1 )P2+DP2^  DPn(2>
where P2 is a resolvase dimer; n is an unknown number; DP2 is complex 2 
and DPn(2) is complex 3, may better describe this binding reaction.
Binding of Tn3 resolvase to subsite II can probably be described by the 
equation
2P+D P+DP DP2
where P is a monomer of resolvase; DP is complex 1 and DP2 is complex 2. 
It has not been shown conclusively that complex 1 is an intermediate in 
the formation of complex 2.
If the stoichiometry and the relationship of the complexes formed in these 
binding reactions is known, then measurements of the amounts of DNA in bands 
produced can be used to examine the nature of the binding which produces 
them. Removing carrier DNA from resolvase binding reactions does not assist 
analysis as, for the conditions used, this can cause aggregation of the complexed 
material.
Looking at Fig. 3.13a, it is clear for subsite II that the amount of | complex 2 
produced at low Tn3 resolvase concentrations is more than doubled by a 2-fold 
increase in the concentration of resolvase added. If the am ount of complex 1 
present is considered insignificant, and the presence of carrier DNA does not 
give a non-linear relationship between the actual and assumed free resolvase 
concentration, then this shows that Tn3 resolvase binding to subsite II to produce 
complex 2 is co-operative. The contrast to the behaviour of M106C resolvase in 
the equivalent assay suggests that the non-linear concentration dependence of 
Tn3 resolvase is unlikely to be an artefact of the binding assay. The data from 
M106C (e.g. Fig. 3.31) are consistent with non-co-operative binding to subsite II.
Due to the presence of more than 1 major complex in most of the other binding 
samples produced (and the lack of information regarding the relationship of 
these complexes) this method of interpretation is unsuitable for the other band 
shift assays described in this chapter.
3.12 Conclusions.
Band shift assays of the Tn3 res/resolvase system gave different patterns of 
complexes when gel conditions were varied. The same was true for the 78 and 
Tn21 systems, but this alone did not account for observed differences of the Tn3 
pattern from those of the 78 and Tn21 systems. Tn3 resolvase bound to subsite II
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sequence when isolated from the rest of res, and the insertion of 10 bp or 5 bp of 
additional DNA at the centre of the isolated subsite II sequence (giving subsite 
(II +10) and subsite (II + 5) respectively) did not appear to inhibit binding of Tn3 
resolvase to the subsite. However band shift assays of the two altered subsites 
did produce patterns of complexes different from that of normal subsite n.
DNase I footprinting of subsites II, (II + 10) and (II + 5) suggested that resolvase 
was binding to each end of each subsite in a similar way. Methylation 
interference experiments, using the same subsites, suggested that the same 
residues (towards the outer ends of the subsites) were involved in the 
resolvase/subsite interactions of each subsite.
Bend analysis of subsite II and subsite (II + 10) showed resolvase-induced 
bending in all complexes observed for both subsites, but it was not evident that 
the degree of bending was increased in any complex, beyond that observed for 
complex 1.
No retarded complexes were observed in band shift assays of Tn3 resolvase with 
(approximate) halves of a modified subsite II, but this may have been a result of 
the sequence modifications made, as binding of Tn3 resolvase to the complete 
element was poorer than to a normal subsite II sequence.
Purified yS resolvase was shown to bind to Tn3 subsite II and to subsites (II + 10) 
and (II + 5). A m utant of y8 resolvase, M106C, which consisted mainly of 
covalently linked resolvase dimers, was also shown to bind to subsites II, (II + 10) 
and (II + 5). The patterns of complexes produced with y8 resolvase were 
remarkably similar to those observed with M106C, supporting the beliefs that 
dimers are the predominant species in y8 resolvase in solution, and that the 
dimer formed by the covalent linking of two M106C monomers is equivalent to 
the dimer involved in binding of y8 to the res site. The differences in the patterns 
of complexes produced by binding of y8 resolvase, or of Tn3 resolvase, to subsite 
II [or (II +10), or (II + 5)] are consistent with the idea of y8 resolvase being mostly 
dimeric, and of Tn3 resolvase being predominantly monomeric in this assay.
By the qualitative criteria defined, co-operative binding was observed in the 
formation of complex 2 of Tn3 resolvase with subsite II.
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Chapter Four 
Production and Purification of 3H-Resolvase
4.1 Introduction.
Determination of the stoichiometry of res/resolvase complexes requires that 
DNA and protein can each be quantified by distinct, yet compatible means. 32P 
end-labelling of DNA fragments is a technique commonly used in molecular 
biology and, as such, was the method of choice for this work. However, the 
means by which resolvase levels should be evaluated was not so obvious.
Having access to purified resolvase, in vitro 125I labelling was an option27; 
however it was possible that the degree of protein modification involved in this 
technique may have affected the binding activity of the labelled species. Another 
approach, using purified protein, would have been to raise antibodies against 
resolvase and use radiolabelled or enzyme-linked antibodies to quantify the 
am ount of protein present50. This approach has potential problems due to the 
circuitous nature of protein quantification by immunoblotting. A third option 
was to radiolabel resolvase as it was translated, prior to purification. This could 
be done in vivo by adding labelled amino acids to medium which is then used to 
grow an expression strain94. In theory this method is also applicable to in vitro 
translation systems, but the availability of a proven in vivo expression strain 
m ade this unnecessary.
The choice of isotope for protein tagging was set by two main criteria; 
compatibility with 32P for dual counting, and availability of affordable modified 
amino acids. ^S-methionine was available within the department, but 35S and 
14C both have decay energy spectra considerably overlapping that of 32P. Quite a 
large number of tritiated amino adds could also be purchased, and the decay 
spectra of 3H and 32P can be easily distinguished, if the 3H activity can be kept in 
excess of 32P activity. For these reasons pilot resolvase expression experiments 
were conducted using both ^S - and 3H-labelled amino acids.
The proposed approach to resolvase purification was to adapt the large scale 
resolvase purification method used to prepare the Tn3 resolvase fractions used in 
Chapter 3 (M. Boocock; pers. comm.). It was necessary to considerably reduce the 
scale of the procedure in order to produce radiolabelled protein of a high specific 
activity, without using excessive amounts of isotope in the induction steps. The 
procedure was expected to be adaptable to lower resolvase levels, as it was 
previously scaled up during its adaptation from other published methods46'64. 
The large scale protocol had been used successfully on more than one occasion 
but, although the general features remained constant, no one purification had 
been reproduced exactly.
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4.2 Tn3 Resolvase Expression Vector pMA6111.
The plasmid pMA6111 (Fig. 4.1) was used to express Tn3 resolvase in the E. coli 
strain JM101. This 4.5 kb plasmid was constructed (by M. R. Boocock) by 
subcloning a 1.3 kb tnpR+ Eco R l/H in  din fragment from pMA49815 to 
pKK223-314, such that resolvase expression is driven by the IPTG inducible tac 
promoter upstream of the Eco RI site.
Over-expression of resolvase from this plasmid (generally by growth in liquid 
media containing between 0.1 mM and 1 mM IPTG) was associated with very 
poor growth of the host cells (compared with an identical culture without 
induction). Where growth rates were not reduced upon IPTG induction it was 
often found that plasmid rearrangements had occurred, resulting in reduced 
resolvase expression. The decrease in post-induction growth rates was used as an 
indirect indicator for the selection of cultures to be used for resolvase expression. 
This 'induction test7 is described in section 4.4.1.
4.3 Pilot Expression of 3H-Resolvase.
Pilot experiments were conducted in order to determine appropriate conditions 
for the expression of resolvase with sufficient incorporation of the isotope used. 
The only resolvase expression strain used was JM101 pMA6111, and all 
inductions used 10 ml cultures. Both (^S-methionine) and 3H (a mix of 
tritiated arginine, isoleudne, leucine, threonine and valine) were tested as 
candidate isotopes, using minimal media based on D & M salts, M9 or M63 
media (defined in Chapter 2). The effects of varying the point of induction, the 
point at which isotope was added and the total expression time were 
investigated.
Levels of resolvase expression were estimated by comparing induced and 
uninduced samples on Laemmli gels. Incorporation of isotope was checked by 
isolating bands of interest from such gels, dissolving the polyacrylamide chip (as 
described in Chapter 2), adding sdntillant and then counting the sample. The 
conditions favoured, as a result of these comparative experiments, were those 
described in section 4.4.
4.4 Small Scale Resolvase Purification.
Once suitable conditions had been found to produce radiolabelled resolvase, it 
was necessary to purify the protein on a scale compatible with the levels of 
isotope which could be used. The growth media (liquid or solid) used 
throughout the expression protocol for the maintenance and induction of JM101 
pMA6111 cells contained:
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Figure 4.1. Tn3 Resolvase Expression Vector pMA6111.
Resolvase expression from the tac promoter is IPTG-inducible, but occurs 
(at lower levels) in the absence of IPTG. The Tn3 sequences inserted to 
pKK223-3 include some, but not all, of the am pidllin resistance gene, pla, 
also present in pKK223-3.
1 x Davis and Mingioli minimal salts 
0.2 % glucose 
5 Mg/ml vitamin Bi 
100 pg /m l Ap.
For simplicity this is referred to as MA medium during the description of these 
experiments.
The method of resolvase induction used for all attempts at small scale 
purifications was similar to that of RD 8 (section 4.4.1). The steps involved in the 
resolvase expression and purification are outlined in Fig. 4.2 and Fig. 4.3, 
respectively.
4.4.1 Expression of Resolvase in Induction RD 8.
JM101 pMA6111 was streaked from -70 °C stocks on to MA plates and incubated 
at 37 °C for 2 days. Colonies from these plates were streaked onto fresh MA 
plates and grown (37 °C) for another two days. Individual colonies were used to 
inoculate 4 x 10 ml aliquots of MA broth (one for each isolate of JM101 
pMA6111). These cultures were grown overnight at 37 °C with aeration (by 
shaking). In the tables of optical density values (Tables 4.1 and 4.2) italics are 
used to indicate the sample used for the resolvase induction.
Isolate A^ OOnm
JM101 pMA6111 #la 0.672
JM101 pMA6111 #lb 0.750
JM101 pMA6111 #3a 0.702
JM101 pMA6111 #3b 0.758
Table 4.1 Optical Density of Overnight JM101 pMA6111 Cultures for RD 8.
The A^oonm of the cultures was measured (Table 4.1) and 2 ml of each sample 
was diluted 50 fold in 100 ml of MA broth and then grown with shaking at 37 °C 
in a 21 flask. At the same time 200 pi of each sample was diluted 50 fold into 
10 ml MA broth and into 10 ml MA broth containing 0.2 mM IPTG. Both 
dilutions were grown at 37 °C with shaking in 20 ml boiling tubes. This was to 
check that the isolates of JM101 pMA6111 grew well in the MA broth, indicating 
few plasmid-free cells, but grew very poorly in the presence of IPTG, as 
previously observed with high levels of resolvase expression from pMA6111. 
These 'induction tests' were grown for 6 h and then compared by eye.
The desired point of induction was at an A6oonm of around 0.6; therefore the
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(a)
Inoculate JM101 pMA6111 into 10 ml 
minimal media. Grow overnight, 37 *C 
with shaking.
Dilute 2 ml of culture (A goonm = 0.7-1.0)
50-fold in fresh media in a 21 flask. 
Grow 37 *C with shaking.
Induction Test.
At Afcoonm = dilute culture 2-fold 
in prewarmed induction media, t j=0.
Transfer 100 ml of induced culture into 
prewarmed 21 flasks. Grow at 37 *C 
with shaking.
RD9 RD8
At tj = 20 min, add 1 mCi 3H- At tj = 20 min add 1 ml
amino adds in 2% ethanol. sterile 2% ethanol. Grow,
Grow, 37 *C with shaking. 37 *C with shaking.
T
At tj = 60 min, transfer to centrifuge 
tubes at 4 G and harvest cells.
T
Separate cell pellet and supernatant. 
Store each at -20 *C.
(b)
Induction Test
Overnight culture of JM101 pMA6111.
Dilute 50 ixl, 50-fold in 
fresh media + IPTG.
Dilute 50 pi, 50-fold 
in fresh media.
Grow for > 4 h at 37 *C, with shaking.
Measure A Measure A,600n m *
Figure 4.2 Summary of Resolvase Expression in Induction RD 8 and 
RD 9.
(a) RD 8 and RD 9 Induction.
The control for RD 9 (RD 10) was produced by the method shown 
for RD 8.
(b) The 'Induction Test'.
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Figure 4.3 Outline of Small Scale Resolvase Purification.
Sample names are as defined in section 4.4. and 4.5. 'PELLET' was 
abbreviated to 'PEL.1 where space was limited.
A^oonm of the main cultures was measured during their growth.
A600nm o f :
Time of JM101 JM101 JM101 JM101
Growth pMA6111 #la pMA6111 #lb pMA6111 #3a pMA6111 #3b
4 h 20 min 0.188 0.179 0.191 0.177
6 h  25 min 0.484 0.460 0.559 0.477
6 h  55 min 0.549 0.531 0.653 0.550
Table 4.2 Optical Density of JM101 pMA6111 Cultures for Resolvase 
Induction RD 8.
Sample JM101 pMA6111 #3a was selected for the resolvase induction on the basis 
of the induction test and the densities of the main cultures. 6 h  55 min after the 
initial dilution, 50 ml of JM101 pMA6111 #3a was mixed with an equal volume of 
prewarmed MA broth containing 0.3 mM IPTG. The diluted culture was then 
incubated at 37 °C with shaking. This induction point was defined as ti = 0 min.
The 3H  amino acids to be used for the tritiated induction were supplied in sterile 
2% ethanol, and so some sterilised 2% ethanol was warmed to 37 °C, then at ti = 
20 min, 1 ml of 2% ethanol was added to the resolvase induction culture, RD 8. 
This was returned to the shaker and continued incubation at 37 °C. At ti = 60 min 
the sample was transferred to a chilled 250 ml centrifuge tube and the cells were 
harvested by centrifugation (3,840 g for 3 min at 4 °C). The supernatant was 
decanted to a separate tube and the supernatant and cell pellet were stored 
overnight at -20 °C.
4.4.2 Purification of Resolvase from Induction RD 8.
The important features of the purification are that the resolvase remains soluble 
after the cells are lysed, that the resolvase co-precipitates with the DNA on 
addition of spermine, and that the resolvase can eventually be eluted (with little 
contamination) from this pellet. Two factors which appear to affect these features 
are the concentration of cell components in the cell lysate (due to the volume in 
which the cells are broken) and the approximate fragment size of the DNA 
present (in turn affected by the method of cell lysis).
In the large scale protocol the cells are broken by three passes on a French Press, 
resulting in significant shearing of chromosomal DNA. The small scale 
purification required the cells to be lysed in much too small a volume to allow 
use of the French Press. In experiments where cells were broken in an ultrasonic 
waterbath, or by lysozyme and repeated freeze/thaw  treatment, the resolvase
48
was precipitated on centrifugation of the lysate. This was presumed to be the 
result of insufficient shearing of the DNA present (as the approximate DNA size, 
examined by agarose gel electrophoresis, was greater than that observed in 
directly sonicated samples). Treatment of such a lysate with further mechanical 
shearing steps did not produce soluble resolvase. Cell lysis by direct sonication 
of the sample did produce soluble resolvase. A num ber of tests were required to 
produce a balance of sample size, volume of lysis buffer and total sonication time 
which could reprodudbly result in good cell lysis (without the vial breaking), 
and resolvase eluting at the desired salt concentration (without excessive 
contamination). The correct spermine concentration for precipitation, and then 
elution of resolvase, was another important consideration.
Solutions and Buffers:
lx  KPM : 25 mM KH2PO4 pH  7.0,5 mM MgCl2, 1 mM EDTA, 0.4 mM DTT, 1
mM benzamidine.
RHB : 2 M NaCl, 20 mM Tris.HCl pH 7.5,0.1 mM EDTA, 0.2 mM DTT.
PMSF 10 m g/m l in ethanol, 
spermine 20 mM in H20 .
The induced cells were thawed on ice, washed in 50 ml of 50 mM KH2P 0 4 
(pH 7.0) and pelleted by centrifugation (12,100 g for 1 min at 4 °C). The cell pellet 
was resuspended in 2 ml of lx  KPM with 20 pi of PMSF, and then transferred to a 
glass sonication vial which had been stored on ice. A 20 pi sample of RD 8 cells 
was taken at this point. The remaining material was placed on ice and set up for 
sonication as shown in Fig. 4.4. The cells were broken by 6 x 10 sec bursts of 
sonication, separated by breaks of 30 sec to prevent overheating. After every 
second sonication step 20 pi of PMSF was added. Once sonication was completed 
a 20 pi sample was removed and the remaining lysate was transferred to a small 
centrifugation tube. At this point the lysate appeared almost iridescent, 
indicating good cell lysis.
The protein content of 1 pi of supernatant from the sonicated and unsonicated 
samples was compared using Bradford's reagent. The supernatant from the 
unbroken cells contained almost no protein (compared by eye with B.S.A. 
standards at 0 ,1 ,2 ,3 ,4  and 5 m g/m l) but the lysate supernatant gave a reading 
of about 4-5 m g/m l of protein. The sonicated material was spun at 50,400 g for 
10 m in at 4 °C to remove cell debris, and any intact cells. The supernatant was 
then split between two 1.5 ml Eppendorf tubes and spun, at 14,000 rpm, in a 
microfuge for a further 3 min (4 °C). The supernatant produced, Sn 1, was mixed
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Figure 4.4 Arrangement of Samples for Sonication.
with 20 pi of PMSF and a 20 pi sample was removed and stored on ice. Sn 1 was 
placed in a small, chilled glass bottle and 4 x 5 pi of 20 mM spermine were 
added, with mixing, to precipitate the nucleic a d d  (and some other material, 
including resolvase). The sample was incubated on ice for 5 min and then 
transferred to Eppendorf tubes. The pretipitated material was collected by 
spinning in a microfuge (14,000 rpm, 4 °C) for 2 min. The supernatant (Sp. Sn) 
was removed and stored on ice. The two pellets were washed for 5 m in in a total 
of 400 pi of lx  KPM, 1 mM spermine and 0.2 m g/m l PMSF. In this and 
subsequent steps, washing consisted of adding the wash buffer, breaking the 
pellet by pipetting and vortexing for 1 min, 3 min on ice, and then 1 m in further 
pipetting, to 5 min total. The sample was then centrifuged for 2 min (14,000 rpm, 
4 °C) and the supernatant, Sn 2 was removed and stored. Washing and 
centrifugation steps were repeated with the following buffers, producing the 
supernatants indicated:
lx  KPM/1 mM spermine/0.2 m g/m l PMSF + 50 mM NaCl (Sn 3)
lx  KPM/1 mM spermine/0.2 m g/m l PMSF + 100 mM NaCl (Sn 4)
lx  KPM/1 mM spermine/0.2 m g/m l PMSF + 200 mM NaCl (Sn 5)
lx  KPM/1 mM spermine/0.2 m g/m l PMSF + 400 mM NaCl (Sn 6)
lx  KPM/1 mM spermine/0.2 m g/m l PMSF +1 M NaCl (Sn 7)
lx  KPM/1 mM spermine/0.2 m g/m l PMSF + 2 M NaCl (Sn 8)
The pellet remaining after the 2 M NaCl wash step was stored as T.F.W /.
The bulk of the resolvase should elute in Sn 7, but it was previously observed 
that the resolvase sometimes eluted at slightly lower salt concentrations. 
Therefore Sn 6 and Sn 7 were each diluted 6 fold with H 2O (after removing a 
40 pi sample from each). The dilutions were placed on ice for 1 h to precipitate 
any resolvase present, and then spun in a microfuge at 14,000 rpm, 4 °C for 20 
min. The supernatants, SD 6a and SD 7a, were removed and the pellets, P6 and
1
P7, were washed in -  x [lx KPM/ 1 M N aC l/ 1 mM sperm ine/
0.2 m g /m l PMSF] by 2 min of gentle pipetting followed by 5 min on ice. The 
samples were spun in a microfuge for 10 min (14,000 rpm, 4 °C) and the 
supernatants, SD 6b and SD 7b, removed. The pellet produced from Sn 6 was 
small, but Sn 7 produced a large, white pellet. Each pellet was resuspended in 25 
pi of RHB by gently pipetting the samples, then returning them to ice, for a total 
of 20 min. Insoluble material was removed by centrifugation in a microfuge 
(14,000 rpm , 5 min, 4 °C).
In the next stage of the large scale purification the resolvase-containing fraction is
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further purified using a size filtration column. However the potential loss of 
material expected with a smaller sample made such a filtration step impractical 
at this point.
The two final fractions, RD 8 f6 (from Sn 6) and RD 8 f7 (from Sn 7) were 
transferred to small Eppendorf tubes and mixed with an equal volume of 
glycerol. The insoluble pellets, FI 6 and FI 7, were stored on ice, along with 
samples from all other stages, with the exception of RD 8 f6 and RD 8 f7 which 
were stored at -20 °C. Samples from most steps were run on a Laemmli gel to 
check for the presence and purification of resolvase throughout (Fig. 4.5).
This gel shows that the pellet produced from the high speed spin (Fig. 4.5, lane 4) 
contained very little resolvase (but most of a second induced species). The 
resolvase had mostly purified in the expected fraction, i.e. Sn 7 and then RD 8 f7, 
and had only small amounts of contaminating material (c.f. R17 f48; Fig. 4.5, lane 
1).
The binding activity of RD 8 f7 was tested by binding to a subsite II fragment, 
and was comparable with that of a purified fraction, R17 f47, from a large scale 
resolvase preparation (data not shown). The recombination activity of RD 8 f7 
was also comparable to that of R17 f47, as tested by in vitro resolution of the 
substrate pMA21 (data not shown).
4.5 Expression of 3H-Resolvase in Induction RD 9.
Overnight cultures of JM101 pMA6111 were produced from -70 °C stocks as 
described for RD 8. Italics are used in Tables 4.3,4.4 and 4.5, to indicate the 
culture used for the resolvase induction.
Isolate A600nm
JM101 pMA6111 Ha 0.854
JM101 pMA6111 #lb 0.748
JM101 pMA6111 #3a 0.898
JM101 pMA6111 #3b 0.742
Table 4.3 Optical Density of Overnight JM101 pMA6111 Cultures for RD 9.
The A600mn of the stationary cultures was measured (Table 4.3) and each culture 
was diluted 50 fold in 100 ml of MA broth which was grown with shaking at 
37 °C in a 21 flask. Induction tests' were prepared as for RD 8 and grown for 5 h 
50 min, then A600nm values were measured for each sample (Table 4.4).
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Figure 4.5. Small Scale Resolvase Purification RD 8.
Resolvase is marked by an arrow.
Lane Sample % run Lane Sample % run
1 1 pi R17f48 11 1 pi R17f48
2 induced cells 0.5 12 supernatant 6 2.5
3 sonicated cells 0.5 13 supernatant 7 2.5
4 pellet PI 1.0 14 supernatant 8 1.2
5 supernatant 1 0.5 15 pellet P.F.W. 2.5
6 spermine sn. 0.5 16 RD 8 f6 10.0
7 supernatant 2 2.5 17 RD 8 f7 10.0
8 supernatant 3 2.5 18 pellet FI6 20.0
9 supernatant 4 2.5 19 pellet FI7 20.0
10 supernatant 5 2.5
Isolate
A^oonm of 
uninduced
A600nmOf
induced
JM101 pMA6111 *la 0.583 0.042
JM101 pMA6111 # lb 0.513 0.047
JM101 pMA6111 #3a 0.734 0.049
JM101 pMA6111 #3b 0.483 0.050
Table 4.4 Optical Density of RD 9 'Induction Test' Samples.
As for RD 8, the A^oonm of the main cultures was measured during their growth 
(Table 4.5).
Time of 
Growth
A600nm o f :
JM101 
pMA6111 Ha
JM101 
pMA6111 #lb
JM101 
pMA6111 #3a
JM101 
pMA6111 #3b
4 h  00 min 0.186 0.167 0.257 0.152
5 h 50 min 0.519 0.466 0.770 0.426
6 h 15 min 0.588 - - -
Table 4.5 Optical Density of JM101 pMA6111 Cultures for Resolvase
Induction RD 9.
Sample JM101 pMA6111 #la was selected for the resolvase induction on the basis 
of the induction test and the density of the main cultures. 6 h 15 min after the 
initial dilution JM101 pMA6111 # la  was mixed with an equal volume (100 ml) of 
prewarm ed MA broth containing 0.3 mM IPTG. The diluted culture was split 
between two prewarmed 21 flasks which were then incubated at 37 °C with 
shaking. This induction point was defined as ti = 0 min.
3H-Amino
Acid
Specific Activity 
(Ci/mmol)
Amount Added 
(nmol)
L- [2,3-3H]-arginine 58.4 3.42
L- [4,5-3H(N)]-isoleucine 111.7 1.79
L- [3,4,5-3H(N)]-leucine 158.0 1.27
L-[4,5-3H(N)Hysine 97.4 2.05
L- [3,4-3H]-valine 65.0 3.08
Table 4.6 Specific Activities of Tritiated Amino Acids Used in Resolvase 
Induction RD 9.
200 \il each of 5 tritiated amino acids (arginine, isoleucine, leucine, lysine, and 
valine, all at 1 pC i/p l in 2% ethanol) were mixed together and warm ed to 37 °C.
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The specific activities of the tritiated amino adds are shown in Table 4.6. At ti =
20 min the 1 ml (1 mCi) of tritiated amino adds was added to one of the induced 
cultures, labelled RD 9, which was then returned to the shaker and continued 
incubation at 37 °C. Immediately after this, 1 ml of 2% ethanol was added to the 
control culture, RD 10 which was also returned to the shaking platform. At ti =
60 min each sample was transferred to a cold 250 ml centrifuge tube and the cells 
were harvested by centrifugation (50,400 g for 3 min at 4 °C). The supernatants 
were decanted to separate tubes and the supernatants and cell pellets were 
stored overnight at -20 °C.
4.6 Purification of 3H-Resolvase from Induction RD 9.
The purification of resolvase from RD 9 was conducted exactly as described for 
RD 8 with the following exceptions :
(i) Sonication;
Cells were set up for sonication as shown in Fig. 4.4, and sonicated as for 
RD 8. However once sonication was completed the lysate did not appear 
iridescent, suggesting incomplete cell breakage. The protein content of 1 pi 
of supernatant from the sonicated and unsonicated samples was also 
compared using Bradford's reagent. The supernatant from the unbroken 
cells did contain almost no protein (compared by eye with B.S.A. 
standards at 0 ,1 ,2 ,3 ,4  and 5 m g/m l) but the lysate supernatant gave a 
reading of about 2-3 m g/m l of protein (c.f. 4-5 m g/m l in RD 8). It was 
believed that sonicating the sample too much m ay have been as 
detrimental to the purification as insufficient sonication. Therefore 
additional steps were not taken.
(ii) Low salt precipitation;
The pellet produced from Sn 6 was pale yellow, but the pellet from Sn 7 
was barely visible.
The two final fractions produced, RD 9 f6 (from Sn 6) and RD 9 f7 (from Sn 7) 
were equivalent to RD 8 f6 and RD 8 f7, respectively. Again material from most 
steps was run on a Laemmli gel to check for the presence and purification of 
resolvase (Fig. 4.6).
This Laemmli gel shows that the pellet produced from the high speed spin (Fig. 
4.6, lane 4) contained substantial levels of resolvase, compared with, for example, 
RD 8. The amount of resolvase present, compared with that in the supernatant 
(lane 5), gives some indication of the proportion of cells that were not broken. As
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Figure 4.6. Small Scale 3H-Resolvase Purification RD 9.
Resolvase is marked by an arrow.
Lane Sample % run Lane Sample % run
1 1 pi R17f48 11 1 pi R17f48
2 induced cells 0.5 12 supernatant 6 2.5
3 sonicated cells 0.5 13 supernatant 7 2.5
4 pellet PI 0.5 14 supernatant 8 1.2
5 supernatant 1 0.5 15 pellet P.F.W. 1.2
6 spermine sn. 0.5 16 RD 9 f6 10.0
7 supernatant 2 2.5 17 RD 9 f7 10.0
8 supernatant 3 2.5 18 pellet FI6 10.0
9 supernatant 4 2.5 19 pellet FI7 10.0
10 supernatant 5 2.5
a result of this the resolvase did not purify in the expected fractions. This may be 
a result of a lower concentrations of total cellular material, from Sn 1 onwards. 
Although Sn 7 (lane 13) gave a very poor resolvase yield, the resolvase present in 
Sn 6 (lane 12) and then RD 9 f6 (lane 16) proved sufficient for the experiments 
planned.
The main problem in the sonication of such a small volume of cells is ensuring 
that the button probe makes good contact with the cell suspension but does not 
touch the glass vial, which is easily cracked. This becomes somewhat harder 
when everything must be contained to prevent the aerosol of tritiated material 
from escaping; i.e. the containment during cell lysis probably reduced the ability 
to fine tune the apparatus, resulting in poor contact between the probe and the 
sample during some steps of sonication.
The binding activity of RD 9 f6 was tested by the execution of the experiments for 
which it was produced. These are described in Chapter 5. The resolution activity 
of RD 9 f6 was comparable to that of R 17 f47 (data not shown).
4.7 Determ ination of Resolvase Concentration of RD 9 f6.
The concentration of resolvase in fraction 6 of RD 9 was determined by amino 
acid analysis of a hydrolysed sample, after OPA derivatisation (Chapter 2). This 
method of analysis was believed to be considerably more accurate than others 
which quantify protein levels using Bradford's reagent, Coomassie stain or direct 
spectrophotometric analysis, especially given the small amount of material 
available. Immunological methods alone could not provide a direct measure of 
resolvase concentration. Many thanks are due to Dr D. Mousdale and 
Ms E. O'Neil, of Bioflux Ltd, who conducted derivatisation and analysis of the 
samples described in this section.
Before RD 9 f6 was analysed, fractions from other resolvase stocks were analysed 
to estimate the amount of RD 9 f6, and the ratio of internal standard (taurine) that 
should be used in the determination of the composition of RD 9 f6. The samples 
used for this purpose were from RD 8 f7 (section 4.4.2), and from a fraction of a 
large scale preparation, R 17 f47.
In using this method of analysis (or the others mentioned in this section) the 
assumption is made that the resolvase samples are free of any contaminating 
material, e.g. other polypeptides. Whilst this is unlikely to be entirely true of any 
protein purified from an in vivo expression system, denaturing PAGE of R 17 f47 
indicated that resolvase accounts for the vast majority of the total material
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present. The comparative manner used to convert the results of amino acid 
analysis to a resolvase concentration also helped to reduce the influence of any 
contaminating material on the final value produced.
As described in Chapter 2, a known volume of the resolvase sample was mixed 
w ith a known concentration of the internal standard, taurine, prior to hydrolysis. 
This material was lyophilised and resuspended several times and finally 
resuspended in a small, known volume. The dilution factor of the stock resolvase 
sample is calculated by:
„  „  . „  Vol. Resolvase Added (pi)Resolvase Dilution Factor = ------------------------------ 7^ —i
Final Sample Volume (|il)
If no loss of material (or inaccuracy in volume measurement) occurs, the
concentration of taurine expected in the analysis is:
, Amount of Taurine Added (pmol)
’Expected' [taul (pM) = -------------------------------------------  -
Final Sample Volume (pi)
Example :
In the analysis of R 17 f47, a 5 pi sample of R 17 f47 was prepared for 
analysis. 4 pi of 1 mM taurine (4000 pmol) was included as an internal 
control. The hydrolysed material was finally resuspended in 100 pi of 
solvent.
5 piResolvase Dilution Factor = — - — = 20.
100 pi
Taurine concentration = 40 pM.
Derivatised material was analysed and the area of the peak produced for each 
residue was calculated. By comparison with peaks produced from derivatised 
standards, these areas were converted to concentration values using the 
following formula:
(peak area of a. a.) • ([standard])
(peak area of standard)
Observed [a. a.] =
The taurine internal standard was used to correct amino acid concentrations, 
taking account of loss of material during hydrolysis, as follows:
(Expected [Tau]) • (Observed [a. a.])r
Corrected [a. a.] =
(Observed [Tau])
If the assumption is made that resolvase is the only polypeptide present in the 
sample analysed, then a resolvase concentration value can be calculated from the
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concentration of each amino acid by:
St k lT  3 T  Rl (Corrected [«•«.]) (Resolvase Dilution Factor) 
*■ K No. of Residues in Tn3 TnpR
This assumption is clearly not true (e.g. Fig. 4.5 and Fig. 4.6). However, as 
resolvase is the major species present in all the samples examined, considering 
only the residues which occur frequently in Tn3 resolvase should give the best 
estimation of the actual resolvase concentration. Additionally some of the 
contaminating species are believed to be derived from intact resolvase and, if 
complementary fragments are represented equally, will have the same specific 
activity as the active resolvase.
The results of amino acid analysis of R 17 f47, RD 8 f7 and RD 9 f6 are given in 
Table 4.7,4.8 and 4.9 respectively. Residues are listed in the order in which they 
were detected, with the exception of taurine. The 'Corrected [a.a.]' value for 
taurine is also the 'Expected [tau]'. Two sets of data, A and B, are listed in Table 
4.9. These were produced by parallel analysis of two RD 9 f6 samples, allowing 
an average resolvase concentration to be determined.
Amino
Acid
Observed 
[a.a.] (pM)
Corrected 
[a.a.] (pM)
Residues in 
Tn3 TnpR
[R17f47]
(pM)
Asx 8.77 9.13 19 9.61
Glx 0.72 0.75 21 0.72
Ser 15.49 16.13 11 29.32
His 3.57 3.71 2 37.13
Gly 58.87 61.30 15 81.73
Thr 14.34 14.93 12 24.88
Ar% 19.76 20.57 20 20.57
Ala 11.93 12.43 16 15.53
Tyr 1.64 1.71 2 17.12
Met 0.00 0.00 5 0.00
Val 15.64 16.29 14 23.27
Phe 5.49 5.72 5 22.87
lie 17.25 17.96 15 23.95
Leu 16.20 16.87 16 21.09
Lys 9.17 9.55 12 15.92
Tau 38.41 40.00 - -
Table 4.7 Amino Acid Composition of R 17 f47.
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Amino
Acid
Observed 
[a.a.] (|iM)
Corrected 
[a.a.] (jiM)
Residues in 
Tn3 TnpR
[RD 8 f7] 
(MM)
Asx 26.57 34.77 19 36.60
Glx 9.02 11.80 21 11.24
Ser 55.00 71.98 11 130.87
His 12.74 16.67 2 166.71
Gly 178.21 233.20 15 310.93
Thr 49.40 64.65 12 107.74
Arg 45.85 60.00 20 60.00
Ala 36.00 47.10 16 58.88
Tyr 2.98 3.90 2 38.96
Met 5.12 6.70 5 26.81
Val 34.08 44.60 14 63.71
Phe 16.47 21.55 5 86.21
lie 37.52 49.10 15 65.47
Leu 38.69 50.63 16 63.29
Lys 26.84 35.12 12 58.54
Tau 15.28 20.00 - -
Table 4.8 Amino Acid Composition of RD 8 f7.
Amino
Acid
Observed [a.a.] 
(|iM)
Corrected [a.a.] 
(\iM)
Residues 
in Tn3
TnpR
[RD 9 f6] 
(\iM)
A B A B A B
Asx 19.89 14.97 24.72 20.99 19 13.01 11.05
Glx 28.60 8.61 35.54 12.07 21 16.93 5.75
Ser 36.96 25.49 45.94 35.76 11 41.77 32.51
His 25.97 16.23 32.28 22.77 2 161.42 113.83
Gly 99.12 80.33 123.21 112.69 15 82.14 75.13
Thr 25.93 18.71 32.23 26.25 12 26.86 21.88
Arg 14.73 1438 1830 20.18 20 9.15 10.09
Ala 12.58 14.29 15.64 20.04 16 9.77 12.53
Tyr 4.68 4.99 5.81 7.00 2 29.07 34.98
Met 3.78 3.10 4.70 4.35 5 9.40 8.70
Val 25.27 31.06 31.41 43.58 14 22.44 31.13
Phe 7.37 9.48 9.16 13.29 5 18.33 26.58
lie 31.34 28.13 38.96 39.47 15 25.97 26.31
Leu 34.68 29.76 43.11 41.75 16 26.95 26.10
Lys 20.99 18.47 26.10 25.92 12 21.75 21.60
Tau 32.18 28.51 40.00 40.00 - - -
Table 4.9 Amino Acid Composition of RD 9 f6.
In Table 4.7,4.8 and 4.9 italics indicate the samples which were used to calculate
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the concentration of resolvase for each fraction. The resolvase concentration 
results are listed in Table 4.10.
The residues used in the determination of the resolvase concentration were 
selected on using the following criteria;
(i) Occurrence in Tn3 Resolvase.
As mentioned, results derived from frequently occurring residues should 
be affected less by minor contaminating species.
(ii) Stability.
Certain residues have been empirically determined to be more reliable due 
to an appropriate stability during hydrolysis. An 'appropriate' stability 
requires that, for the hydrolysis conditions used, all peptide bonds present 
will be broken, but that the amino add  itself should remain intact.
(iii) Peak Separation.
The separation of material on the column is directly reflected by the 
distribution of the peaks produced on the trace. The most accurate values 
will be produced from large, discrete peaks.
Because of these criteria, the resolvase concentrations of R 17 f47 and RD 8 f7 in 
Table 4.10 are an average of the values produced for arginine, alanine, valine, 
isoleucine, leucine and lysine. A sample of Tn21 resolvase was also analysed 
(data not shown) and good agreement of concentration values was observed with 
the same six amino adds. The value for RD 9 f6 (Table 4.10) does not include 
valine results due to the discrepancy between samples A and B. The data used to 
calculate a [Tn3 TnpR] value for RD 9 f6 showed greater variation than that of the 
other fractions examined. This may be a result of greater contamination in RD 9 
f6, but there is no indication of which values, if any, are incorrect.
Purified Fraction [Tn3 TnpR] 
(|lM)
R17f47 20.06
R D 8f7 61.65
R D 9f6 19.02
Table 4.10 Resolvase Concentration of R 17 f47, RD 8 f7 and RD 9 f6.
Dilutions of RD 8 f7 (and R 17 f47) and an undiluted sample of RD 9 f6 were run 
on a Laemmli gel to allow comparison of their protein content (Fig. 4.7). The 
concentrations produced by amino acid analysis were compatible with the ratios 
of material on the gel, although the value for R 17 f47 appeared a little lower than
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1 2 3 4 5 6 7 8 9  10
Figure 4.7. Comparison of Some Purified Tn3 Resolvase Fractions.
1 pi samples of a number of resolvase fractions were run on a Laemmli gel 
to allow comparison of the resolvase concentration of each. Dilutions were 
run in an attempt to produce tracks containing approximately equal 
amounts of resolvase. Resolvase is marked by an arrow.
Lane Fraction Dilution
1 RD 8 f7 neat
2 if 2-l
3 fi 2-2
4 if 2 - 3
5 RD 9 f6 neat
6 RD 8 2 - 4
7 R17f48 2 - 3
8 R17f47 neat
9 I f 2-l
10 I f 2-2
the comparison suggested. This may have been due to the greater purity of R 17 
{47.
4.8 Determ ination of Resolvase Specific Activity in  RD 9 f6.
Given the concentration of resolvase in RD 9 f6, the specific activity, Asp., can be 
calculated, once the volume-specific activity, Ay, of the resolvase is determined. 
The measurement and adjustment of RD 9 f6 activity was similar to that of stock 
DNA samples and isolated complexes, described in more detail in Chapter 5.
A known volume of RD 9 f6 (by weight) was placed in a scintillation vial w ith 10 
ml of /Ecosdnt/ fluid and 1 ml of 30% H2O2 (similar conditions to those in which 
activities of complexes were measured). The activity of the sample was counted 
(10 min, using a Wallac 1409/11 vl.4 liquid scintillation counter). The measured 
3H activity, 3H Ax (counted at time Tx), was recorded in counts per minute 
(cpm) and converted (using a Wallac 3H-spectra library and quenching data) to a 
measurement of disintegrations per minute (dpm).
3H Ax (cpm) = 22668.5 cpm 3H Ax (dpm) = 61878.4 dpm
Tx = 06:50,22/11/92 Counting Efficiency = 36.6 %
The average 3H Ax (dpm) value of a number of 'blank' samples was subtracted 
from the RD 9 f6 3H Ax (dpm).
'Blank' adjusted 3H Ax = (61878.4 - 22.7) dpm  = 61855.7 dpm
Finally this activity was adjusted (for decay) to a nominated counting date, To 
(00:00,1st October 1992), giving 3H Ao (dpm). If AT = Tx -  Tq , and the half life 
of the isotope is t, then 3H Ao is calculated by;
A0 = A x .2<a™>
i.e. AT = 52.28 days t = 4492.58 days
RD 9 f6 3H  Ao = (61855.7). [2®2-28/4492.58)] = 62356.7 dpm
It was assumed that only the 50% glycerol in RD 9 f6 would significantly alter its 
density from that of H 2O. As glycerol has a density of 1.26, and H2O has a 
density of 1.00, the density of RD 9 f6 was estimated to be 1.13. The RD 9 f6 
sample counted weighed 0.76 mg and so the sample volume was (0.76/1.13)|il. 
Hence the volume-specific activity, Ay, of RD 9 f6 is:
62356.7 dpm '
A v -
(0.76/1.13) pi
= 92714.5 dpm /nl
The specific activity, Asp., of the resolvase in RD 9 f6 is calculated using the 
formula;
59
Sp* jResolvase]
f Av (dpm/|Lil) >
dpm /pm ol
i.e. RD 9 f 6 ASp = ^92714.5 dpm /pP  
 ^ 19.02 \iM ,
= 4874.4 dpm /pm ol
4.9 Sources of Error.
A number of small, inherent errors exist in the determination of the specific 
activity of resolvase in RD 9 f6. Accuracy of volume measurement, statistical 
errors in scintillation counting and accuracy of quenching and background 
adjustments are all factors to consider. These are discussed further in section 5.3. 
Comparison of data sets A and B in Table 4.9 shows that a significant source of 
error exists in the amino a d d  analysis itself, but this is difficult to quantify. 
However, the major errors in this value arise from the question of the purity of 
RD 9 f6.
Elsewhere in this work the terms 'RD 9 f6' and 'resolvase' have been used 
somewhat interchangeably, and this would be acceptable given the assumption 
that all the amino add  (and 3H) content of RD 9 f6 is in the form of resolvase. 
Analysis of samples run on a Laemmli gel (Fig. 4.7) shows that this is untrue for 
R 17 f47 and RD 8 f7, as well as RD 9 f6. Whilst matters would have been 
improved if RD 9 f6 were as pure as R 17 f47 (or even RD 8 f7), the same 
problems would still require consideration.
In order to determine how much of the 3H activity of RD 9 f6 was accounted for 
by resolvase, a sample of RD 9 f6 was run on a gel, and a gel chip containing the 
resolvase was isolated. The remainder of the lane containing RD 9 f6 was 
sectioned into equally sized gel chips. Each sample was dissolved, mixed with 
'Ecoscint' fluid and then sdntillation counted. The resolvase sample accounted 
for greater than 90% of the total 3H activity detected.
The extent to which contaminating protein has affected the resolvase 
concentration value calculated for RD 9 f6 is less obvious. The small amounts of 
material available made quantification difficult. It is possible to estimate the 
relative intensities of bands on a Laemmli gel, but this would only introduce 
further inaccuracies due to methods of measurement and from unequal staining 
of different species. By deriving the resolvase concentration of RD 9 f6 from 
stable amino acids which are most abundant in resolvase (and give compatible 
values for a number of resolvase samples) the effect of contaminants will have 
been minimised, or even eliminated.
60
The resolvase specific activity of RD 9 f6 was not adjusted to compensate for the 
presence of contaminating protein as the effect of this material could not be 
quantified. However, the consequences of the errors mentioned here should be 
borne in m ind when considering the absolute stoichiometry data (Chapter 5). 
Despite these reservations, this method of determination of resolvase 
concentration (this chapter), and the method used to quantify levels of resolvase 
(Chapters 4 and 5), are still believed preferable to the alternatives discussed.
4.10 Conclusions.
A method was developed for the production of small amounts of partially 
purified, tritiated resolvase from the expression strain JM101 pMA6111. The 
resolvase produced had a specific activity of 4874.4 dpm/|xl, and exhibited the 
expected binding and resolution activities, although it was not as pure as other 
resolvase fractions previously produced using the same protocol. The 
concentrations, binding activities and resolution activities determined for 
different resolvase fractions (R 17 f47, RD 8 f7 and RD 9 f6) were consistent with 
the calculated resolvase concentration of RD 9 f6. The small scale resolvase 
preparation described will also be of use in the analysis of mutants of resolvase, 
as a simpler alternative to large scale purification.
61
Chapter Five 
Stoichiometry of Complexes of Resolvase w ith
5.1 Introduction.
The observation of discrete protein/DNA complexes by non-denaturing PAGE49 
is particularly useful when trying to dissect the resolvase resolution reaction into 
its component steps. However problems can arise when comparing altered DNA 
sites and subsites, or modified proteins, according to the pattern of complexes 
they produce. Evidence is required to show which different complexes, if any, 
can be considered equivalent, particularly in the case of res/resolvase, where so 
many complexes result from the action of one protein on a single site. 
Additionally, the investigation of the kinetics of protein/D N A  interactions using 
such an assay20 can be better understood if the nature of the complexes is known.
The band shift assay is a widely exploited technique (e.g.6/7/17/49/58/60/83/84) but 
there are comparatively few systems for which the stoichiometry of the retarded 
complexes has been determined (e.g.16'20'22'27'50'94). Despite the small num ber of 
examples a variety of techniques have been used in the determination of the 
protein component of complexes produced, and the choice of a method for 
protein quantification is discussed in Chapter 4. However in almost all cases, 
including this work, 32P end-labelling was the favoured method for measuring 
the amount of DNA present. This technique was an obvious choice due to its 
familiarity, the availability of the reagents required and the properties of the 32P 
isotope itself.
5.2 Preparation of DNA Samples for Stoichiometry Determ inations.
The DNA fragments to be used in stoichiometric determinations were produced 
by restriction endonuclease digestion of plasmids pDB22, pDB2004, pDB2107 and 
pDB2507. The res site or res derivative present in each construct (described in 
more detail in Chapter 3) is as follows; 
pDB22 Tn3 res site.
pDB2004 Tn3 subsite II.
pDB2107 Tn3 subsite II derivative, 'subsite (II + 10)', w ith an
additional 10 bp inserted at the centre of subsite II. 
pDB2507 Tn3 subsite II derivative, 'subsite (II + 5)', with an additional
5 bp inserted at the centre of subsite II.
The fragments used for binding are represented in Fig. 5.1 and the steps involved 
in DNA preparation and quantification are summarised in Fig. 5.2. An overview 
of the operations used to convert raw data to final stoichiometry values is shown 
in Fig. 5.3.
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Binding Fragment Parent 
Site Size Plasmid
B 43 28 22 , 34 5 25 12E
1------------------+> **-------- ^ — 1 res 169 bp pDB22
subsite I subsite II subsite III
E as 34 20 H subsite H 89 bp pDB2004
subsite (n+5) 100 bp pDB2507
subsite (11+10) 109 bp pDB2107
Figure 5.1 DNA Fragments Used in Stoichiometry Experiments.
Abbreviations of restriction enzyme sites; E=Eco RI, H =Hin d ill and B-Bam  HI. 
39 : sizes, in base pairs, of sites and inter-site distances,
i -  □ : binding site.
► : terminal inverted repeat.
■  : additional inserted sequence.
  : other DNA.
Initially the approximate DNA concentration was determined for a large scale 
plasmid preparation of each construct to be used. This was done by measuring 
the A260nm of a dilution of each sample, in order to determine the amount of 
DNA to be digested. About 100 jig of each plasmid (55 - 57 pmol) was digested 
with an excess of Eco RI (Enz. 1 in Fig. 5.2) which cuts each plasmid once to give 
full length linear product. After digestion each sample was extracted once with 
phenol and twice with chloroform prior to ethanol precipitation. The DNA 
pellets were dried, then resuspended in 50 pi of lx  TE. A fraction of this stock 
material was diluted in lx  TE in order to measure its absorbance at 260 nm  (and 
280 nm), allowing accurate determination of the DNA concentration. The 
assumption was made that the density of the DNA stocks and of lx  TE were 
effectively 1, and that the most accurate means of measuring the amounts of each 
added was by weighing them on a fine balance. 5 pi of each plasmid stock was 
transferred (using a Hamilton syringe) to a weighed Eppendorf tube and the 
weight was recorded. About 1 ml of lx  TE was added and the weight was noted 
again. The samples were then mixed and transferred to a 1 cm quartz cuvette for 
determination of the A260nm and A280nm values against a blank of lx  TE.
Plasmid
Size
(bp)
Stock
A260nm
A260nm /  
A280nm
Cold [DNA] 
(pM)
pDB22 2,833 38.38 1.78 1.04
pDB2004 2,724 34.22 1.78 0.97
pDB2107 2,744 31.83 1.88 0.89
pDB2507 2,735 36.24 1.87 1.02
Table 5.1 Concentration of Unlabelled Digested Plasmid Stock.
Concentration values for each linearised plasmid stock ("Cold 
[DNA]") were derived from the A260nm value using an average
molar extinction coefficient, £, of 13,0001/m ol/cm  per base pair. 
More accurate coefficients for A /T  or G /C  pairs within a 'typical' 
sequence were not found in the literature. However the base 
composition and sequence distribution of each plasmid was quite 
even and so the average value is acceptable.
The value for A260nm/A280nm should be 1.8 for double stranded DNA73 and the 
observed values indicate that the samples are not significantly contaminated 
with RNA, dNTP's, protein or phenol, all of which would absorb at 260 nm and 
result in the observed DNA concentration being artificially high.
DNA from the same plasmid preparations was also 32P end-labelled by digesting 
about 1 pg of each plasmid (about 0.5 pmol) with Eco RI and end-labelling using
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Figure 5.2 Preparation and Quantification of Samples in Stoichiometry 
Experiments.
(a) Producing the Complexes.
(b) Adjustment of DNA Volume-Spedfic Activities.
is used to denote radioactive material and 'Enz.' (for enzyme) is used to 
indicate restriction endonucleases or their cut sites. For all plasmids used, 
Enz. 1= Eco RI and Enz. 3=Sca I. For pDB2004, pDB2107 and pDB2507, 
Enz 2-Hin  d ill but for pDB22 Enz. 2-Bam HI.
the Klenow fragment of DNA polymerase I as described in Chapter 2. The 
labelled DNA was purified by subsequent extraction with phenol and then 
chloroform, ethanol precipitated and resuspended in 50 pi of lx  TE.
Dilutions were made from each of the labelled samples (10-fold serial dilutions, 
to 10"5) and about 10 pi of each (volume measured accurately by weight) was 
added to 10 ml of scintillation fluid, mixed and counted to determine the 
volume-specific activity, Ay, of the labelled material, measured as counts per 
minute per microlitre (cpm/pl). In order to adjust this value with regard to the 
DNA fragment to be bound, some of each labelled sample was run on a 
polyacrylamide gel with and without further digestion by Sea I (Enz. 3 in Fig.
5.2). The bands were visualised by autoradiography and cut from the gel. The gel 
chips were dissolved in 1 ml of 30% H2O2, then mixed with 10 ml of sdntillant 
and counted. The two bands cut from the Eco RI treated samples were full length 
linear plasmid and unincorporated dNTP's. These were measured to show the 
proportion of the activity present which was incorporated into the plasmid DNA. 
The Eco RI and Sea I digested material also gave two bands, of approximately 1.7 
and 1.0 kb (the unincorporated material was nm  off the gel). The smaller of these 
two fragments contained the resolvase binding site in each case. These bands 
were sdntillation counted to determine any difference in the efficiency of 
labelling at each end of the DNA.
Next, labelled and unlabelled linear material was mixed for each plasmid, the 
am ount of each added being measured by weight. The mixed samples were 
digested with a second restriction endonuclease which would cut at only one 
position to release the binding site on a small DNA fragment (< 200 bp), leaving 
the majority of the plasmid intact. For pDB22 the enzyme used was Bam HI, for 
the other three plasmids it was Hin dill (these are Enz. 2 in Fig. 5.2). After 
digestion the DNA was extracted and precipitated as described previously. The 
pellets were dried and resuspended in 2x TG 9.4 binding buffer. The amount of 
DNA added from the unlabelled stock was known, as was the activity (cpm and 
dpm) added from the labelled sample, and so the specific activity of the mixed 
material can be calculated in cpm /m ol of binding site if the DNA contribution 
from the labelled sample is assumed to be insignificant in calculating the total 
DNA present. Approximate ratios of unlabelled to labelled plasmid ranged from 
a "cold DNA' excess of at least 320 fold (pDB22) to a 'cold DNA' excess of at least 
3000 fold (pDB2507).
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Figure 5.3. Summary of the Calculation of Relative and Absolute 
Stoichiometry Values for 'Complex n \
(a) Stoichiometry Values.
(b) Specific Activities of Stock Material.
Ax=activity counted at time Tx.
Ag=activity adjusted to nominated time TQ.
Agp =specific activity.
The terms used are described further in sections 5.2. and 5.6.
Plasmid
Digested
By:
Stock 32p a 0 
(dpm)
Volume
Counted(pl)
Stock 32p Ay 
(dpm /pi)
pDB22 Eco RL/Bam HI 212,681.7 9.66 22016.7
pDB2004 Eco RI/H in  dm 328,256.4 9.90 33157.2
pDB2107 Eco RI /H in  dIH 112,400.7 9.65 11647.7
pDB2507 Eco RI /H in  din 132,512.4 9.71 13647.0
Plasmid
Fraction
Incorporated
Plasmid 32P 
Ay (dpm /pi)
Labelling
Efficiency
Site 32p Ay. 
(dpm /|il)
pDB22 0.93 20,369.2 51.89% 10,570.4
pDB2004 0.91 30,263.5 45.89% 13,887.8
pDB2107 0.93 10,795.8 52.42% 5,659.4
pDB2507 0.93 12,756.1 47.96% 6,118.0
Table 5.2 Activity of Binding Site Fragment in Labelled Stock Solution.
Ao is the activity of given samples when adjusted from the 
measured activity, Ax at time, Tx, to the activity at a nominated 
time, To, in this case 00:00 on 1/10/92. Ay denotes the volume- 
specific activity of a sample. Traction incorporated' shows what 
fraction of the total activity present is as end-labelled plasmid. 
'Labelling efficiency' measures the proportion of incorporated 
counts represented by the DNA fragment containing the binding 
site. Both values are ratios of the activities of material cut from gels. 
The Ay values were calculated with regard to the binding site as 
follows:
Binding Site Ay = (Plasmid A y ). (Labelling Efficiency)
Plasmid Ay = (Stock Ay (dpm/pl)).(Fraction Incorporated)
Plasmid
Cold [DNA] 
(pM)
Volume 
Used (pi)
Site Ay 
(dpm /pi)
Volume 
Used (pi)
Site Asp. 
(dpm /pm ol)
pDB22 1.04 14.81 10,570.4 4.85 3,321.9
pDB2004 0.97 14.75 13,887.8 2.95 2,874.4
pDB2107 0.89 14.74 5,659.4 4.87 2,095.3
pDB2507 1.02 14.77 6,118.0 4.88 1,983.2
Table 5.3 Specific Activity of Binding Site Fragment in Final Binding Mix.
'Volume Used' is the amount of each linearised plasmid stock 
(unlabelled or labelled) mixed together for further digestion, prior 
to binding. The contribution of labelled DNA to the overall DNA 
concentration is assumed to be negligible.
5.3 Sources of Error.
The errors inherent in the data used to determine stoichiometry values are as 
follows;
(i) Measurement of sample volumes.
Sample volumes were determined by weight, using a balance accurate to
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50 pg. This represents a relative error of less than ±2% for all samples 
considered.
(ii) Scintillation counting.
All cpm values listed were produced from counting samples for a 
minimum of 10 min each, therefore the total number of counts recorded 
was 10 fold greater than the cpm value. For a single measurement the 
standard deviation, a, in counting a total number of counts, n, is 
approximately equal to V n. Therefore if n=10,000 counts (i.e. 1,000 cpm), 
then o=100 counts, which is a relative error of ±1%. For all the values used 
in these calculations the relative error of counting was less than ±2%. 
Correction factors applied to cpm values to account for quenching and 
background activity ('blank' samples) may give rise to errors which are 
difficult to quantify, but are likely to be quite small.
(iii) Measurement of DNA concentration.
The spectrophotometer used in the determination of DNA concentrations 
read accurately to ±0.001 A. This results in a relative error of less than ±1% 
of the absorbance readings for the samples examined. The DNA stocks 
used were purified using CsCl/EtBr gradients, and so digested samples 
with an A260nm/A280nm ratio of about 1.8 are unlikely to contain 
significant contaminating material that would alter the A260nm value, and 
hence the observed DNA concentration.
(iv) Measurement of resolvase concentration.
It is considerably more difficult to evaluate the error involved in 
determining the concentration of the resolvase used, other than to say that 
it is likely to be one of the largest errors in the production of an absolute 
stoichiometry value. This matter is discussed in Chapter 4.
Of the factors considered so far relative stoichiometry values are only affected by 
the statistical error in counting of radioactive samples, whereas all four of these 
factors are relevant to an absolute value. Other errors to consider are those which 
arise from the method of analysis itself. Such errors are more difficult to quantify 
but m ust still be taken into account when considering the results produced. For 
example;
(v) Gel artefacts.
In order to isolate the different complexes they m ust be cut from the 
different parts of the gel on which they have been run. However other 
material (smeared DNA or contaminating protein) may run in a similar 
position to the complex of interest, whilst other complexes may have a 
comparatively clean background. Levels of background material appeared
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lowest for the less retarded complexes (e.g. Fig. 5.4).
(vi) Isolation of bands.
Isolating a sample by cutting a small gel chip involves the risk of 
excluding some of the material present, but taking a large gel chip 
includes a greater proportion of any background activity present. Also a 
variation in the size of gel slice taken may affect the counting 
characteristics of samples once dissolved. Whilst these factors will affect 
all material taken from gels they are particularly significant for ratios such 
as Traction Incorporated' and 'Labelling Efficiency', shown in Table 5.2. 
Larger complexes are less affected by these problems.
Because of these sorts of errors more emphasis should be placed on relative 
stoichiometry results for major, less retarded complexes, i.e. complexes 1 and 2 of 
subsite (II + 10), complexes 1 and 2 of subsite (II + 5) and complexes 2 and 4 of 
res. However the reproducibility of the results produced using the different 
binding sites, and from different tracks of different gels (including the smaller 
scale experiments mentioned in section 5.5), suggests that these errors are quite 
small.
5.4 Preparation of Protein Samples for Stoichiometry Determinations.
Purification and quantification of tritiated resolvase for these experiments is 
discussed in Chapter 4.
5.5 Binding Reactions.
Initially binding reactions were carried out using approximately 0.5 pmol of 
plasmid (~ 1 Jig) per 10 pi binding reaction, with no other carrier DNA present. 
0.4 pi of the appropriate resolvase dilution was added to each sample which was 
mixed, incubated (10 min, 37 °C)and then placed on ice prior to loading to the 
gel, as for standard binding reactions. The omission of additional carrier DNA 
was acceptable as the resolvase is no longer in such great excess over the amount 
of DNA present; however the appearance of some of the tracks containing higher 
resolvase concentrations suggests that the large plasmid fragment was 'mopping 
up ' some of the resolvase. The first gel produced (subsite II; not shown) was 
stained using ethidium bromide and bands were visualised on a 254 nm 
wavelength UV transilluminator. The expected band pattern could be seen in 
some photographs of the gel but the faintest complexes were not visible by eye. 
This problem increased on prolonged exposure to UV while bands were being 
cut from the gel (due to photobleaching of the stain) such that the last bands 
removed were located with reference to rulers in the photograph and their
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absence from the gel was finally checked by a long exposure shot of the gel. All 
four sites investigated were used in binding reactions as described except that 
the complexes were identified by silver staining the gels. Photographs of silver 
stained band shift gels do not show the complexes very clearly but they were 
more obvious to the naked eye and could be cut with the gel on a light box and 
so were not subject to photobleaching. Although the silver staining method 
required soaking for a total of 90 min (c.f. 45 min for EtBr) the first hour of this 
was in a fixing solution, and therefore there was no concern of greater diffusion 
of complexes in this time. Each gel chip removed was placed in a 20 ml 
scintillation vial with 1 ml of 30% H2O2. The vial was sealed and incubated at 
55 °C for up to 72 h to dissolve the polyacrylamide. 10 ml of /Ecosdnt/ fluid was 
mixed with the sample which was then scintillation counted.
On the whole the cpm values produced for these complexes were below the 
levels required to give statistically acceptable results. However the data 
produced were analysed to, at least, give better estimates of the amounts and 
ratios of DNA and resolvase that should be used.
More DNA was prepared for binding by mixing labelled and unlabelled plasmid 
stocks (known volume by weight) and digestion as described previously. Once 
purified, the DNA samples were used for binding reactions as before except that 
the reaction volumes (but not concentrations) were increased 5 fold, i.e. 2.5 pmol 
of plasmid DNA was mixed in 50 pi of binding buffer to which 2 pi of a resolvase 
dilution was added. Mixing, incubation, loading, etc., remained the same but 
wells of a larger volume were used. Once loaded, the gels were run and silver 
stained in the same way, and bands were removed, dissolved and counted as 
before.
The definition of the complexes in these gels (Fig. 5.4 and 5.5) was somewhat 
reduced. The third and fourth complexes seen with subsite (n + 5) could not be 
distinguished from each other (Fig. 5.5) and complex 5 produced from the res site 
was not visible against the background staining in lanes containing RD 9 f6 (Fig. 
5.4). This background is unlikely to be unbound resolvase running on the gel as 
the background was low in equivalent R17 f48 tracks, and no material was 
observed in attempts to run resolvase on such gels in the absence of DNA. The 
smearing in these tracks probably represents a small amount of contaminating 
protein from RD 9 f6, or could be retarded DNA as observed with high 
concentrations of resolvase in some other gels (e.g. Fig 3.13b). Some samples 
were taken from the smeared areas for counting, to check that levels of
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Figure 5.4. Large Scale Band Shift Assay with res and Subsite II.
’U' denotes unbound target DNA, complexes are indicated by cN where N 
is the complex number (see Chapter 3 for further details). Some silver- 
stained complexes were visible by eye but are not clear in monochrome 
photographs. The subsite II sample with R17 f48 resolvase was loaded 
between two lanes (both numbered 2 in this figure).
Lane DNA Resolvase
1 pDB2004 (Hin d i l l /E co  RI) R.H.B.
2 " 2"3 R17 f48
3 " 2'1 RD 9 f6
4 " neat RD 9 f6
5 pDB22 (Bam HI/EcoRI) R.H.B.
6 " R17 f48
7 " 2'1 RD 9 f6
8 " neat RD 9 f6
subsite II
subsite (11+10)subsite (II+5)
Figure 5.5. Large Scale Band Shift Assay with Subsite (II + 5) and Subsite 
(II +10).
'U' denotes unbound target DNA, complexes are indicated by cN where N 
is the complex number (see Chapter 3 for further details). Some silver- 
stained complexes were visible by eye but are not clear in monochrome 
photographs.
Lane DNA Resolvase
1 pDB2507 (Hin dill/Eco RI) R.H.B.
2 " 2"3 R17 f48
3 " 2"1 RD 9 f6
4 " neat RD 9 f6
5 pDB2107 (Hin dlll/Eco RI) R.H.B.
6 " 2‘3 R17 f48
7 " 2'1 RD 9 f6
8 " neat RD 9 f6
contamination would not significantly alter results from complexes in those 
regions.
5.6 Subsite II Stoichiometric Determination.
The samples produced were counted for 10 min each using a Wallac 1409/11 
liquid scintillation counter version 1.4. This is a windowless counter which was 
installed with the manufacturers own software to supply 3H- and 32P- spectrum 
libraries as well as quenching data for the appropriate scintillation fluid and vial 
type. Nonetheless dilutions of 3H and 32P stocks were mixed in different ratios 
and counted in 10 ml of sdntillant to check the validity of the software to the 
amounts of material being used.
The isolated complexes were counted approximately every five days (for a 
period of 1 month) to check that the change in the assigned values of each isotope 
was consistent with the expected decay rate. All runs of counting included at 
least 3 blank samples containing H 2O2 and sdntillant, and the average value of 
the blanks was subtracted from each experimental value from the same run 
(giving "blank adjusted' cpm and dpm values). Repeatedly counting the samples 
over a period of weeks meant that the 32P values were highest and most accurate 
in the initial rounds of counting. However the 3H values were likely to be more 
accurate in the final analysis as the decay in their activity was minimal on this 
time scale but the 32P values were at their lowest, and so the 3H peak was least 
affected by the tail of the 32P energy peak. Because of this the calculations to 
determine the relative and absolute stoichiometry of the complexes were based 
on the 32P values from the initial count of each sample, and the 3H value from 
the last count. In order to check the observed decay rates of the isotopes in each 
sample all data were adjusted to the same start date (Ao = 00:00 on 1st October 
1992), which was essential for all data to be used in absolute stoichiometry 
determinations.
Manipulations of the data produced using subsite II are described below, with 
the steps involved summarised in tables and sample calculations where 
necessary. The data produced with the three other binding substrates were 
processed in the same manner and are shown in tabular form.
Although the samples were counted for 10 min each, values for 3H and 32P 
activities were recorded in counts per minute (cpm) and disintegrations per 
minute (dpm). The dpm  values were calculated by the scintillation counter from 
the cpm values based on the programmed quench data and with respect to an 
external control source. The ratio of cpm to dpm for particular counting
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conditions should be fairly consistent for any given isotope when the values of 
different samples are to be compared. 32P is not subject to significant quenching 
and so the counting efficiency for all samples was close to 100%. 3H is quenched 
and an efficiency of about one third is expected for 3H counting. Almost all the 
3H data used in these calculations had counting efficiencies of 32% to 34%. 
Although some data shown in the activities tables have values outside this range, 
not all the data listed were carried forward to the final calculations.
Data were adjusted to a nominated date (00:00 on 1/10/92) as follows:
If Ax is the activity of a sample when counted at a time, T x , and t is the half-life 
of the isotope then the activity of the sample can be calculated for a different 
time, To-
If AT = Tx -  T0 , and the activity of the sample at To is Aq then;
A0 = A x .2(AT/t)
The following blank adjusted values were produced for complex 2 of subsite II 
using undiluted RD 9 f6:
3H: AX = 20179.7 dpm  Tx = 29/10/92,19:37 t = 4492.575 days
32P: AX = 4612.0 dpm  TX = 4/10/92,21:36 t = 14.3 days
For T0 = 1/10/92,00:00,
3H: AT = 28.817 days Ao = (20179.7). [2(28.817/4492.575)] = 20269.6 dpm
32P: AT = 3.9 days Ao = (4612.0).[2<3-9/ 14*3>] = 5571.7 dpm
The subsite II, c2 ,365 nM f6 sample (where c 'n ' is complex number 'n ', and 'X' 
mM f6 represents a final RD 9 f6 concentration of 'X' mM) gave activities from 
different times of counting which were not consistent with each other once 
adjusted for decay. The 32P value produced on the first counting was 5% lower 
than the other adjusted values (all within 1%). This may have been the result of 
incomplete mixing of the sample with the scintillation fluid as the counter used is 
not designed for Cerenkov counting. This would have been corrected when the 
samples were mixed again between measurements. The 3H value for this sample 
showed the same discrepancy, but the difference in the values was about 30%, 
compared with less than 10%. A 10% variation in 3H activities was a result of the 
progressive decay of 32P in each sample allowing better detection of the 3H 
present and so all 3H values used were from the final rounds of counting. 
Because of this variation in the subsite II, c2,365 nM f6 sample the 32P activity 
quoted was derived from counting on 12/10/92 instead of 4/10/92.
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Ax Efficiency of AX
Complex [R] (cpm) Counting (dpm)
c 1 730 nM 251.3 31.73% 792.0
c 1 365 nM 467.7 33.26% 1406.0
c 2 730 nM 6484.6 32.10% 20200.5
c 2 365 nM 6130.9 33.35% 18385.7
c 3 730 nM 1676.3 33.40% 5019.0
c3 365 nM 587.9 33.98% 1730.3
Ax (blank Time of Counting Ao
Complex [R] adjusted dpm) (=TX) (dpm)
c 1 730 nM 771.2 29/10/92 19:16 774.6
c 1 365 nM 1385.2 29/10/92 19:27 1391.3
c 2 730 nM 20179.7 29/10/92 19:37 20269.6
c 2 365 nM 18364.9 29/10/92 19:48 18446.7
c 3 730 nM 4998.2 29/10/92 19:59 5020.4
c3 365 nM 1709.5 29/10/92 20:09 1717.1
Table 5.4 3H Activities for Subsite II Complexes (pDB2004).
[R] is the final concentration of resolvase which was present in the 
binding reaction.
AX Efficiency of AX
Complex [R] (cpm) Counting (dpm)
c 1 730 nM 336.9 99.26% 339.4
c 1 365 nM 647.8 99.37% 651.9
c 2 730 nM 4604.1 99.54% 4625.4
c2 365 nM 2948.7 99.97% 2949.7
c3 730 nM 813.2 99.32% 818.8
c3 365 nM 380.4 99.37% 382.8
Ax (blank Time of Counting Ao
Complex [R] adjusted dpm) (=TX) (dpm)
c 1 730 nM 326.0 4 /10/92  21:15 393.5
c 1 365 nM 638.5 4/10/92  21:26 771.1
c2 730 nM 4612.0 4/10/92  21:36 5571.7
c2 365 nM 2936.3 12/10/9219:22 5204.1
c3 730 nM 805.4 4 /10/92  21:58 973.7
c3 365 nM 369.4 4/10/92  22:08 446.7
Table 5.5 32P Activities for Subsite II Complexes (pDB2004).
Two binding reactions containing RD 9 f6 were prepared for each substrate to try 
to produce an optimal yield of each complex. Although the overall amount of 
complex in each track was not identical the ratio of protein to DNA should have 
been constant and so the average 3H and 32P activities were taken (where
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appropriate) in order to determine the relative and absolute stoichiometry 
values.
Example: for complex 2 3H Ao = (20269.6 + 18446.7)/2 = 19358.1
32P A0 = (5571.7 + 5204.1)/2 = 5387.9
In some cases the amount of material present in complex from one reaction was 
considerably less than that of the other and so often the smaller sample m ay have 
been excluded from further calculations. An absolute limit was not placed on the 
dpm  value required for a complex to be included so that results could be 
produced for all complexes detected. However it is obvious that greatest 
emphasis should be placed on the results derived from the largest values.
Example: for complex 2 3H A o/32P Ao = 19358.1/5387.9 = 3.59
Although the ratio 3H A q/32P Ao is an indicator of the resolvase to DNA ratio, 
the 3H Ao and 32P Ao values do not represent real concentrations. The benefit of 
this ratio is to allow a comparison with the resolvase/DNA ratio in other 
complexes. The column "complex n/com plex 2" in Table 5.6 shows how the 
am ount of resolvase (relative to DNA) increases in successive complexes. These 
values were produced by dividing the 3H A o/32P Ao ratio for a given complex, n, 
by that for complex 2.
Complex
3H Ao 
(dpm)
32P A0 
(dpm)
3H A o/
32P A 0
complex n /  
complex 2
c l 1391.3 771.1 1.80 0.50
c2 19358.1 5387.9 3.59 1.00
c3 5020.4 973.7 5.16 1.44
Table 5.6 Relative Stoichiometry of Subsite II Complexes (pDB2004).
Obviously the ratio 'complex n/com plex 2' for complex 2 will be 
exactly 1.00 for all substrates investigated.
The absolute stoichiometry of a complex can be determined if 3H Ao and 32P Ao 
are converted into amounts of resolvase and subsite II fragment, respectively. 
This can be done by dividing each value by the appropriate specific activity.
The derivation of the specific activity of the resolvase in f6 of RD 9 is shown in 
Chapter 4 and the specific activity of the DNA samples is discussed earlier in 
section 5.2.
RD 9 f6; Asp. = 4,874.39 dpm /pm ol.
subsite II; Asp. = 2,874.38 dpm /pm ol.
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Once the activities were expressed as pmol of resolvase or pmol of subsite II 
fragment the absolute stoichiometry is derived by dividing the amount of 
resolvase present by the amount of subsite II DNA.
Complex
Resolvase
(pmol)
subsite II 
(pmol)
Resolvase: 
Subsite II
c 1 0.29 0.27 1.06
c2 3.97 1.87 2.12
c3 1.03 0.34 3.04
Table 5.7 Absolute Stoichiometry of Subsite II Complexes (pDB2004).
5.7 Relative Stoichiometry of Complexes of res.
The data for complexes produced with a full res site are presented in Tables 5.8, 
5.9 and 5.10. As the calculations were equivalent to those described for subsite II 
fewer steps are shown. In some cases calculations are based on data from only 
one complex, e.g. where the cpm values of a complex in one track were 
significantly less than that in the other (cl; 730 nM [R]), or where the Ao values 
produced from different times of counting showed unreasonable fluctuation (c3; 
365 nM  [R]) and, of course, in the case of c6; 365 nM [R] where complex was not 
visible against the background staining. No data are presented for complex 5 as it 
could not be detected on the gels. Again this was probably due to increased 
background in this area of the gel. However the mobility, distribution and 
relative intensity of the other complexes indicate their correct assignation and 
that the results observed under these conditions are relevant to the 'normal' 
smaller scale experiments described in Chapter 3.
Complex [R]
*H Ax (cpm) 3h a x
(dpm)
Efficiency of 
Counting
3H A o
(dpm)
c 1 730 nM 168.2 468.8 35.88% 450.0
c 1 365 nM 279.3 838.1 33.33% 820.9
c 2 730 nM 2296.9 6875.4 33.41% 6885.2
c 2 365 nM 3680.9 10795.4 34.10% 10822.8
c 3 730 nM 732.5 2230.1 32.85% 2219.1
c 3 365 nM 820.5 2420.5 33.90% 2410.4
c 4 730 nM 5016.1 14965.2 33.52% 15011.3
c 4 365 nM 2610.1 7810.9 33.42% 7825.0
c 6 730 nM 5843.3 17631.0 33.14% 17689.1
Table 5.8 3H Activities of Wild Type res Site Complexes (pDB22).
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Complex [R]
32p AX 
(cpm)
32p Ax 
(dpm)
Efficiency of 
Counting
32p A0 
(dpm)
c 1 730 nM 189.9 189.7 100.11% 214.1
c 1 365 nM 407.0 407.4 99.90% 478.7
c 2 730 nM 1610.1 1613.8 99.77% 1945.2
c2 365 nM 2560.9 2561.7 99.97% 3098.5
c 3 730 nM 361.6 361.3 100.08% 423.2
c 3 365 nM 477.5 478.7 99.75% 566.2
c4 730 nM 1734.8 1735.3 99.97% 2096.0
c4 365 nM 989.5 987.2 100.23% 1185.8
c 6 730 nM 1450.4 1453.7 99.77% 1754.4
Table 5.9 32P Activities of Wild Type res Site Complexes (pDB22).
Complex
3HA o
(dpm)
32p A0 
(dpm)
3H A o/  
32p A0
complex n /  
complex 2
c 1 820.9 478.7 1.71 0.49
c 2 8854.0 2521.9 3.51 1.00
c3 2219.1 423.2 5.24 1.49
c4 11418.1 1640.9 6.96 1.98
c6 17689.1 1754.4 10.08 2.87
Table 5.10 Relative Stoichiometry of Wild Type res Site Complexes (pDB22).
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5.8 Relative Stoichiometry of Complexes of Subsite (II +10).
As with the res site data, extended calculations are not shown. Data from 
complex 3 were considered significantly more reliable from one of the two 
reaction tracks (730 mM [R]). All other ratios were derived from average values.
Complex [R]
3H Ax (cpm) 3H Ax 
(dpm)
Efficiency of 
Counting
3HA o
(dpm)
c 1 730 nM 874.6 2607.9 33.54% 2598.7
c 1 365 nM 1393.5 4182.6 33.32% 4180.5
c 2 730 nM 4502.5 13694.9 32.88% 13735.6
c 2 365 nM 4333.0 12907.5 33.57% 12944.6
c 3 730 nM 4571.7 14150.7 32.31% 14193.5
c 3 365 nM 2632.4 7977.8 33.00% 7992.8
Table 5.11 3H Activities of Subsite (II +10) Complexes (pDB2107).
Complex [R]
32P AX 
(cpm)
32P A X
(dpm)
Efficiency of 
Counting
32P A0 
(dpm)
c 1 730 nM 784.3 782.0 100.29% 940.6
c 1 365 nM 1262.9 1260.7 100.17% 1527.0
c 2 730 nM 1995.7 1995.5 100.01% 2427.4
c 2 365 nM 1948.5 1949.8 99.93% 2372.3
c 3 730 nM 1510.5 1508.8 100.11% 1832.7
c 3 365 nM 931.9 934.4 99.73% 1129.1
Table 5.12 32P Activities of Subsite (II +10) Complexes (pDB2107).
Complex
3H A o
(dpm)
32P A0 
(dpm)
3H A o/
32p a 0
complex n  /  
complex 2
c 1 3389.6 1233.8 2.75 0.49
c2 13340.1 2399.9 5.56 1.00
c3 14193.5 1832.7 7.74 1.39
Table 5.13 Relative Stoichiometry of Subsite (II +10) Complexes (pDB2107).
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5.9 Relative Stoichiometry of Complexes of Subsite (II + 5).
Only three complexes were visible with subsite (II + 5) presumably due to the 
inability to separate the doublet previously defined as complexes 3 and 4. Again 
this may be a result of the large amounts of material used, or the choice of stain. 
As with the subsite (II + 10) data not all calculation steps are shown, and complex 
3 data are derived from the Ao values of c3; 730 nM [R] only.
complex [R]
3H Ax (cpm) 3H Ax 
(dpm)
Efficiency of 
Counting
3H A o
(dpm)
c 1 730 nM 1766.0 5208.3 33.91% 5210.9
c 1 365 nM 2697.0 8018.5 33.63% 8033.7
c2 730 nM 3691.5 11085.4 33.30% 11114.5
c 2 365 nM 2973.8 8698.0 34.19% 8716.3
c 3 730 nM 6958.5 20687.0 33.64% 20759.5
c3 365 nM 1825.1 5434.3 33.58% 5437.9
Table 5.14 3H Activities of Subsite (II + 5) Complexes (pDB2507).
Complex [R]
32P A x
(cpm)
32p AX 
(dpm)
Efficiency of 
Counting
32P A 0
(dpm)
c 1 730 nM 1757.9 1762.2 99.76% 2149.4
c 1 365 nM 2760.0 2762.2 99.92% 3379.7
c 2 730 nM 1711.1 1708.6 100.15% 2085.0
c 2 365 nM 1474.9 1478.4 99.76% 1802.6
c 3 730 nM 2033.8 2037.5 99.82% 2491.3
c 3 365 nM 583.1 583.0 100.02% 701.3
Table 5.15 32P Activities of Subsite (II + 5) Complexes (pDB2507).
Complex
3H A o
(dpm)
32P A 0
(dpm)
3H A o/  
32P A0
complex n  /  
complex 2
c 1 6622.3 2764.5 2.40 0.47
c2 9915.4 1943.8 5.10 1.00
c3 20759.5 2491.3 8.33 1.63
Table 5.16 Relative Stoichiometry of Subsite (II + 5) Complexes (pDB2507).
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5.10 Comparison of Absolute Stoichiometry Values of Sites Examined.
Site;
Complex
Resolvase
(pmol)
DNA Site 
(pmol)
Resolvase: 
DNA Site
II; c2 3.97 1.87 2.12
res; c2 1.82 0.76 2.39
(II + 10); c 2 2.74 1.15 2.39
(II + 5); c 2 2.03 0.98 2.08
Table 5.17 Absolute Stoichiometry of Complex 2 of Sites Investigated.
Values shown are derived as described for subsite II (Table 5.7) 
from the activities in Tables 5.6,5.10,5.13 and 5.16, the DNA 
specific activities in Table 5.3 and the resolvase specific activity, 
Asp. = 4,874.39 dpm /pm ol, calculated in Chapter 4.
As discussed in section 5.3, the relative stoichiometry results for major complexes 
of each site are considered most reliable, however the results for other complexes 
all conform to the same pattern of binding. If the absolute resolvase/DNA 
stoichiometry value for complex 1 is likely to be an integer (other than 0) then it 
is probable that the absolute stoichiometry of complex 2 is an even whole 
number, as two binding units of resolvase associate with each DNA molecule in 
complex 2, and one resolvase binding unit associates with each DNA molecule in 
complex 1. This in turn simplifies the interpretation of the absolute stoichiometry 
results, i.e. if the value for complex 2 is expected to be 2 ,4  or a larger even 
integer, then the results in Table 5.17 clearly show that this stoichiometry is 2 
resolvase monomers per DNA site, for all four binding sites investigated.
The relative stoichiometry values produced were in close agreement for 
equivalent complexes of different sites. The results shown in Table 5.17 were 
calculated from the same data as the relative stoichiometries, but also took into 
account resolvase and DNA specific activities. As the same resolvase specific 
activity value was used in each case, differences in the absolute stoichiometries 
shown m ust partly be due to differences in the observed DNA specific activities. 
This reflects some variation in the determination of DNA Stock volume-specific 
activities or, more probably, factors such as ’Efficiency of Labelling1.
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5.11 Conclusions.
The relative stoichiometry data presented for res, subsite II, subsite (II + 10) and 
subsite (II + 5) show that each subsequent complex observed represents binding 
of a single additional resolvase unit. The calculation of absolute values shows 
that, for all four of these binding sites, the binding unit is a monomer of 
resolvase.
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Chapter Six 
Mutagenesis of the Tn3 tnpR  gene
6.1 Introduction.
Mutants of the DNA invertase Gin have been produced which no longer require 
the accessory factor FIS to direct inversion of an appropriate substrate43. Some 
mutations of Cin, which can direct recombination in the absence of the enhancer 
element, have also been reported26. Although termed FIS-independent, inversion 
by the Gin mutants is still subject to stimulation by FIS. The FlS/enhancer- 
independent mutations identified are the result of single amino add  
substitutions, which lie between positions 70 and 115 of the protein sequence.
In protein sequence alignments (Fig. 6.1), the positions of FIS-independence 
mutations of Gin, and of enhancer-independence mutations of Cin, coinddes 
with the region in y8 resolvase which has been shown to be involved in 
protein/protein contacts between subunits of the 1-2 dimer, believed to bind 
subsites of y8 res, prior to synapsis34. The equivalent region is expected to be 
responsible for interactions between monomers of Gin bound to a gix site. 
Further mutagenesis of a FIS-independent Gin produced FIS-dependent 
revertants with a normal inversion phenotype. Amino acid substitutions which 
gave rise to FIS-dependent revertants were located in the N-terminal region of 
Gin. The same substitutions which create FIS-dependent revertants abolish 
recombination activity when introduced to (otherwise) wild-type Gin.
A model of Gin-mediated inversion has been proposed38, which is related to 
models for resolution by Tn3 resolvase (see Chapter 1). In the Gin model the 
accessory factor (FIS bound to the enhancer) assists in the formation of a -2 
synapse, to allow recombination of the two Gin-bound gix sites. By analogy, the 
subsite I sequences in a res synapse are considered equivalent to the gix sites, 
with subsites II and III serving, as accessory sites, to stabilise the -3 synapse.
M utants of Tn3 resolvase were sought which could direct recombination of a 
substrate with two copies of subsite I only, to question the validity of this 
comparison.
6.2 Choosing a Resolvase Expression Vector as a Target for Mutagenesis.
The availability of a number of related resolution substrates, which could be 
adapted to allow in vivo screening for the desired mutants, dictated that the 
resolvase expression vector used should be compatible with these plasmids. It 
was also desirable to have an expression vector which could give reasonable 
rates of resolution in vivo (with wild type res sites) without greatly reducing cell 
growth rates because of very high levels of resolvase production. The resolvase
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Figure 6.1. Sequence Alignment of Tn3 Resolvase, y8 Resolvase, M u G in 
and PI Cin.
Underlined residues in Gin and Cin sequences indicate positions at which 
substitutions giving FIS-independent Gin or enhancer-independent Cin 
were detected. The substitutions reported for each invertase were as 
follows;
Gin; SF75 IV94 FV104 HY106 MV114
Cin; RH71 HY106
The reported amino add  positions do not exactly match the positions 
shown here as a result of aligning the invertase and resolvase sequences.
The underlined y5 residue indicates the position at which a methionine is
substituted by cysteine to create y8 M106C mutant resolvase, described in 
Chapter 3.
The region of y8 resolvase shown to make contacts between two resolvase 
subunits forming a 1-2 dimer is indicated (approximately) by a line above
the y8 sequence. The equivalent regions are expected to provide a similar 
function in Tn3 resolvase, Gin and Cin.
expression vector pMA6111, described in Chapter 4, failed to meet either of these 
criteria, but a pACYC177 derivative, pCIA70 (Fig. 6.2) was acceptable on both 
counts. pCIA70 DNA was kindly supplied by P. Haffter. Resolvase expression 
from pCIA70 is driven by the lacuvs promoter, which is induced in the presence 
of IPTG. Overnight growth of cells containing pCIA70 gave complete resolution 
of a pBR322-based resolution substrate, carrying two directly repeated res sites, 
when IPTG was included in the growth medium (see Fig. 6.5). W ithout IPTG in 
the medium resolution of the same substrate was detected, but some unresolved 
plasmid remained. No large scale resolvase purification protocol had been 
developed using pCIA70, but, if the desired mutants were isolated, it w ould have 
been possible to transfer the altered coding region to pMA6111, for 
overexpression and purification.
Directed mutagenesis techniques, or methods needing a single stranded DNA 
target, would have required the construction of a suitable new plasmid, which 
may not have satisfied the expression or compatibility criteria discussed. Hence it 
was considered reasonable initially to choose a method of mutagenesis which 
could be used with an acceptable resolvase source, i.e. pCIA70.
6.3 Construction of Substrates for Identification of Desired M utants.
A substrate which would allow for screening of the desired m utants had already 
been produced by A. L. Bednarz8. pAL225 has two copies of subsite I cloned into 
pBR322, in direct repeat (Fig. 6.3). The design of this plasmid was based on 
pMA21, a pBR322 derivative containing two, directly repeated, copies of the Tn3 
res site (Fig. 6.3). Resolution of pMA21 in vivo, followed by decatenation by DNA 
gyrase, would produce two smaller, unlinked DNA circles, each containing a res 
site (Fig. 6.4). One of these would carry the ampidllin resistance gene, fila, and 
the pBR322 origin of replication, and could be maintained in vivo. However the 
other product, coding for tetracycline resistance, would not be replicated and so 
w ould be lost after in vivo resolution. The same would be true of resolution of 
pAL225, if it occurred. Therefore resolvase mutants which directed this reaction 
could be screened by selecting for pCIA70 pAL225 transformants which were 
am pidllin resistant but tetracycline sensitive, and then checking for resolution by 
analysing the plasmid DNA present in the chosen isolates. This m ethod requires 
replica plating of colonies, which could cause problems when looking for a small 
num ber of Apr Tcs colonies amongst a very high Apr Tcr background (i.e. many 
unresolved substrates). A more direct approach was made possible by 
subcloning a galK expression cassette into pAL225. This cassette was derived 
from the MCKenney promoter probe vector, pKOSOO55 and PCS34983. A 200 bp
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Figure 6.2. Map of Resolvase Expression Vector pCIA70.
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Figure 6.3. Resolution Substrates pMA21, pAL211, pAL225 and pAL265, 
and Their galK  Derivatives.
(a) Source of Tn3 res site and Tn3 subsite I fragments used to produce 
pMA21, pAL211, pAL225 and pAL265.
(b) The map of pMA21 shows general features which it has in common 
with pAL211, pAL225 and pAL265. The relative orientation of the 
sites present in each of these plasmids is also indicated.
(c) A map of the pMA21 derivative pDB4 indicates restriction sites and 
genes common to each of the galK resolution substrates. Orientations 
of recombination sites in pDB5, pDB6 and pDB7 are also shown. 
pDB5 is derived from pAL225, pDB6 from pAL211 and pDB7 from 
pAL265.
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Figure 6.4. Resolution (and Decatenation) of pMA21 and pDB4.
(a) Resolution of pMA21. In vivo resolution results in deletion of 
pMA21t, as it lacks an origin of replication.
(b) Resolution of pDB4. As for pMA21t, pDB4g is lost following in vivo 
resolution.
Hin dUl/Dra I fragment, containing the E. coli argR promoter, was cloned from 
pCS349 to the Hin dill and Sma I sites of pK0500, producing pXAP (M. Burke; 
pers. comm.). The argR promoter and galK gene were subcloned, as a Hin 
d m / Acc I fragment, between the Hin dill and Eco RV sites of pAL225 (producing 
pDB5; Fig. 6.3) and of pMA21 (to give pDB4; Fig. 6.3). The insertion of this 
fragment to each resolution substrate disrupted the tetracycline resistance gene. 
Similar constructs were produced by subcloning the same galK fragment to the 
same restriction endonuclease sites in the plasmids pAL211 and pAL2657, giving 
pDB6 and pDB7 respectively (Fig. 6.3). Each of these plasmids has a copy of 
subsite I placed in direct repeat with a wild type res site. The difference between 
pDB6 and pDB7 is the orientation of the pairs of sites relative to the other 
plasmid sequence. The relative orientation of the sites in pDB4 is the same as 
pDB6, and in pDB5 is as for pDB7. The resolution product of pDB4 which retains 
the origin of replication (and pla) is named pDB4o, and the other product, with 
the galK gene is called pDB4g (Fig. 6.4). Similarly the (potential) products of 
pDB5, pDB6 and pDB7 are denoted by the suffix o (for origin) or g (for galK).
In vivo resolution of pDB4, pDB5, pDB6 or pDB7 can be assayed by selection of 
Apr galK' isolates, if using Aps galK" cells (that are wild type for other genes 
involved in the uptake and metabolism of galactose, e.g. galP, galU, lacY, etc.), 
such as DS941, because the galK cassette becomes covalently unlinked from the 
plasmid origin of replication following resolution of the substrate. pDB5 was 
constructed to allow screening for a resolvase m utant capable of directing subsite 
I by subsite I resolution. pDB4 was made as a control, to test that resolution could 
be detected. pDB6 and pDB7 were made to allow for selection of resolvase 
mutants giving increased levels of resolution between res and an isolated subsite 
I. If the desired phenotype (resolution between a pair of subsite I's) was not 
isolated from a single round of mutagenesis, mutants selected using pDB6 or 
pDB7 may have been good candidates for further modification, in an attem pt to 
produce a resolvase which had no accessory site requirement.
6.4 M ethods of Selection for Resolution of pDB4, pDB5, pDB6 and pDB7.
Two different approaches were considered for identifying deletion of galK from 
these resolution substrates. The presence of 2-deoxygalactose in growth medium  
results in an accumulation of 2-deoxygalactose-l-phosphate in galK+ cells3. 
Accumulated 2-deoxygalactose-l-phosphate inhibits the utilisation of glycerol as 
a carbon source (bacteriostasis), and so a minimal medium containing 
2-deoxygalactose, with glycerol as the carbon source, will select against gal+ cells 
(D-fucose was also required to stimulate 2-deoxygalactose uptake in DS941, by
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induction of galP). Although this approach could reduce the total num ber of 
colonies screened, an expression period would be required after the introduction 
of mutagenised pCIA70, to allow resolution of pDB5, and segregation of 
resolution products. The desired mutant resolvase may be very slow to resolve 
pDB5 (especially as it is a multicopy plasmid) and so growth over many 
generation times may be required. This in turn could result in a num ber of 
isolates being derived from the same original mutation. DS941 containing 
pCIA70 and pDB4 was grown in non-selective media to give a mix of galK+ and 
galK" cells, which were then plated on selective media containing 
2-deoxygalactose, D-fucose and glycerol. No obvious difference was noticed 
between colonies produced from cells containing resolved or unresolved pDB4, 
and so this is not a suitable selection method.
Cells which are g a t  form red colonies when grown on MacConkey agar plates 
containing galactose, but gaf cells give white colonies56. MacConkey agar 
contains the pH indicator 2-methyl-3-amino-6-dimethyl-aminophenazine 
(neutral red) which is red at pH <6.8 and yellow at pH  >8.0. Bacterial 
fermentation of reducing sugars (e.g. galactose) lowers the pH  of the medium 
around the colony, giving red (or pink) cells. When galactose is the only sugar 
present gar cells metabolise amino adds in the media, producing ammonia and 
resulting in an increase in pH. This causes the neutral red dye to become yellow, 
and so these colonies appear pale yellow or white.
MacConkey galactose (Mac Gal) plates (containing am pidllin and kanam ydn) 
were used to examine a mixed population of resolved and unresolved pDB4 in 
DS941 pCIA70. After overnight growth at 37 °C both red and white colonies were 
produced (Fig. 6.5). Single colony gel analysis of the different coloured colonies 
showed that all white colonies examined contained only pDB4o sized (and 
pCIA70 sized) plasmids, and were presumably ga f. Red colonies were observed 
to contain either bands corresponding to pDB4 and pCIA70, or also contained a 
spedes of the size expected for resolution products of pDB4 (Fig. 6.5). In both 
cases the cells would be expected to be gal+.
A second indicator medium containing 2,3,5 triphenyl-2H-tetrazolium chloride 
(TTC, red tetrazolium) was also tested. This indicator can be reduced to form a 
red precipitate (red formazan) only at high pH. Conversely to MacConkey agar, 
cells metabolising galactose in this medium would give white colonies, as the 
TTC could not be reduced at the low pH produced, and so would remain 
colourless56. At the higher pH produced by growth of ga f cells the TTC would be
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Figure 6.5. Detection of In Vivo Resolution Using MacConkey Galactose 
Medium.
(a) In vivo resolution by resolvase expressed from pCIA70.
(b) Relationship of colony colour to resolution products.
Lane 1 - DS941pDB4 (+IPTG)
2 - DS941 pCIA70pDB4 (-IPTG)
3 - DS941 pCIA70pDB4 (-IPTG)
4 - DS941 pCIA70pDB4 (+IPTG)
5 - DS941pDB5 (+IPTG)
6 - DS941 pCIA70pDB5 (-IPTG)
7 - DS941 pCIA70pDB5 (+IPTG)
8 -Hin dill digested X DNA marker.
(b)
s.c. substrate 
pCIA70
s.c. galK product
s.c. Apr product
reduced to form a deep red precipitate. Unfortunately this effect was only 
observed when comparing chromosomal gar and g a t E. coli. No difference was 
observed between DS941 pCIA70 pDB4 colonies and DS941 pCIA70 pDB4o 
colonies grown on the same plates.
For these reasons Mac Gal Ap Kn plates were considered the best selective media 
for distinguishing DS941 pCIA70 pDB5 from DS941 pCIA70 pDB5o.
6.5 In Vivo and In Vitro Resolution of pDB4, pDB5, pDB6 and pDB7 by Tn3 
Resolvase.
As the resolution substrates produced were designed to test for resolution in vivo 
by m utants of resolvase, it seemed sensible to first check levels of resolution by 
wild type Tn3 resolvase, for each plasmid. Also the stability of each plasmid was 
checked over a number of cell generations.
pDB4, pDB5, pDB6 and pDB7 were each transformed to DS941. After 
transformation the cells were diluted in L-broth (+ Ap) and grown overnight, 
with shaking, at 37 °C. The following day samples were removed, plated to Mac 
Gal Ap plates and incubated at 37 °C overnight. Samples were also diluted 100- 
fold in fresh L-broth with Ap. These were again grown overnight at 37 °C with 
shaking. Cells from these cultures were diluted and grown another three times, 
giving a total of five periods of growth to stationary phase (estimated to be 50 to 
100 generations). Samples from each culture were checked by plating to Mac Gal 
Ap, but no white colonies were detected (dilutions were plated as small colonies 
or overcrowding of the plate can affect the pH, and hence colony colour). DNA 
was isolated from plated samples and analysed by gel electrophoresis. No 
resolution products were observed.
To investigate resolution by Tn3 resolvase DS941 pCIA70 cells were transformed 
with pDB4, pDB5, pDB6 or pDB7. Transformants were subcultured, to give 
growth for approximately 60 generations, in L-broth with Ap and Kn, both with 
and w ithout IPTG. Samples from each culture were plated to Mac Gal Ap Kn, 
and plasmid DNA was isolated from the remaining cells. Some DNA from each 
was examined by gel electrophoresis (Fig. 6.6).
Amongst the uninduced samples only resolution product of pDB4 was detected 
(i.e. a pDB4o sized species), but some pDB4 was still present. Similarly, for the 
induced samples pDB4o was the only resolution product observed, but in this 
case no pDB4 was seen, presumably having all been resolved.
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Figure 6.6. In Vivo Resolution of pDB4, pDB5, pDB6 and pDB7.
Strains were grown for approximately 60 generations, with or without 
induction, prior to isolation of DNA samples.
Lane 1 - DS941 pCIA70 pDB4 (-IPTG)
2 - DS941 pCIA70 pDB5 (-IPTG)
3 - DS941 pCIA70 pDB6 (-IPTG)
4 - DS941 pCIA70 pDB7 (-IPTG)
5 - DS941 pCIA70 pDB4 (+IPTG)
6 - DS941 pCIA70 pDB5 (+IPTG)
7 - DS941 pCIA70 pDB6 (+IPTG)
8 - DS941 pCIA70 pDB7 (+IPTG)
A = supercoiled substrate; B = supercoiled pCIA70; C = supercoiled 
product.
It was possible that small amounts of resolved product were present in the other 
samples, but could not be seen on the gel. Any resolution product present could 
also remain undetected using MacConkey plates if it had not been fully 
segregated from unresolved copies of the parental plasmid. The sensitivity of this 
assay can be improved by isolating the plasmid DNA from a sample, 
transforming to fresh DS941, and plating to Mac Gal Ap. This should increase the 
probability of isolating any resolution product present. If detection of such 
products is being inhibited by a very high background of parental plasmid, 
further steps can be introduced. The isolated plasmid DNA can be cut w ith a 
restriction endonuclease (e.g. Hin dill) such that the parental plasmid and galK* 
product are both linearised, but the ori+ product is not cleaved. As linearised 
DNA is a poor substrate for transformation (compared with supercoiled DNA92) 
any ori+ product present will be more easily detected when the digested samples 
are transformed to DS941, and plated on Mac Gal Ap.
To test for low levels of resolution DNA isolated from the induced and 
uninduced samples described, was digested for 2 h with an excess of Hin dill. 
Half of each digest was run on an agarose gel (Fig. 6.7), and the remaining DNA 
was used to transform DS941 cells. Transformation products were grown on Mac 
Gal Ap plates, and colonies were scored.
Plasmids in 
Sample.
IPTG
Induction.
Red Colonies 
(
White Colonies
fcaO.
pCIA70 + 
pDB4
- 0 >1500
+ 0 >2000
pCIA70 + 
pDB5
- 4 0
+ 0 1
pCIA70 + 
pDB6
- 1 1
+ 0 6
pCIA70 + 
pDB7
- 9 5
+ 6 20
Table 6.1. In Vivo Resolution Products Detected by Transformation After 
Hin d ill Digestion.
Plasmid DNA was prepared from some of the different colonies produced by 
transformation of the Hin d ill digested material, and examined by gel 
electrophoresis (Fig. 6.8). In all cases the DNA from red colonies contained only 
resolution substrate sized species, and the DNA from white colonies contained 
only an ori+ resolution product sized species. Restriction endonuclease digestion 
analysis of these DNA samples supported the identification of these species. It is
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Figure 6.7. Hitt d ill Digestion of In Resolution Reactions.
DNA samples shown in Fig. 6.6 were digested with an excess of Hin dill 
for 2 h. This should linearise pDB4, pDB5, pDB6, pDB7 and pCIA70, but 
not pDB4o, pDB5o, pDB6o, pDB7o.
Lane 1 - DS941 pCIA70 pDB4 (-IPTG)
2 - DS941 pCIA70 pDB4 (+IPTG)
3 - DS941 pCIA70 pDB5 (-IPTG)
4 - DS941 pCIA70 pDB5 (+IPTG)
5 - DS941 pCIA70 pDB6 (-IPTG)
6 - DS941 pCIA70 pDB6 (+IPTG)
7 - DS941 pCIA70 pDB7 (-IPTG)
8 - DS941 pCIA70 pDB7 (+IPTG)
Figure 6.8. In Vivo Resolution Products After Hin d ill digestion and 
Transformation.
After Hin dill digestion samples (see Fig. 6.7) were transformed to 
competent DS941. Transformants were plated to MacConkey Gal Ap. See
main text (section 6.5) for further details.
Lane "Reaction" Induction Colony Co
1 pCIA70 pDB4 - white
2 pCIA70 pDB4 + white
3 pCIA70 pDB4 + white
4 pCIA70 pDB5 - red
5 pCIA70 pDB5 - red
6 pCIA70 pDB5 + white
7 pCIA70 pDB6 - red
8 pCIA70 pDB6 - white
9 pCIA70 pDB6 + white
10 pCIA70 pDB7 - red
11 pCIA70 pDB7 - white
12 pCIA70 pDB7 + white
13 pCIA70 pDB7 + red
Lane 14 - DS941pCIA70pDB4 marker sample.
likely that the red colonies were produced from undigested parental plasmid, as 
most red colonies were generated from the samples containing the largest 
amounts of intact resolution substrate.
This method does not give a measure of the relative levels of resolution but does 
serve to show the presence of rare recombination events. Although these results 
suggest that some resolution of pDB6 and pDB7 occurs in vivo, and that this is 
probably resolvase dependent, the sample numbers produced are very low. The 
results produced with pDB5 can not be considered significant. Similar results 
were produced when a recA strain, AB2463, was used instead of DS941.
The same approach was used to study resolution of these plasmids in vitro, (to 
compare with the plasmids pMA21, pAL225, pAL211 and pAL265, from which 
they were derived). Purified pDB4, pDB5, pDB6 and pDB7 DNA was used for in 
vitro resolution reactions using C9.4 reaction buffer (described in Chapter 2). The 
reactions were incubated at 37 °C for 18 h and then stopped by heating to 70 °C 
for 5 min. Each sample was split in two, and one half was digested with Hin dill, 
after adjusting the NaCl concentration to a suitable level for Hin d ill activity. 
Some digested and undigested material from each reaction was used to 
transform DS941 cells, which were then plated to Mac Gal Ap plates. The 
remaining material was run on an agarose gel (Fig. 6.9).
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pDB4 pDB5 pDB6 pDB7 
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HSBSB
Figure 6.9. In Vitro Resolution of pDB4, pDB5, pDB6 and pDB7.
(a) Hin dill digested material.
(b) Undigested material.
Resolution reactions were in C9.4 buffer at 37 °C for 18 h. Substrates 
as indicated. Tn3 resolvase dilutions (R14 f46) for each lane were as
follows: 1) R.H.B.; 2) 2'5; 3) 2"4; 4) 2’3.
Bands are denoted as follows:
A= o.c. substrate; B= nicked catenane; C= semi-nicked catenane;
D= linear substrate; E= semi-nicked catenane; F= s.c. substrate;
G= o.c. Apr product; H= s.c. Apr product.
Where present, s.c. catenane or linear galK product co-migrate with s. 
substrate.
Resolution
Substrate.
Resolvase
Dilution.
Red Colonies 
(*a/+).
White Colonies
(#*o.
Plasmids 
Resolved (%)
pDB4
None 127 0 0
2-5 44 166 79
2-4 71 121 63
2-3 74 134 64
pDB5
None 164 0 0
2-5 185 0 0
2-4 159 0 0
2-3 177 0 0
pDB6
None 270 0 0
2-5 160 3 2
2-4 214 8 4
2-3 122 4 3
pDB7
None 75 0 0
2-5 256 8 3
2-4 103 2 2
2-3 - - -
Table 6.2. In Vitro Resolution Products Detected by Transformation.
Resolution
Substrate.
Resolvase
Dilution.
Red Colonies
w +)-
White Colonies
o?«o.
pDB4
None 38 0
2-5 31 255
2-4 16 227
2-3 33 96
pDB5
None 109 0
2-5 8 0
2-4 16 0
2-3 10 0
pDB6
None 8 0
2-5 16 5
2-4 15 9
2-3 2 7
pDB7
None 33 0
2-5 16 1
2-4 13 12
2-3 2 19
Table 6.3. In Vitro Resolution Products Detected by Transform ation After 
Hin d ill Digestion.
Again, red colonies are probably the result of transformation of 
DS941 by undigested resolution substrates.
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Analysis of the resolution reactions by gel electrophoresis shows that about 80% 
of the pDB4 substrate has been converted to resolution product (Fig. 6.9). On 
close inspection of the original gel photographs some resolution products were 
also visible in the pDB6 and pDB7 reaction tracks, but no recombinant material 
was observed with pDB5. These results, in general, agree with the levels of 
resolution measured by detection of the galK reporter, after transformation (Table 
6.2). Even the most sensitive method of detection used (transformation after 
Hin dm  digestion) failed to show resolution products of pDB5 (Table 6.3). The 
plasmid content of g a t  and gal isolates was confirmed by gel electrophoresis of 
purified DNA, as described previously.
The levels of in vitro resolution observed here concur with those previously 
reported using related substrates8, but products of in vivo recombination between 
an isolated subsite I and a res site were not detected previously.
6.6 Production and Screening of M utants of pCIA70.
At the time of choosing a method of mutagenesis, directed (or site-specific) 
approaches were ruled out for three main reasons. Mutations thought to be 
responsible for FIS-independent phenotypes in Gin were not located in specific 
regions of the protein, in particular GinKR162 was believed to produce the 
strongest FIS-independent phenotype yet lay in the proposed DNA binding 
motif (however it was later shown that this phenotype was the result of a second 
substitution, GinMV114, and that KR162 alone did not affect recombination). 
Secondly, some substitutions giving rise to FIS-independent Gin were already 
present at equivalent positions of the resolvase sequence, e.g. GinFV104. Finally, 
for the reasons listed in section 6.2, it was considered preferable to choose a 
mutagenesis protocol compatible with pCIA70, rather than trying to create new 
resolvase expression vectors for a particular mutagenesis approach.
In vivo chemical mutagenesis of a double stranded DNA template, using 
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG; Fig. 6.10), was used to produce 
FIS-independent mutants of Cin26. MNNG mutagenesis produces transitions57'66 
(i.e. G*C base pairs to A*T, and T• A to C«G; see Fig. 6.10) and so the possible 
range of coding changes produced is limited, but several FIS-independent 
derivatives of Cin were created. Hence MNNG seemed a reasonable candidate 
for initial attempts at mutagenesis of pCIA70.
DS941 pCIA70 was treated with MNNG (Chapter 2) at a range of concentrations 
(0,50,100 or 200 M-g/ml final) for a range of times (0,10,30 or 60 min). The 
mutagenised DS941 pCIA70 samples were grown overnight and then pCIA70
87
(a) N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)
1NH MNNG
N —H
f  V - * -
r ~= <
CHi
/
H
Guanine 0 6-Methylguanine Thymine
(b) G C  ► A*T
CH-
3NH
CH
CH
MNNG --H —N
H
.4Thymine O -Methylthymine Guanine
(c) T *A  ► C*G
Figure 6.10. Principal Consequences of M utagenesis by  M NNG. 
(from Miller, 1992)
(a) Chemical structure of MNNG.
(b) G #C to A*T Transition.
(c) T*A to C*G Transition.
DNA was isolated. Some pCIA70 DNA from each sample was transformed into 
DS941 pDB4 and plated to Mac Gal Ap Kn + IPTG, to assay for levels of 
mutagenesis. The pCIA70 from cells which were given a 10 min exposure to 200 
(ig/m l MNNG produced 20 to 30% red colonies. Exposure to less MNNG 
corresponded to a lower proportion of red colonies, and longer exposure 
corresponded to significantly fewer transformants. The DNA content of cells 
from these plates was checked. Red colonies contained little or no pDB4o (Fig. 
6.11), suggesting reduced or abolished resolution activity due to the MNNG 
treatment of pCIA70. Mutations produced may have affected the function or 
expression of resolvase, but not the stability of pCIA70, as isolates were 
maintained on medium containing Kn. The number of independent tnpR' 
mutations produced was not determined.
The remaining pCIA70, treated with 200 |ig /m l MNNG for 10 min, was used to 
transform DS941 pDB5. Following transformation, the cells were diluted in 
phage buffer (Chapter 2) and plated to Mac Gal Ap Kn IPTG medium. The 
samples were diluted to prevent overcrowding of plates, which could give small 
colonies which would not respond correctly to the screening method used. 
Approximately 40,000 colonies were screened.
Thirty-nine white (or very pale pink) colonies were isolated, and streaked to 
fresh Mac Gal Ap Kn plates. The sizes of plasmids present in each isolate was 
checked by gel electrophoresis of purified DNA. Four isolates contained 
plasmids corresponding to the size of pDB5o (but also contained some pDB5). 
The pCIA70 derivative from each was transformed to DS941, grown on Mac Gal 
Kn plates and then replica plated to Mac Gal Ap Kn. Knr Aps cells were pooled 
for each isolate, grown in L-broth with Kn, and used to prepare pCIA70 DNA 
(this should eliminate any pDB5o from later steps). This material was used to 
transform DS941 pDB4 or DS941 pDB5. Transformants were grown on Mac Gal 
Ap Kn IPTG plates. In all cases the transformants which had contained pDB4 
gave exclusively white colonies, and those which had contained pDB5 gave red 
colonies. The plasmid content was analysed (by gel electrophoresis) and showed 
complete resolution of pDB4, but no recombination of pDB5.
Mutagenesis of pCIA70 was repeated using a 10 min treatment with 200 p g /m l 
MNNG, but desired resolvase mutants were not detected.
6.7 Production of a New Resolvase Expression Vector, to Allow Directed 
Mutagenesis.
When it became apparent that all the FIS-independent Gin (and enhancer-
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Figure 6.11. Screening of Mutagenised pCIA70 Using pDB4.
MNNG treated (200 JJ-g/ml MNNG for 10 min) pCIA70 was used to 
transform competent DS941pDB4. Transformants were plated to 
MacConkey Gal Ap Kn +IPTG, and grown overnight. Red and white 
colonies were patched to fresh plates and then analysed by 'single colony' 
gel electrophoresis.
Lane Colony Colour pDB4 resolution
1 white complete
2  it tt
3
4 red very poor
5 " poor
6 " absent
7 " very poor
8
9 " poor
10 " very poor
n
*22 I* H
Lane 13 - Hin dill digested X DNA marker.
independent Cin) mutations were in the same area of protein sequence, it seemed 
preferable follow a mutagenesis strategy which was directed to the equivalent 
region of Tn3 resolvase.
To allow this, a 1.3 kb tnpR+ Eco FI/Hin  d ill fragment was subcloned (from 
pMA6111) between the Eco RI and Hin dill sites of pSelect-162, to produce 
pDB6001 (Fig. 6.12). In addition to its pBR322 replication origin, the pSelect-1 
plasmid contains a single stranded phage origin of replication, allowing 
preparation of single stranded circular DNA, which is an appropriate template 
for directed mutagenesis. In pDB6001 the resolvase reading frame was placed 
downstream of a T7 RNA polymerase promoter, which should not be recognised 
by E. coli RNA polymerases. T7 RNA polymerase was supplied using a strain 
(BL21) carrying a X lysogen (DE3) which expresses T7 RNA polymerase from an 
IPTG-inducible promoter. Hence resolvase expression from pDB6001 would be 
expected only when present in BL21DE3, grown in the presence of IPTG. In 
practice some T7 RNA polymerase is produced in BL21 DE3 without IPTG 
induction, and so some resolvase expression would be expected from uninduced 
cells. Resolvase expression from pDB6001 was tested in two ways. Competent 
DS941, BL21 and BL21 DE3 cells were transformed by pDB6001 and grown with 
and w ithout IPTG induction. BL21 DE3 containing pDB6001 grew poorly under 
induction, a feature associated with resolvase overexpression from pMA6111. 
Whole cell extracts were prepared for all the induced and uninduced samples 
(including DS941, BL21 and BL21 DE3 without pDB6001) and analysed by 
denaturing PAGE (Fig. 6.13). The extract from induced BL21 DE3 pDB6001 
showed a very slight increase in a band which ran in the same position as a 
purified resolvase marker. The level of expression was much less than that 
observed with pMA6111. Varying the growth time or point of induction may 
have improved this.
pLS134 is a Cmr plasmid which contains two directly repeated copies of Tn3 
res86. It is compatible with pDB6001 and so was used as a substrate for in vivo 
resolution, to test for expression of resolvase from pDB6001. Competent DS941, 
BL21 and BL21 DE3 cells were first transformed with pLS134. Next pDB6001 was 
used to transform DS941, BL21 and BL21 DE3, both with and without pLS134. 
Samples were grown overnight, with or without IPTG induction, and the 
plasmid content of each sample was checked by gel electrophoresis of isolated 
DNA (Fig. 6.14). pLS135, the ori+ resolution product of pLS134, is approximately 
4 kb in size, and pLS134 is about 6 kb86.
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Figure 6.12. Maps of pSelect-1 and of Resolvase Expression Vectors 
pDB6001 and pDB6020.
To prevent overcrowding some promoter elements are shown, along with 
restriction enzyme sites, in polylinker boxes. The direction of transcription 
from these elements (when active) is indicated by a small arrow.
The ffla gene (Apr) in each plasmid contains a single base substitution 
which removes a Pst I site and abolishes gene function. The approximate 
position of this substitution is denoted by a white line in the gene symbol. 
Other pia sequences are present in pDB6001, but this truncated gene does 
not confer ampidllin resistance.
Tn3 _  
resolvase
Figure 6.13. Expression of Tn3 Resolvase from pDB6001.
Samples were grown to stationary phase, diluted 10-fold in media with or 
without IPTG, and then grown for 2 h further. Cells from each sample 
were harvested, lysed, and then analysed by denaturing PAGE.
Lane Sample
1 1 pi of R14 f46 Tn3 resolvase marker.
2 DS941
3 DS941 +IPTG
4 BL21
5 BL21 +IPTG
6 BL21 DE3
7 BL21DE3 +IPTG
8 DS941 pDB6001
9 DS941 pDB6001 +IPTG
10 BL21 pDB6001
11 BL21 pDB6001 +IPTG
12 BL21 DE3 pDB6001
13 BL21 DE3 pDB6001 +IPTG
As mentioned previously, growth of BL21 DE3 pDB6001 was very poor in  the 
presence of IPTG. In this case the same strain also grew poorly w ithout IPTG 
induction. No resolution of pLS134 was observed in any of the strains used, 
w ithout the presence of pDB6001. Surprisingly, inclusion of pDB6001 gave 
complete resolution of pLS134 in all three strains examined, regardless of IPTG 
induction. One possible explanation would be if DS941 and BL21 both contained 
a source of T7 RNA polymerase. However, other expression systems driven by 
T7 RNA polymerase have been shown to be inactive in DS941 (Fig. 6.14). An 
alternative explanation is that resolvase expression, in DS941 and BL21, is being 
driven by another promoter, upstream of the T7 promoter. No obvious candidate 
promoters were shown on maps of pSelect-1 but similar Tn7 polymerase- 
independent expression has been observed using other pSelect-1 derivatives (S. 
Bell; pers. comm.).
In some respects this basal expression of resolvase was fortuitous. As T7 RNA 
polymerase-directed expression of resolvase frompDB6001 inhibits cell growth, 
it is unsuitable for in vivo resolution assays. However pDB6001 in DS941 appears 
to give an acceptable resolution activity for screening of resolvase mutants.
6.8 Production of pDB6001 Compatible In Vivo Resolution Substrates.
Unfortunately pDB4, pDB5, pDB6 and pDB7 are incompatible with pDB6001, as 
they all have pBR322 replication origins. It was dedded to produce derivatives of 
pDB4, pDB5, pDB6 and pDB7 which were compatible with pDB6001 but would 
allow the same general screening method to be used. The following features were 
considered desirable in the new set of resolution substrates;
(i) pBR322-compatible origin of replication.
(ii) Antibiotic resistance marker other than Tcr or Apr . pDB6001 is Tcr and 
would be selected as Apr, following the pSelect-1 mutagenesis strategy.
(iii) Low plasmid copy number. Selection of gal’ cells containing galJC 
resolution products would be easier if segregation from a large number of 
unresolved resolution substrates was not required prior to detection.
The pSClOl plasmid occurs naturally in Salmonella panama, bu t can stably 
maintain six to seven copies per chromosome equivalent, in E. co//51. Although 
pSClOl encodes Tcr (this is the origin of the Tcr gene of pBR322) it is otherwise 
compatible with pBR322, and hence pDB6001 also. A 2,213 bp Hinc II/Rsa  I 
fragment of pSClOl, containing the replication region (for replication and 
partitioning of pSClOl), was purified, and Bam HI linkers were attached at each 
end (by S. Rowland). The Bam HI fragment was ligated to a Bam HI fragment
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pDB6001
pLS134
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Figure 6.14. In Vivo Resolution of pLS134 by pDB6001.
Strains with or without the resolution substrate pLS134, were transformed by 
pDB6001 (or pMA4727) and plated to selective media. Transformants were 
patched to fresh plates, grown, and then analysed by 'single colony' gel
electrophoresis. pLS135 is the ori+ resolution product of pLS134. pMA4727 is an 
expression vector with resolvase expressed from a T7 polymerase promoter.
Lane Sample Lane Sample
1 DS941 pLS134 11 BL21 pLS134
2 DS941 pLS134 +IPTG 12 BL21 pLS134 +IPTG
3 DS941 pDB6001 13 BL21 pDB6001
4 DS941 pDB6001 +IPTG 14 BL21 pDB6001 +IPTG
5 DS941 pDB6001 pLS134 15 BL21 pDB6001 pLS134
6 DS941 pDB6001 pLS134 +IPTG 16 BL21 pDB6001 pLS134 +IPTG
7 DS941 pMA4727 17 BL21DE3 pLS134
8 DS941 pMA4727 +IPTG 18 BL21DE3 pLS134 +IPTG
9 DS941 pMA4727 pLS134 19 BL21DE3 pDB6001
10 DS941 pMA4727 pLS134 +IPTG 20 BL21DE3 pDB6001 +IPTG
21 BL21DE3 pDB6001 pLS134
22 BL21DE3 pDB6001 pLS134 +IPTG
11 12 13 14 15 16 17 18 19 20 21 22
(-1.5 kb) of pUC4K, which carries a Knr gene. This generated two, similar Knr 
plasmids, pDB703 and pDB704 (Fig. 6.15). The difference between pDB703 and 
pDB704 is the relative orientation of the two cloned DNA fragments. Partial Pst I 
digestion, followed by complete Nde I digestion, of pDB703 and pDB704 allowed 
the production of two 3.06 kb DNA fragments, containing the pSClOl replication 
region and the Knr gene from pUC4K. Each of these fragments was ligated to a 
5.5 kb Nde I/P st I fragment (carrying both res (sub)sites and the galK cassette) of 
pDB4, pDB5, pDB6 or pDB7. The resulting plasmids were nam ed as shown in 
Table 6.4.
Resolution Substrate 
Derived From:
Substrate
Produced:
pDB703 +
pDB4 pDB34
pDB5 pDB35
pDB6 pDB36
pDB7 pDB37
pDB704 +
pDB4 pDB44
pDB5 pDB45
pDB6 pDB46
pDB7 pDB47
Table 6.4. Naming of New Resolution Substrates.
Constructs were made from both pDB703 and pDB704 in case transcription of the 
Knr gene in one direction caused problems. All substrates produced appeared 
viable and stable in DS941.
In vivo resolution of each new substrate was tested in DS941 pDB6001.
Competent DS941 was transformed with one of each of the new substrates. These 
transformants were then transformed with pDB6001, and grown on Mac Gal Tc 
Kn plates. Cells containing pDB6001 with pDB34 or pDB44 gave white colonies 
(resolution products), but no red colonies. No resolution was detected using the 
other substrates. DS941 containing pSClOl derived resolution substrates, but no 
pDB6001, gave only red colonies. Sample colonies were picked and analysed by 
the 'single colony gel' method. In all cases red colonies showed no resolution 
products, and white colonies contained a resolution product sized species, bu t no 
resolution substrate.
6.9 Directed M utagenesis of pDB6001.
pDB6001 was mutagenised following the pSelect-1 protocol (Chapter 2). The two 
mutagenic oligonucleotides used were a 27 bp 'Ampicillin Repair
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Figure 6.15. In Vivo Resolution Substrates, produced from pSClOl 
Derivatives pDB703 and pDB704.
Maps are shown for pDB703 and pDB704. Next to each m ap is a diagram 
showing the common features of the resolution substrates produced. The 
relative orientation of res sites in each plasmid is the same as for the 
substrate from which it was derived. For further details see Table 6.4 and 
Fig. 6.3.
Oligonucleotide' (identical to that supplied with the 'Altered Sites' kit62) and a 66 
bp degenerate oligonucleotide, designed to mutate codons 105 to 123 of Tn3 
resolvase (Chapter 2). Both oligonucleotides are complementary to the single 
stranded DNA produced from the fl replication origin of pDB6001.
A single base change has been engineered in pSelect-1, such that a Pst I site is 
removed and the pla gene no longer produces a functional enzyme. If the 
am pidllin repair oligonucleotide is annealed, and used to prime transcription, 
plasmids produced from the newly replicated strand are Apr . After in vitro 
replication, the mismatched plasmid is transformed to a repair deficient strain of 
E. coli, and eventually Ap1 transformants are selected. If the second mutagenic 
oligonucleotide anneals correctly, then most Apr plasmids produced contain its 
new sequence also. The first (5') 6 bases of the 66 bp degenerate oligonucleotide 
were synthesised as for a normal oligonucleotide, and so should not produce any 
mutations. The next 54 bases were synthesised using phosphoramidite reagents, 
each contaminated with small amounts of the three other nucleotide precursor 
reagents, such that an incorrect base should be inserted at an average of once per 
complete DNA molecule produced31. The final 6 bases were synthesised using 
uncontaminated reagents.
These two oligonucleotides were used to mutagenise pDB6001, but the Apr 
products isolated were all smaller than pDB6001, and did not contain an Xho I 
site introduced by the incorporation of the degenerate oligonucleotide. The tnpR+ 
fragment inserted to pSelect-1 to give pDB6001 (Fig. 6.12), also contained most of 
the Tn3 Pla gene (from the 5' end through to the Pst I site). This sequence is in the 
opposite orientation to the mutagenised pla of pSelect-1, and so large regions of 
complementary sequence will exist on each strand of pDB6001. Results of 
restriction analysis of the mutagenised pDB6001 species were consistent with 
their having arisen from rearrangement between the two, non-functional pla 
sequences present, to generate an Apr product.
To overcome this problem the tnpR+ Eco R l/Ssp  I fragment (-0.9 kb) of pDB6001 
was subcloned between the Eco RI and Sma I sites of pSelect-1, to give pDB6020 
(Fig. 6.12). This fragment contains no Tn3 pla coding sequences. In vivo resolution 
of pDB34, pDB35, pDB36, pDB37, pDB44, pDB45, pDB46 and pDB47 by pDB6020 
was as observed for pDB6001. However time did not permit further attempts at 
site-directed mutagenesis using pDB6020.
6.10 Conclusions.
Plasmids were produced to allow positive selection for in vivo resolution of a pah-
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of res sites; a res site and an isolated subsite I; and a pair of isolated subsite I 
elements. Using these plasmids no resolution of two isolated subsite I elements 
was detected in vivo or in vitro. Resolution with subsite I and a res site was 
detected at less than 1% of the level observed with a two res substrate, both in 
vivo and in vitro.
Chemical mutagenesis of resolvase expression vector pCIA70 did not produce 
resolvase mutants capable of directing in vivo resolution of a substrate containing 
two isolated subsite I elements.
A resolvase expression vector suitable for directed mutagenesis, pDB6020, was 
produced. Compatible resolution substrates carrying either two res sites, one res 
site and an isolated subsite I, or two subsite I elements, were also produced to 
allow screening of mutagenised pDB6020.
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Chapter Seven 
Discussion
7.1 Stoichiometry of complexes of Tn3 resolvase w ith res, subsite II, subsite 
(II +10) and subsite (II + 5).
Possible sources of error in the data used to determine stoichiometry values of 
complexes are discussed in Chapters 4 and 5. Relative stoichiometry values for 
complexes containing large amounts of material (e.g. complexes 1 and 2 for 
subsite (II + 10) or (II + 5)) should be least affected by such errors. The relative 
stoichiometry results suggest that the number of resolvase units per DNA site in 
each complex 2 is double that of complex 1. This resolvase/DNA value increases 
linearly for sequentially numbered complexes of res, with the possible exception 
of complex 5. The increase in the resolvase to DNA ratio between complexes 4 
and 6 is the same as that between complexes 2 and 4, and 1 and 3. Results 
produced for complex 3 of subsite II and (II + 10) and for complexes 3 and 4 
(combined) of subsite (II + 5) did not seem to fit so well to this general pattern. 
This may reflect genuine differences in the stoichiometry of (and nature of 
binding in) these complexes.
As calculated for complexes 1 and 2, the ratio of resolvase units per DNA site is
0.5:1. This is consistent with a resolvase unit which binds one DNA fragment to 
give complex 2 but makes contact with two DNA fragments in complex 1. This is 
unlikely as synapsed complexes would be expected to be more retarded than the 
complexes described. No complexes of intermediate mobility were detected in 
band shift assays containing different sized DNA fragments, carrying the same 
binding site. If the complexes are not generated by resolvase binding to more 
than one DNA fragment at a time (or by binding of truncated resolvase) then the 
binding unit m ust be a whole number of monomers, and the absolute 
stoichiometry of complex 2 must be 2,4 or a larger even integer.
Even taking into account the difficulties of accurately determining resolvase and 
DNA specific activities, the absolute stoichiometry value for each complex 2 
(Table 5.17) is clearly 2, rather than 4. Hence the binding unit is a resolvase 
monomer. For res, subsite II, subsite (II +10) and subsite (II + 5) complex 1 has 1 
resolvase monomer per DNA fragment, and complex 2 has two monomers per 
DNA site. Complexes 3,4 and 6 of res have, respectively, 3 ,4  and 6 resolvase 
monomers per DNA (complex 5 is expected to fit this pattern by containing 5 
resolvase monomers per res site). Based on the relative stoichiometry values 
produced, complex 3 of subsite II and of subsite (II + 10) are expected to contain 
more than 2 resolvase monomers (possibly 3) per DNA molecule. The third 
complex isolated from subsite (II + 5) is also expected to have more than two
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monomers per DNA molecule, and may have exactly three resolvase units per 
site. Alternatively the value determined may represent an average ratio 
produced from two complexes (complex 3 and 4, described in Chapter 3), which 
could not be differentiated in the large scale experiment used, but have different 
stoichiometries.
Subsites (II + 10) and (II +5) both produce large amounts of monomer bound 
complex, relative to subsite II. A time course of binding to subsite II showed 
similar levels of complex 1 in all samples, but complex 2 levels increased with 
time. The observed pattern of complex formation is consistent with complex 1 
being an intermediate in the formation of complex 2 from unbound DNA (Fig. 
3.3d). If complex 1 were only produced by dissociation of complex 2 (Fig. 3.3c) 
then the amounts of each complex would be expected to be directly related. In an 
equivalent analysis of binding to subsite (II + 10), levels of complex 1 and 2 both 
increased with time. These complexes could result independently from binding 
of resolvase monomer and dimer, respectively. Alternatively complex formation 
may be similar to that described for subsite n, but without the same degree of co- 
operativity of binding. As subsite (II + 10) complex 1 and 2 levels both increase 
with time, some or all of complex 1 could be a breakdown product of complex 2 
(Fig. 3.3c).
7.2 Resolvase-Induced Bending of Subsites II and (II +10).
Binding of a resolvase monomer to subsite II or to subsite (II + 10) produces a 
bend at the centre of the subsite. This may result from shuffling of the resolvase 
monomer (between positions on the subsite) producing bending at symmetrical 
points within the site, to give an averaged central bend (Fig. 7.1). With or without 
shuffling a resolvase monomer bound to part of the subsite could produce a bend 
directly at the subsite centre (or several bends, with an average at the centre). 
However, if resolvase binds primarily to sequences at the end of the subsite then 
the bend position of subsite (II + 10) would be expected to be displaced from that 
of subsite II, unless shuffling occurs, or the resolvase makes DNA contacts on 
both sides of the inserted sequences. As the actual position of resolvase-induced 
bends is not known it is difficult to interpret the slight increase in bending 
observed with subsite II complex 2. Similar analysis of subsite (II + 5) (or 
multiple copies of other subsites) may reveal information about the phase of the 
bend, or bends produced49. Resolvase-induced bending of res15, and of subsite I7 
was previously demonstrated. It appears that induced bending by binding of a 
monomer of resolvase is a common feature of binding to each subsite of res.
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(a)
Figure 7.1. Resolvase-induced Bending of a Subsite in Complex 1
Resolvase is represented by circles, and the DNA by lines, w ith boxes
indicating the subsites.
(a) Binding of a resolvase monomer, inducing a bend at the point of 
binding. Shuffling produces bending at each side of the subsite, 
giving an average bend positioned at the subsite centre.
(b) Binding of a resolvase monomer at one point of the subsite, 
producing a bend at the centre of the subsite. This could be the 
result of several bends, with an average at the centre, or of resolvase 
binding to several parts of the subsite, either side of the centre. It is 
not possible to portray the range of potential contacts made, or 
bends induced. This model neither requires nor excludes the 
possibility of shuffling.
7.3 Binding of Resolvase to a Partial Subsite.
W hen complex 1 of subsite (II + 10) and complex 1 of subsite (II + 5) were each 
shown to contain monomer-bound DNA it seemed possible that high yields of a 
monomer-bound species might be generated by binding to a DNA fragment 
containing half of subsite II (if subsite II complex 1 material does not accumulate 
because of rapid conversion to a dimer bound species). However no complexes 
were observed with approximate half-sites of a modified subsite (subsite IIBN). 
This may partly be the result of DNA substitutions made to allow the isolation of 
half-sites, as binding to the whole modified subsite was poor (compared to 
subsite II). Comparison with mutations made in y5 subsite I68 suggests that the 
mutations made to the right side of subsite II should not significantly reduce 
binding to that half. It has been shown that a DNA fragment containing more 
than half of Tn3 subsite I (right end 20 bp, of 28 bp total) generates only one faint 
complex with Tn3 resolvase7. The production of high yields of monomer-bound 
DNA may require more than one resolvase monomer target sequence per DNA 
fragment, to allow increased complex stability via shuffling. Alternatively a 
resolvase monomer bound at one 'half' of a subsite may normally contact 
sequences beyond the centre of the subsite. If shuffling does occur then the 
reduced binding of Tn3 resolvase to subsite IIBN could be accounted for by a 
reduced affinity of resolvase for the left end, and hence for the whole site.
7.4 Positioning of Resolvase on Subsites II, (II +10) and (II + 5).
DNase I footprinting of subsites n, (II + 10) and (II + 5) does not yield 
information about specific complexes, but did show cleavage protection and 
enhancement at equivalent positions in each subsite. Where examined, much of 
the additional sequence at the centre of subsites (II + 10) and (II + 5) was also 
protected by resolvase, without resulting in exposed regions not present with 
subsite II. For subsites II, (n + 10) and (n + 5) the strongest DNase I cleavage 
enhancement was at bonds between R1A and R2C, and between L4C and L6A 
(see Fig. 3.20). Positions R2G and L5G (on the complementary strand; see Fig. 
3.23) were shown, by methylation interference experiments, to be required for 
binding of resolvase. Methylation of L5G prevented any complex formation, but 
R2G is not required in the production of complex 1. This suggests that complex 1 
of subsites II, (II + 10) and (II + 5) may be generated by a resolvase monomer 
binding to the left hand side of the site (i.e. no shuffling). If shuffling does occur 
then the resolvase bound to give complex 1 may not make the same contacts as 
that in complex 2 (i.e. R2G is not required for complex 1). Previous methylation 
protection experiments have shown G residues at these (or adjacent) positions to 
be important in binding to each end of subsites I, II and III15'25. Methylation
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inhibition analysis of the complementary strand of each subsite should show if 
resolvase in complex 1 makes different contacts from that in complex 2 (i.e. 
whether L2G is required for complex 1).
7.5 Comparison of Binding of Tn3 Resolvase and y8 Resolvase.
As has been mentioned y8 resolvase is believed to be predominantly dimeric in 
solution34, and to bind to subsites of res as a dimer. Comparison of oxidised and 
reduced samples of the y8 mutant resolvase M106C by denaturing PAGE clearly 
demonstrated that a dimer sized species can be created as a result of the M106C 
substitution. However some monomer sized resolvase was present in the 
oxidised sample. The substitution in y8 M106C may alter its ability to form 
unlinked 1,2 dimers, compared with wild type y5 resolvase. The similarity of the 
pattern of complexes generated by binding of y8 resolvase and y8 M106C was 
striking. All complexes generated with y8 resolvase were also produced with y8 
M106C, although the titration range of y8 M106C appeared to be a little wider.
Table 7.1 shows the mobility of complexes generated by Tn3 or y8 resolvase with 
subsites II, (II + 10) and (II + 5), relative to the mobility of the unbound DNA. The 
same subsite DNA fragments were used with each resolvase. The complexes 
produced using y8 M106C ran in the same position as those for wild type y8 
resolvase.
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Binding
Site.
Complex
Number.
Mobility (mm). Relative Mobility. Tn3Rm/y8Rm
Tn3 y8 Tn3 y8 (%)
subsite
II
3 - 62 (48.35) 48.06 (100.60)
2 67 75 55.83 58.14 96.03
1 86 100 71.67 77.52 92.45
0 120 129 100.00 100.00 100.00
subsite
11+10
3 50 55 48.08 47.83 100.52
2 59 69 56.73 60.00 94.55
1 74 88 71.15 76.52 92.99
0 104 115 100.00 100.00 100.00
subsite
II+5
4 52 59 46.85 47.97 97.66
3 55 70 49.55 56.91 87.07
2 64 79 57.66 64.23 89.77
1 83 99 74.77 80.49 92.90
0 111 123 100.00 100.00 100.00
Table 7.1 Relative M obility of Complexes Generated w ith Tn3 or y8 
Resolvase.
Mobilities were measured (in mm) from an autoradiographs of the 
dried gels. Relative mobilities (Rm) are expressed as percentages. A 
ratio of the relative mobilities of complexes produced with each
resolvase (TnSRm/ySRm) is given, also as a percentage. Only two 
complexes (1 and 2) were detected for these Tn3 resolvase/subsite 
II samples. The complex 3 relative mobility shown in brackets was 
calculated from a different set of Tn3 resolvase/subsite II samples.
Complex 1 of subsite II with Tn3 resolvase appears similar to that produced with 
y8 or y8 M106C resolvase, suggesting that each may contain monomer bound 
DNA fragments. The slight difference in relative mobility may reflect a difference 
in the average bend induced on binding. The patterns of formation of complex 2 
are consistent with monomers of Tn3 resolvase binding co-operatively to give a 
dimer bound site, for a dimer of y8 M106C to bind directly to the subsite, and for 
wild type y8 resolvase to form complex 2 by both of these routes. As the least 
retarded y8 resolvase complex is assumed to contain monomer-bound DNA it is 
likely that monomers of y8 resolvase are present in solution. By comparison with 
the pattern of complexes produced with y8 M106C (allowing for the presence of 
monomer in this sample) it is probable that the equilibrium between dimeric and 
monomeric y8 resolvase, in solution, favours the dimeric species. It is unlikely 
that Tn3 resolvase is entirely monomeric in solution, but it appears that 
monomers are the predominant species. The third complex generated by Tn3 
resolvase with subsite II is believed to contain 3 resolvase monomers per DNA
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fragment. Methylation interference experiments did not indicate that any 
additional interactions (with G residues) were required to form this complex and 
so, if present, the third resolvase molecule may form protein to protein a n d /o r  
protein to DNA contacts. The third complex produced with y5 resolvase and y8 
M106C has a similar mobility as the Tn3 equivalent but, as M106C gives quite a 
strong complex 3 band, it would be surprising if they all contained 3 resolvase 
monomers per DNA fragment.
The comparatively low levels of complex 1 observed for binding of y8 resolvase 
or M106C with subsites (11 + 10) and (II + 5) strongly support the idea of y5 
resolvase being mostly, but not exclusively, dimeric and of Tn3 resolvase 
containing high levels of monomer. The small amounts of complex 1 produced 
do have a similar relative mobility to those with Tn3 resolvase. The second 
complexes produced with the different resolvases also migrate at a similar rate. 
Despite the y8 proteins' dimeric state, complex 2 is not the major band produced 
with subsite (II + 10) or subsite (II + 5). This may be due to the inability of pre­
formed dimers to fit to the altered spacing of the m utant sites (the subsite (II + 5) 
complex 2 band is weakest for both proteins). The equivalent complexes formed 
using Tn3 resolvase may not have interactions between the bound resolvase 
subunits. Such interactions, if present, are often associated with bending of the 
DNA site, but as binding of a resolvase monomer induces a DNA bend it is 
difficult to determine the presence or absence of further resolvase-induced 
bending.
Complex 3 of subsite (II + 10) with Tn3 resolvase is likely to be similar to that of 
subsite II. Complexes 3 and 4 of subsite (II + 5) might arise from different 
arrangements of the same number of molecules, or may, respectively, contain 3 
and 4 monomers of resolvase per DNA subsite. Because of the intensity of the 
third complex generated by wild type or M106C y8 resolvase with subsite 
(II + 10), it seems probable that it will contain a whole number of dimers 
(presumably 2) per subsite. For subsite (II + 5) with y8 resolvase complex 3 is 
faint, but with M106C it is barely visible. Complex 4 appears strong for both, 
very much like the third complex generated with subsite (II + 10). These 
observations would be consistent with subsite (II + 5) complex 3 and 4 
containing, respectively, 3 and 4 monomers of resolvase per DNA fragment.
7.6 Summary of Features of Binding of Tn3 resolvase.
Fig. 7.2 summarises the proposed composition of complexes generated by Tn3 
resolvase with Tn3 res, subsite II, subsite (II + 10) and subsite (II + 5). It is
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Figure 7.2. Summary of Composition of Complexes formed with Tn3 
Resolvase.
'U' indicates an unbound DNA fragment. Complexes are num bered in 
order of decreasing mobility. Resolvase is represented by circles, and the 
DNA by lines, with thicker lines indicating die subsites.
Stoichiometries indicated for res complex 5; subsite II complex 3; subsite 
(n +10) complex 3; and subsite (II + 5) complexes 3 and 4, are inferred as 
a result of successive monomer-binding steps. The positioning of 
resolvase on the DNA is not intended to exclude the possibility of other 
arrangements of resolvase (e.g. one monomer binding to several points 
across the subsite). As no additional methylation interference was 
observed with higher complexes of subsite II, (II + 10) or (II + 5), some 
resolvase in these complexes is shown not contacting the DNA. There is, 
as yet, no evidence to suggest whether or not this is the case.
believed that binding of a Tn3 resolvase dimer to each subsite of res is co­
operative but this may not be true of the subsite II derivatives produced. The 
arrangement of resolvase subunits in complex 3 of subsites II and (11 + 10) and 
complexes 3 and 4 of subsite (II + 5) is unknown. It is expected that, as for y8 
resolvase with y8 res, higher order interactions occur in fully occupied Tn3 res 
sites, and that shuffling of resolvase occurs between subsites of res28'72.
It is proposed that the data presented indicate that each complex produced by 
binding of Tn3 resolvase res represents successive binding of a resolvase 
monomer to one half of a res subsite, until all subsites are bound by a dimer of 
resolvase. Complexes of subsite II (and its derivatives) are also believed to be 
formed by successive monomer binding, but higher complexes (i.e. complex 3 
and 4) represent 'overloading' of the subsites, compared with those in res. The 
occupation of subsites (or half-subsites) by resolvase appears not to follow just 
one order, and probably varies in a manner reflecting the affinity of resolvase for 
each binding site. Shuffling of resolvase between subsite halves (on the same 
DNA fragment) is the most likely explanation of the stability of complexes 
during the band shift assay. However, simple interpretation of the results of 
methylation interference experiments disputes this feature of resolvase binding 
(section 3.8). Although this model of binding of Tn3 resolvase to res is based on 
binding of resolvase monomers, it is unlikely that Tn3 resolvase is exclusively 
monomeric in solution, but binding of resolvase dimers would not be expected to 
produce additional complexes to those described for monomer binding.
7.7 Band Shift Assay Conditions.
Experiments to compare the importance of conditions used for band shift assays 
have shown that the pattern of complexes observed does vary with the 
conditions used. However subsequent experiments have demonstrated a 
significant difference in the nature of binding of Tn3 and y8 resolvases. The 
differences between Tn3 and Tn21 binding patterns are also likely to result from 
differences in the ratio of monomeric and dimeric species present in solution.
7.8 Mutagenesis of Tn3 Resolvase.
The search for mutants of Tn3 resolvase which can direct resolution of two 
isolated subsite I's was unsuccessful (as were tests for equivalent mutants of y5 
resolvase: M. Boocock; pers. comm.). The alignment of FlS-independent 
mutations26'43 with the 1,2 dimer interface of y8 resolvase74 suggests an obvious 
target region for future attempts to produce such mutants. Secondary mutations 
which give FIS-dependent revertants of FIS-independent Gin mutations were all 
positioned around the N-terminal end of Gin (R. Kahmann; unpublished data.),
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i.e. GinMV114 is a FIS-independent mutant, GinMV114/KE34 is FIS-dependent 
but recombination proficient and GinKE34 exhibits no detectable recombination 
activity. Some of the mutations which give rise to FIS-dependent revertants are 
amino acid substitutions, which coincide with the position of substitutions in y8 
resolvase which abolish recombination activity but do not prevent binding to 
res33. However these mutations do prevent formation of higher order structures 
such as the 'resolvosome'. These residues are positioned at the crystallographic 
2 , 3 / 2 ' tetramer interface74, and such an interaction could be involved in y5 
synapsis. There are certain problems in interpreting the crystallographic data, 
particularly as the active site S10 residues in a 1,2 dimer are separated by more 
than 3 nm, too far apart to allow interaction with the correct phosphodiester 
bonds at the centre of subsite I74.
Considering a simplistic model of inversion, it might be expected that FIS- 
independent mutants were made 'sticky ' enough to hold together a synapse, and 
direct strand exchange without the assistance of FIS44. It would be surprising if 
these mutations were strengthening the interface between Gin monomers bound 
to the same gix site (it has been indirectly demonstrated that Gin binds gix as a 
monomer: R. Kahmann; unpublished data.). However this interface may be 
important in stabilising the synapse during strand exchange, or at some other 
point, due to a conformational change during, or following, synapsis.
The range of iteration products created by y8 resolvase and by Tn3 resolvase with 
'mismatch' substrates (described in Chapter 1) suggests that the y8 resolvase 
synapse remains intact under conditions in which the Tn3 synapse dissociates81 
(but can reform). Further analysis would be required to determine whether the y8 
synapse is strengthened in a way which would make y8 resolvase a preferable 
subject for production of an accessory-site-independent resolvase.
7.9 Future Experiments.
Methylation interference experiments conducted on the second strand of subsites 
II, (II +10) and (II + 5) would give more information about where complex 1 
resolvase is bound. Use of other modification interference methods (e.g. 
ethylation) would give information about other bases in the subsites. By only 
considering G residues at present, our picture of the contacts that resolvase 
makes with the DNA may be somewhat misleading. Substitution of certain 
residues required for complex formation (e.g. L2G or R2G) could provide further 
information about the position of resolvase in different complexes. If shuffling is 
required for stable complex formation then it would be expected that both of the
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substituted sites would fail to generate complex 1. However if a subsite 
containing both substitutions produced complex 1, then neither position would 
be involved in the contacts required for monomer binding. If only one of the 
mutated sites failed to generate complex 1 then it would appear that resolvase 
occupies the subsite in a non-random order. Substitution of other bases in parts 
of the subsite (by introduction of degeneracy during oligonucleotide synthesis, or 
by a forced misincorporation technique) may provide information for a greater 
number of the DNA positions than modification interference would allow. 
M utant subsites may also reveal the smallest partial subsite required for binding 
of a single resolvase monomer. At present this would appear to require more 
than half of subsite II.
The alteration in the phase of the binding sites in subsite (II + 5) makes it an 
interesting substrate for bending analysis. Some indication of the phase of the 
resolvase-induced bends in subsite II could be produced by bend analysis of 
DNA fragments containing two copies of the subsite, separated by different 
lengths of sequence (e.g. by 5,7, and 10 bp).
If bending of DNA in complex 1 is produced by resolvase binding at several 
points across the subsite, then it may be possible to produce truncated forms of 
resolvase which would not make the full range of contacts, and hence not induce 
the same bend.
Alteration of the tnpR gene to allow production of a m utant resolvase with 
additional C-terminal residues could assist in the identification of the 
stoichiometry of subsite (n +10) complex 3 and of subsite (II + 5) complexes 3 
and 4. A short run (about 20) of amino acids added to the C-terminal sequence of 
resolvase could alter the mobility of complexes generated by binding of the 
m utant (especially if charged residues are added)49. Band shift analysis using a 
mix of wild type and m utant resolvase would be expected to produce complexes 
of intermediate mobility, e.g. with subsite (II + 10) the following would be 
expected; two 'complex V  bands (one for each resolvase), three 'complex 2' bands 
(two homodimer complexes, 1 heterodimer band); (possibly) four 'complex 3' 
bands (two homotrimers, two heterotrimers). Separation of complexes and 
identification of weak bands could be problematic, but conditions could be 
varied so that not all complexes were produced in all samples7. Such a mutation 
could affect the binding properties of the resolvase produced, but may not. A Gin 
m utant of this type of has been created, carrying an antibody epitope at its C- 
terminus (R. Kahmann; unpublished data.). This m utant invertase binds
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normally and has been used in experiments which suggest that Gin binds as a 
monomer, and dimerises on the gix site. Similar results would be expected of 
equivalent experiments with Tn3 resolvase, but not y5 resolvase.
After further characterisation of binding to subsites II, (II + 10) and (II + 5), it may 
prove desirable to produce other sequence insertions (both larger and smaller), 
and perhaps deletions, at the centre of subsite n. Unfortunately the binding 
characteristics of subsite IIBN make it unsuitable for production of other subsite 
derivatives. At present there is no obvious rationale for substituting subsite II in 
res with subsite II derivatives.
The resolvase expression vector pDB6020 will hopefully prove suitable for many 
site-specific and site-directed mutagenesis strategies, particularly a further search 
for an accessory-site-independent resolvase. It may prove worthwhile to 
introduce unique restriction sites within the resolvase coding region of pDB6020, 
via silent mutations, as this would allow cassette mutagenesis of the 1,2 dimer 
interface region, and create a cassette mutagenesis template for future 
mutagenesis projects. Silent mutations which introduce restriction sites can be 
produced simply in pDB6020 using the pSelect mutagenesis strategy.
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